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Abstract
The parasite Cryptosporidium is a global cause of diarrheal disease resulting in death, malnutrition, and
stunted growth in young children and animals. There is no vaccine and treatment options are limited
within these patient populations, underscoring the need for the development of novel therapeutics.
Cryptosporidium infects epithelial cells in a specialized intracellular, but extracytoplasmic niche.
Following the establishment of infection, cells exhibit profound changes in morphology, physiology, and
transcriptional activity. While it is unknown how the parasite induces these changes, host-targeted
parasite effectors have been hypothesized to be driving factors, though none have been identified. We
utilized genetic approaches to visualize the localization of highly polymorphic proteins and found
members of the C. parvum MEDLE protein family exported to the cytosol of infected cells. The MEDLE2
protein is constitutively translocated across the lifecycle of the parasite by an export machine installed
following the establishment of infection. Here we use genetic approaches to map the cellular and
molecular requirements for export and define a pathway that directs proteins to the host cell across all
intracellular life stages of Cryptosporidium. Proper host targeting of MEDLE2 required an intrinsically
disordered structure and an N terminal signal peptide and export sequence. Introduction of ordered
domains or targeted mutagenesis of these export sequences prevented targeting to the host cell. Direct
expression of MEDLE2 in mammalian cells was sufficient to trigger an ER stress response, which was
similarly observed during infection. Finally, MEDLE2 was also used to deliver model antigens to the host
cell to drive the expansion of model antigen specific T cells, thus establishing new tools to interrogate
host-pathogen interactions. Taken together, our studies reveal a Cryptosporidium secretion system
capable of delivering effector proteins into the infected enterocyte. The discovery of parasite effectors
that influence the host cell generates novel tools that may be utilized to generate a more complete
understanding of the host-parasite interactions to inform the development of future prophylactic
treatments.
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ABSTRACT

CRYPTOSPORIDIUM PARVUM EXPORTS PROTEINS TO ITS
EPITHELIAL HOST CELL
Jennifer Dumaine
Boris Striepen

The parasite Cryptosporidium is a global cause of diarrheal disease resulting in
death, malnutrition, and stunted growth in young children and animals. There is
no vaccine and treatment options are limited within these patient populations,
underscoring the need for the development of novel therapeutics.
Cryptosporidium infects epithelial cells in a specialized intracellular, but
extracytoplasmic niche. Following the establishment of infection, cells exhibit
profound changes in morphology, physiology, and transcriptional activity. While it
is unknown how the parasite induces these changes, host-targeted parasite
effectors have been hypothesized to be driving factors, though none have been
identified. We utilized genetic approaches to visualize the localization of highly
polymorphic proteins and found members of the C. parvum MEDLE protein
family exported to the cytosol of infected cells. The MEDLE2 protein is
constitutively translocated across the lifecycle of the parasite by an export
machine installed following the establishment of infection. Here we use genetic
approaches to map the cellular and molecular requirements for export and define
a pathway that directs proteins to the host cell across all intracellular life stages
of Cryptosporidium. Proper host targeting of MEDLE2 required an intrinsically
disordered structure and an N terminal signal peptide and export sequence.
vii

Introduction of ordered domains or targeted mutagenesis of these export
sequences prevented targeting to the host cell. Direct expression of MEDLE2 in
mammalian cells was sufficient to trigger an ER stress response, which was
similarly observed during infection. Finally, MEDLE2 was also used to deliver
model antigens to the host cell to drive the expansion of model antigen specific T
cells, thus establishing new tools to interrogate host-pathogen interactions.
Taken together, our studies reveal a Cryptosporidium secretion system capable
of delivering effector proteins into the infected enterocyte. The discovery of
parasite effectors that influence the host cell generates novel tools that may be
utilized to generate a more complete understanding of the host-parasite
interactions to inform the development of future prophylactic treatments.
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Chapter 1: Introduction
1.1 Cryptosporidiosis: A Global Public Health Problem
The apicomplexan parasite Cryptosporidium is a leading cause of
diarrheal disease worldwide. Infectious diseases accounted for nearly 2/3
of the deaths in children under 5 years of age in 2010, with pneumonia
and diarrhea being leading causes of childhood mortality (James et al.,
2018). More specifically, 1 in 10 childhood deaths during the first 5 years
of life is attributable to diarrheal diseases, with the greatest number of
fatalities occurring in sub-Saharan Africa and southeast Asia (James et
al., 2018; Liu et al., 2012) . Following these observations, two large scale
studies sought to determine the causative agents of childhood diarrheal
disease responsible for these deaths through longitudinal observation of
enrolled study populations. Despite differing study designs and
participant cohorts, both the Global Enteric Multicenter Study (GEMS) and
Global Burden of Disease (GBD) studies concluded that Cryptosporidium
is a leading cause of diarrheal mortality (Kotloff et al., 2013; Troeger et al.,
2017). The incidence of Cryptosporidium infection is highest in the first
two years of life, with the contribution to global childhood diarrheal
mortality decreasing after this point (Kotloff et al., 2013; Troeger et al.,
2017). Infection with the parasite results in protective immunity, but this
immunity is not sterile and may require multiple exposures to develop,
likely explaining the decrease in cryptosporidiosis incidence with age
(Chappell et al., 1999; Kabir et al., 2021; Kotloff et al., 2013; Okhuysen et
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al., 1998). Children in resource poor settings carry a disproportionate
burden of severe disease (Choy and Huston, 2020; Korpe et al., 2016;
Korpe et al., 2018; Troeger et al., 2017). Malnutrition enhances the risk of
severe cryptosporidiosis, and at the same time, the disease impacts the
nutritional state, which can lead to impaired growth (Checkley et al., 1998;
Costa et al., 2011; Mondal et al., 2009; Moore et al., 2010).
Cryptosporidium affects childhood health beyond acute illness,
quantifiable by a measure of Disability Adjusted Life Years (DALYs) (Checkley et
al., 1997; Korpe et al., 2016). The contribution of Cryptosporidium to DALYs is
explained by growth faltering as a consequence of infection (lower height and
weight), which leads to additional poor health outcomes, such as increased risk
for developing cardiac and metabolic diseases later in life (Checkley et al., 1998;
Checkley et al., 1997; Khalil et al., 2018; Korpe et al., 2016). Initiatives to
improve access to safe water and sanitation have decreased the DALYs lost due
to diarrheal disease in recent years, highlighting the contribution of these factors
to the global burden of enteric diseases (Troeger et al., 2017). Cryptosporidiosis
also results in economic losses in endemic areas and following spontaneous
outbreaks in other regions through costs associated with disease treatment and
reducing productivity in the work force (Corso et al., 2003; Rafferty et al., 2017).
Taken together, the morbidity and mortality associated with Cryptosporidium
infection underscore the urgent public health problem surrounding this pathogen.
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1.1.1 Epidemiology of Cryptosporidiosis
The first human Cryptosporidium infections were reported in 1976
in two individuals living in rural areas and having close contact with
animals, illuminating the potential contribution of zoonosis in disease
transmission (Meisel et al., 1976; Nime et al., 1976). Simultaneous case
studies detail self-limiting enterocolitis in an otherwise healthy 3-year-old
child and a more protracted case of severe watery diarrhea in an
immunosuppressed 39-year-old man (Meisel et al., 1976; Nime et al.,
1976). In both cases, histological staining of bowel biopsy samples
revealed Cryptosporidium as the etiological cause of diarrhea; however,
the clinical disease progression vastly differed in the two patients (Meisel
et al., 1976; Nime et al., 1976). Symptomatic infection in the 3-year-old
child resolved with minimal intervention apart from hydration support,
while diarrheal episodes did not subside in the immunosuppressed 39year-old man until 2 weeks following cessation of immunosuppressive
drug administration (Meisel et al., 1976; Nime et al., 1976). These first
reports of human Cryptosporidium infections illustrate the dichotomy in
clinical disease influenced by a multitude of factors governing host
susceptibility to infection and clinical outcome. Disease progression and
susceptibility to Cryptosporidium infection varies based upon host
immune status, age, and nutritional state in infected humans and
animals.
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1.1.2 Cryptosporidiosis in Immunocompromised Individuals
Recognition of Cryptosporidium as a cause of gastrointestinal
disease in humans was concurrent with the acquired immunodeficiency
syndrome (AIDS) epidemic of the 1980’s. Clinical disease caused by
cryptosporidiosis is characterized by watery diarrhea, nausea, vomiting
and stomach cramping. A Centers for Disease Control and Prevention
(CDC) Morbidity and Mortality Weekly Report (MMWR) described
cryptosporidiosis outbreaks in 12 immunocompetent individuals as
presenting with the aforementioned symptoms, but that symptomatic
infection spontaneously resolved within one month of onset (Anonymous,
1982). However, a second MMWR detailing disease progression in 21
AIDS patients described chronic, unrelenting and potentially life
threatening infections (1982). Due to the increased incidence of
Cryptosporidium infections observed within the AIDS patient population,
cryptosporidiosis received designation as an AIDS-defining opportunistic
infection in human immunodeficiency virus (HIV) infected individuals
(Petersen, 1992). Patients within HIV+ community exhibited heterogeneity
in disease progression, with some patients exhibiting self-limiting
symptoms, while others experienced recurring, chronic or deadly
infections that could result in extraintestinal disseminated infections to the
biliary duct or the lungs (Chen et al., 2003; Petersen, 1992). A prospective
study in AIDS patients in Spain with chronic diarrhea showed
extraintestinal infection was present in 30% (13/43) patients with
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diagnosed intestinal cryptosporidiosis, with parasites detectable in bile
and sputum (López-Vélez et al., 1995).
It is now recognized that the number of CD4+ T cells present can
serve as a predictive correlate of disease severity for cryptosporidiosis.
CD4+ T cell counts below 200 cells/ mm3 of blood are associated with
increased risk for developing Cryptosporidium infection and indicates poor
disease prognosis (Ahmadpour et al., 2020; Blanshard et al., 1992;
Manabe et al., 1998; Soave et al., 1984). This was exemplified in a
London based study of a HIV+ patient population where 5% of all HIV+
patients were diagnosed with cryptosporidiosis, while 21% of AIDS
patients (CD4+ T cell counts < 200 cells/ mm3) received the same
diagnosis (Blanshard et al., 1992). Patients with the lowest CD4+ T cell
counts (less than 50 / mm3) survived for a median of 5 weeks compared
to 36 weeks for those with higher CD4+ T cell counts and transient
infections (Blanshard et al., 1992). Treatment with highly active
antiretroviral therapy (ART) decreases the risk for Cryptosporidium
infection, likely due to improved CD4+ T cell counts (Ahmadpour et al.,
2020). Similarly, treatment of mice with a CD4+ neutralizing antibody
increases susceptibility to Cryptosporidium infection, supporting that the
heightened susceptibility of AIDS patients to Cryptosporidium is a
consequence of the loss of CD4+ T cells due to HIV (Ungar et al., 1991).
Together these observations highlight the importance of CD4+ T cells in
performing critical effector functions to limit Cryptosporidium infections.
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Additional groups of immunocompromised patients exhibit
increased susceptibility to Cryptosporidium infections. Most notably
patients with primary immunodeficiencies and those undergoing
immunosuppressive therapies have an increased risk for becoming
infected with Cryptosporidium and developing severe disease, particularly
those with diseases or treatments impacting CD4+ T cell numbers (Hunter
and Nichols, 2002). Cryptosporidium infections have been reported in
children with severe combined immune deficiency syndrome (SCID), Xlinked hyperimmunoglobulin M syndrome (CD40 ligand deficiency), and
primary CD4 lymphopenia (Dupuy et al., 2021; Kocoshis et al., 1984;
Levy et al., 1997; Wolska-Kusnierz et al., 2007). Furthermore, patients
with reduced CD4+ T cell counts as a result of immunosuppressive
therapies for transplantation or cancer treatment have heightened risk for
developing infection (Florescu and Sandkovsky, 2016; Sreedharan et al.,
1996). While the molecular mechanism underlying each of these
syndromes varies, in every case, the patients presenting with
cryptosporidiosis exhibited disseminated infections (lungs and bile duct)
characterized by protracted, and in some cases fatal, infections.
1.1.3 Cryptosporidiosis in Children
Cryptosporidiosis presents as acute enterocolitis that is typically
acute and self-limiting in immunocompetent children; however, due to the
volume of water lost during diarrheal episodes, hydration with
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supplemental fluids may be required during symptomatic infection (Borad
and Ward, 2010; Nime et al., 1976). The large-scale multicenter GEMS
study published in 2013 identified Rotavirus, Cryptosporidium,
enterotoxigenic Escherichia coli producing stable toxin (ST-ETEC) and
Shigella, respectively, as the leading causes of diarrheal disease in
children under the age of 5 (Kotloff et al., 2013). Cryptosporidium infection
was found to be a major risk factor (Hazard Ratio 2·3; 95% CI; 1·3 - 4·3)
for premature death in children aged 12-23 months (Kotloff et al., 2013).
The adjusted attributable fraction for contribution to moderate to severe
diarrhea caused by Cryptosporidium infection is highest in weaned infants
until 2 years of age, but gradually declines after age 24 months for
populations studied in The Gambia, Mali, Mozambique, Kenya, India,
Bangladesh, and Pakistan (Kotloff et al., 2013; Troeger et al., 2017). The
inverse relationship between incidence of cryptosporidiosis and age is
thought to be a consequence of immunity developed following multiple
exposures to infection throughout early childhood (Chappell et al., 1999;
Kabir et al., 2021; Kotloff et al., 2013; Okhuysen et al., 1998).
Cryptosporidium infection disproportionately infects children in resource
poor settings due to a combined effect between the fecal oral
transmission of the parasite, limited sanitation and water availability, and
the complex interplay between malnutrition and disease (Choy and
Huston, 2020; Mondal et al., 2009; Moore et al., 2010).
Childhood Cryptosporidium infection has lasting adverse effects
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apart from the period of acute disease (Khalil et al., 2018). Both
symptomatic and asymptomatic cryptosporidiosis result in growth
faltering, as evident with reduced height and weight (lower height-for-age
Z scores), and delayed growth catch up (Checkley et al., 1998; Checkley
et al., 1997; Moore et al., 2010). Cryptosporidium infection reduces
nutrient absorption due to altered tissue structure and physiology caused
by the infection (Adams et al., 1994; Kumar et al., 2018). As a result,
infection itself can lead to changes in nutrient state within the host. Case
control studies caried out on populations of children in Guinea-Bissau
(Mølbak et al., 1997) and Brazil (Agnew et al., 1998) revealed changes in
nutrition status following Cryptosporidium infection. Malnourished children
are also at higher risk for developing severe cryptosporidiosis. Studies
carried out in children in Peru (Sarabia-Arce et al., 1990) and Bangladesh
(Mondal et al., 2009) indicated that malnourished children are at
increased risk for experiencing Cryptosporidium infection. Similarly, in a
murine model of malnutrition, experimental challenge infection with
Cryptosporidium resulted in increased levels of parasite shedding and
exacerbated weight loss following infection (additional 20% lost) (Costa et
al., 2011). Malnutrition predisposes children to Cryptosporidium infection,
but because Cryptosporidium infection itself modulates nutrient
absorption, a cycle of malnutrition and reinfection emerges, the underlying
mechanism remains poorly characterized and warrants further studies to
better understand the interplay between infection and nutrition.
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1.1.4 Cryptosporidiosis in animals
The veterinary importance of cryptosporidiosis was recognized
following the first reported bovine Cryptosporidium infection; however,
because the case involved coinfection with other viral and bacterial
pathogens, the clinical consequences of Cryptosporidium infection were
not fully appreciated until the development of experimental models of
infection (Panciera et al., 1971). Neonatal calves infected with purified
Cryptosporidium oocysts exhibited severe diarrhea (Tzipori et al., 1983).
Experimentally infected calves and piglets revealed gross abnormalities
of the intestinal epithelial cell morphology due to infection, with stark
differences in the villous structure and overall shape and organization of
the cell monolayer as a consequence of infection (Heine et al., 1984;
Tzipori et al., 1982). Animals that resolve Cryptosporidium infections
exhibit reduced growth due to reduced nutrient absorption from altered
villous structure as a consequence of the infection (Checkley et al., 1998;
Checkley et al., 1997; Thomson et al., 2017). The high mortality rate,
together with the cost of treatment, contributes to cryptosporidiosis being
a cause of economic loss in the sheep and cattle industries (Thomson et
al., 2017).
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1.2 Cryptosporidium the organism
Cryptosporidium is a single-celled protozoan parasite belonging to the
phylum Apicomplexa. Ernest Edward Tyzzer was the first to identify
Cryptosporidium in the gastric glands of laboratory mice (Tyzzer, 1907, 1910).
Originally it was thought the genus Cryptosporidium was monospecific; however,
extensive population genetic studies allowed the monolithic Cryptosporidium to
be replaced by a multitude of species, sub species, and strains (Checkley et al.,
2015; Xiao et al., 1999). Following the International Code of Zoological
Nomenclature guidelines (ICZN), Cryptosporidium species determination is made
based upon natural host specificity and molecular genotyping (ICZN, 1999). PCR
amplification of multiple loci encoding microsatellites and species-specific
heterogenic target genes has become the gold standard for species identification
(Xiao, 2010). In particular, the 60 kDa glycoprotein (gp60) exhibits interspecific
variation and is recognized as the single most polymorphic marker identified in
the Cryptosporidium genome, making this locus commonly targeted for
genotyping efforts (Xiao, 2010). Additionally, whole genome sequencing has
revealed other candidate loci demonstrating interspecific polymorphisms, such as
small subunit (SSU) rRNA, HSP-70, TRAP-C1, COWP, gp900 (Xiao, 2010; Xiao
et al., 1999). These polymorphic genes include those found on the parasite
surface, on the oocyst wall or on sporozoite surface with speculated roles in cell
adhesion (Xiao, 2010; Xiao et al., 1999). Cryptosporidium speciation appears to
be driven by host adaptation resulting in narrowing specialization, however, the
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sexual lifecycle of the parasite and frequent coinfections within the same host
allows for regular recombination events and rapid convergent evolution of host
specificity (Guo et al., 2015; Nader et al., 2019).
There are 38 different Cryptosporidium species are recognized by the
scientific community (Baptista et al., 2021). Most species are adapted to a single
host taxon, with Cryptosporidium species’ range encompassing fish to mammals
(Baptista et al., 2021). Of these, 9 species have been identified as having natural
mammalian hosts: C. parvum (calves), C. hominis (humans), C. wrairi (guinea
pigs), C. andersoni (mainly yearlings and adult cows), C. muris (mice), C. canis
(dogs) C. felis (cats), C. cuniculus (rabbits), and Cryptosporidium Chipmunk
genome I (Chalmers, 2012; Xiao, 2010; Xiao et al., 2004).

1.2.1 Cryptosporidium metabolism
All Cryptosporidium species infect epithelial cells and largely rely upon
uptake of host nutrients and metabolites due to the greatly reduced metabolic
capabilities of the parasite (Abrahamsen et al., 2004; Xu et al., 2004).
Cryptosporidium lacks a functional mitochondrion and instead utilizes a
degenerate mitochondrion-like organelle known as the “mitosome” (Abrahamsen
et al., 2004; Keithly et al., 2005; Liu et al., 2016; Xu et al., 2004). The primary
energy demands of the parasite are met through glycolysis. Cryptosporidium
exhibits a reduction in anabolic enzymes, requiring alternative mechanisms for
the parasite to acquire such resources. Sequencing analysis reveals an
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expanded number of amino acid and sugar transporters to scavenge nutrients
and metabolites (Abrahamsen et al., 2004; Baptista et al., 2021; Guérin and
Striepen, 2020; Liu et al., 2016; Xu et al., 2004).
Not only do Cryptosporidium species exhibit differences in genetic
sequences and natural hosts, but there are also recognized differences in
parasite biology between species. C. andersonii and C. muris live in the
epithelium of the gastric glands of the host, while the other mammalian inhabiting
Cryptosporidium species reside in the epithelium of the distal small intestine.
Comparative genetic analysis has revealed differences in metabolic capabilities
between gastric residing (C. andersonii) and intestinal dwelling Cryptosporidium
species (C. ubiquitum and C. parvum) (Liu et al., 2016). More specifically, C.
andersonii exhibits divergent mitosome metabolic capabilities from other
Cryptosporidium spp., by encoding a complete set of enzymes for the
Tricarboxylic Acid Cycle (TCA) cycle in addition to glycolysis (Liu et al., 2016).
Furthermore, intestinal dwelling species exhibit a progressive reduction in the
enzymes of the electron transport chain (ETC) when compared to the gastric
residing species. For example, C. andersonii possesses the NADH
dehydrogenase (Complex I), succinate dehydrogenase (Complex II) and 1
subunit of ubiquinol-cytochrome c oxidoreductase (Complex III), while the
genome of the intestinal resident C. parvum only encodes the NADH
dehydrogenase (Liu et al., 2016). As a result, it is hypothesized that
Cryptosporidium spp. have undergone reductive evolution due to the nutrient
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availability of the niche in which they reside. In support of this, intestinal resident
species C. parvum and C. hominis, have acquired the tryptophan synthase gene
(cgd5_4560) to catalyze the biosynthesis of tryptophan from serine and indole
produced by intestinal bacteria, while the corresponding gene is lacking in gastric
dwelling species where the microbiome is absent (Liu et al., 2016).
In contrast to other Apicomplexa, Cryptosporidium has lost its apicoplast, a
non-photosynthetic plastid organelle originating from algae through a secondary
endosymbiotic event (Figure 1.1; (Abrahamsen et al., 2004; Guérin and
Striepen, 2020). Consequently, Cryptosporidium spp. have lost the capability to
synthesize isoprenoids, fatty acids, and heme ordinarily carried out within this
organelle in other apicomplexans (Guérin and Striepen, 2020).

1.2.2 Cryptosporidium secretory organelles
While the biology of Cryptosporidium has diverged from its Apicomplexan
relatives, the structural elements required for classification as Apicomplexa
remain conserved (Figure 1.2). Cryptosporidium exhibits the hallmark structures
present in the apical complex characteristic of the phylum Apicomplexa. The
anterior portion of the infective life stage of the parasite is comprised of
supportive cytoskeletal components such as the conoid, the polar rings, and the
sub-pellicular microtubules (Adeline, 2011; Matsubayashi et al., 2008); (Figure
1.2). Apicomplexa, including Cryptosporidium, possess three distinct types of
secretory organelles, which can be distinguished from one another based upon
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morphology and localization within the parasite (Guérin and Striepen, 2020). The
rod shaped micronemes localize most anteriorly and are the first to discharge
their protein contents in a Calcium-dependent manner during parasite invasion of
host cells (Chen et al., 2004; Lumb et al., 1988). Cryptosporidium has a single
club shaped rhoptry organelle, protein thought to expel protein contents used for
invasion and establishment of infection following contact with a host cell (Chen et
al., 2004; Keithly et al., 2005; Matsubayashi et al., 2008). Dense granules are
localized both at the anterior and posterior ends of the parasite and are the last
to secrete proteins during and post-invasion (Adeline, 2011; Chen et al., 2004;
Matsubayashi et al., 2008) (Figure 1.1, Figure 1.2).
1.2.3 Cryptosporidium invasion
The polarization of the parasite is important for the establishment of
infection. The apical end containing the secretory organelles is oriented towards
the host cell during invasion (Figure1.2; (Lumb et al., 1988). The establishment
of Cryptosporidium infection is a rapid process culminating in membranous
encasement of the parasite to form a new intracellular compartment referred to
as the parasitophorous vacuole (PV) (Guérin and Striepen, 2020; Lumb et al.,
1988). The unique niche in which Cryptosporidium resides has been described
as “intracellular but extracytoplasmic,” meaning the parasite lives within the cell,
but that this localization is discrete from the host cell cytoplasm (Elliott and
Clark, 2000). Electron micrographic observation of Cryptosporidium reveals a
dense actin band at the host parasite interface parasite under the site of
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infection (Chen and LaRusso, 2000; Elliott and Clark, 2000) (Figure 1.3). Two
host cell signaling pathways have been proposed to lead to actin polymerization
following Cryptosporidium infection. Both pathways converge upon the
involvement of the Actin Related Protein (Arp) 2/3 complex; however, the
proposed upstream signaling molecules differ (Chen et al., 2003; Elliott et al.,
2001; Forney et al., 1999). One pathway requires phosphatidylinositol 3 kinase
(PI3K), cell division control protein 42 (cdc42) and neural Wiskott-Aldrich
syndrome protein (N-WASP) to result in activation of the Arp2/3 complex (Elliott
et al., 2001; Forney et al., 1999). The second pathway involves activation of the
Src tyrosine kinase, which in turn phosphyrolates cortactin, allowing Arp2/3 to
be activated (Chen et al., 2003). To date, potential parasite factors involved in
either of these processes remain unresolved but are hypothesized to interact
with host cell surface receptors during invasion or be injected into the host cell
cytoplasm by secretory organelles as part of the invasion process (Guérin and
Striepen, 2020).

1.2.4 Cryptosporidium transmission
Cryptosporidium is a food and waterborne pathogen transmitted
through a fecal oral route. As Cryptosporidium infection results in profuse
watery diarrhea, additional infective parasites are shed in oocysts into
the external environment during symptomatic infection, heightening the
risk for additional transmission events (Eisenberg et al., 2005). Because
15

transmission occurs following contact with infected people and animals,
infection is endemic in resource poor settings where access to clean
water is limited, living situations are crowded, and the domicile is
proximal to animals (Bouzid et al., 2018). Waterborne outbreaks also
occur in the developed world where advanced water treatment strategies
are more common, but subject to compromise due to failure of water
filtration systems (Chalmers, 2012; Gharpure R, 2019; Mac Kenzie et al.,
1994). One such example of an outbreak attributable to this origin was
the Milwaukee Outbreak of 1993. From retrospective analysis, an
estimated 400,000 cases of diarrhea resulted from the outbreak, not only
in Milwaukee, but also across the United States from travelers in the
airport ingesting contaminated water. The low infectious dose required
for Cryptosporidium infection contributed to this outbreak and similar
situations (Mac Kenzie et al., 1994). Although the etiological agent was
quickly identified and a boil water order issued, the Milwaukee outbreak
resulted in a $64.6 million USD loss of productivity and $31.7 M costs in
medical treatment during this timeframe, highlighting the economic
impact of Cryptosporidium outbreaks (Corso et al., 2003). Initially it was
thought dairy farming and agricultural runoff introduced C.parvum
oocysts into local water sources; however, retrospective genetic analysis
revealed C. hominis as the causative agent of the outbreak (Sulaiman et
al., 1998). Excess rain compounded with snow runoff and changing
water currents caused storm sewers containing human waste to overflow
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and contaminate influent water sources in Lake Michigan for a water
treatment facility in southern Milwaukee (Eisenberg et al., 2005; Mack,
2009) . Nonfunctional water filtration systems then allowed
Cryptosporidium contaminated water sources to be distributed for 4 days
across the city of Milwaukee (Mack, 2009). Infections resulting in
diarrhea during this time further contaminated water intake sources,
compounding the problem (Eisenberg et al., 2005) . Since the Milwaukee
Outbreak of 1993, Cryptosporidium remains a leading cause of
spontaneous waterborne diarrheal outbreaks across the United States,
as well as on a global scale (Chalmers, 2012; Gharpure R, 2019; Hlavsa,
2021; Hlavsa et al., 2018; Mack, 2009).
Seasonal sources of Cryptosporidium outbreaks in the US and the UK
have been traced to public pools and other recreational water activities, as the
oocysts containing the infective stages of Cryptosporidium are resistant to
chlorine and other water treatment strategies (Chalmers, 2012; Gharpure R,
2019; Hlavsa, 2021; Hlavsa et al., 2018; Turabelidze et al., 2007). Foodborne
infections occur less frequently, but outbreaks of cases have been traced to
contaminated apple cider, unpasteurized milk, and unwashed raw produce due to
contact with animals in a farm setting (Gharpure R, 2019). Most human disease
is due to infection with C. hominis, which only infects humans, and C. parvum
which can be zoonotically transmitted (Feng et al., 2018; Nader et al., 2019).
However, the contribution to human disease from other species varies locally.
For example, human infections with C. meleadgridis, which naturally infects
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turkeys, is endemic in regions of Peru and Thailand (Chalmers, 2012). Human
infections with other species, such as C. ubiquitum, C.canis, C. felis, and C.
cuniculus, have been reported, but with infrequent occurrence and mainly in
immunocompromised individuals (Chalmers, 2012). Human Cryptosporidium
infections occur through both anthroponotic (human to human) and zoonotic
(animal to human) transmission, making primary risk factors for acquiring
infection contact with children in childcare or children who wear diapers, contact
with infected individuals, and contact with domestic or farm animals (Chalmers,
2012; Gharpure R, 2019; Nader et al., 2019).

1.2.5 The lifecycle of the parasite
Cryptosporidium spp. resides within epithelial cells in a unique
intracellular localization restricted from direct contact with the host
cytoplasm. The lifecycle of the parasite is monoxenous, with all its steps
occurring within a single host. Cryptosporidium is a haploid organism, and
the parasite life cycle is characterized by rounds of asexual (merogony)
and sexual (gametogony) reproduction (Guérin and Striepen, 2020). The
parasite life cycle culminates in production of infective oocysts to
propagate the infection (Figure 1.4). The first phase in the parasite
lifecycle is asexual and commences upon ingestion of contaminated food
or water sources containing parasite oocysts. The oocyst wall of
Cryptosporidium is a multi-layer, complex structure that provides
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environmentally stable protection for the four infective sporozoites housed
inside (Jenkins et al., 2010; Samuelson et al., 2013). Their complex
molecular structure affords resistance of Cryptosporidium oocysts to
chlorination and other chemical water treatment strategies (Jenkins et al.,
2010; Robertson, 2014). The fibrillar glycocalx forms the outer boundary
of the oocyst wall, forming an outer impenetrable layer (Samuelson et al.,
2013). Acid-fast lipids stainable with carbol fuchsin are sandwiched
between the outer glycocalyx and an inner layer containing mainly of
oocyst wall proteins (OWPs) (Samuelson et al., 2013). (Samuelson et al.,
2013). Serine and threonine rich glycoprotein tethers anchor the
sporozoites to the oocyst wall interior, where they remain until a series of
environmental cues (including change in temperature and pH) trigger the
excystation process to begin (Samuelson et al., 2013).
Following excystation, the sporozoites invade epithelial cells and
establish the intracellular trophozoite stage (Tyzzer, 1910). After an initial
growth phase, the haploid parasites undergo multiple rounds of nuclear
division and a budding process known as merogony to produce 8
merozoites, which are morphologically similar to sporozoites (Jumani et
al., 2019; Tandel et al., 2019; Tyzzer, 1907, 1910; Wilke et al., 2018);
(Figure 1.4). From the time of initial infection to egress by merozites,
which appear morphologically similar to sporozoites, the parasite resides
within a single host cell for approximately 11.5 hours before emerging to
reinfect nearby cells (Guerin, in press 2021). Upon invasion by
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merozoites, the asexual replication process begins again. The replication
process is highly synchronous and recent work suggests the
Cryptosporidium lifecycle is programmed to undergo a set number of
asexual divisions before transitioning to reproduction by gametogony
(Tandel et al., 2019). The current model of the parasite lifecycle holds
that a developmental intermediate known as the type II meront gives rise
to the sexual stages (Jumani et al., 2019; Wilke et al., 2018). However,
others have suggested that the gametes appear directly from type I
meronts (Tandel et al., 2019; Tyzzer, 1910).
While the origin of the sexual life stages continues to be debated, it
is clear that two days after infection, asexual meronts are replaced by
male (hereafter “macrogamont”) and female (hereafter “macrogamont”)
gamonts (Jumani et al., 2019; Tandel et al., 2019). Each microgamont
gives rise to 16 microgametes, which then egress to reach an intracellular
macrogamont (Tandel et al., 2019). Fertilization of the macrogamete (1N)
by a microgamete (1N) leads to formation of a diploid zygote (2N) that
subsequently undergoes meiosis and sporogony to result in an infective
oocyst containing 4 infective sporozoites (Guérin and Striepen, 2020). It is
unresolved how the extracellular male locates and penetrates the host cell
to reach the intracellular female, but the proposed models for how this is
accomplished include release of a pheromone by the intracellular female
to direct the males to infected cells or trafficking of a parasite receptor to
the plasma membrane of infected host cells (Guérin and Striepen, 2020).
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Two populations of oocysts result from gametogony, namely the
autoinfective “thin-walled” oocysts and “thick-walled” oocysts (Robertson,
2014). Currently it is hypothesized that the thin-walled oocysts contribute
to chronic infection within the same host, while the thick-walled oocysts
are shed in in feces to the environment and contribute to host-host
transmission (Figure 1.4). Lifecycle progression appears to be essential
(Tandel et al., 2019; Wilke et al., 2018). Therefore, interruption of the
lifecycle may be a promising target for intervention strategies.

1.2.6 Treatment
Compared to the antibiotics used to treat Shigella infection and the
Rotavirus vaccine now widely available, chemotherapeutics and
prophylactic measures to prevent cryptosporidiosis are limited. Currently
there is no vaccine to prevent Cryptosporidium infection in humans or
livestock. Nitozoxanide remains the only treatment approved by the U.S.
Food and Drug Administration; however, it is only efficacious in reducing
the duration of illness in immunocompetent adults and children (Amadi et
al., 2002; Choy and Huston, 2020). Nitoxanide treatment performs no
better than placebo in randomized clinical trials involving
immunocompromised individuals (HIV patients) and malnourished
children, thereby implicating the host immune system as aiding in
parasite clearance (Abubakar et al., 2007; Amadi et al., 2002). Because
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the disease burden is highest within immunocompromised and
malnourished populations, there is great need for the development of
novel anti-cryptosporidial compounds. The divergence of
Cryptosporidium biology from other Apicomplexa eliminates many
traditional apicoplast drug targets; however, recent success with high
throughput phenotypic screening of repurposed drug candidates has led
to the identification of Cryptosporidium growth inhibitors (Abrahamsen et
al., 2004; Love et al., 2017; Vinayak et al., 2020). Drug development and
repurposing efforts have been aided by advances in technical tools
available to the field, such as the advent of genetic tractability and
improvements in in vitro culture techniques and life stage specific
antibodies, allowing for target validation within the parasite (Vinayak et
al., 2020; Vinayak et al., 2015; Wilke et al., 2019; Wilke et al., 2018).
High throughput phenotypic screening identified the repurposed
Leprosy drug Clofazamine as demonstrating potent anti-cryptosporidial
activity (Love et al., 2017). Safety and efficacy of Clofazamine was
tested in HIV+ patients in randomized study in Malawi; however, the drug
candidate was terminated at Phase II clinical trial due to insufficient
ability to attract participants (ie. low accrual rate) (Choy and Huston,
2020; Nachipo et al., 2018). Testing of 7 additional compounds
demonstrating anti-cryptosporidial activity remains in preclinical stages
(Choy and Huston, 2020). Three of the preclinical candidate compounds
share similar targets, with all converging upon interference with protein
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translation through disrupting the function of amino acid tRNA
synthetases (lysyl, methiontyl, phenylalanyl) (Baragaña et al., 2019;
Buckner et al., 2019; Vinayak et al., 2020). The remaining candidate
compounds exert their effects by interfering with various targets, namely
the Cryptosporidium calcium-dependent protein kinase 1 (CDPK1),
phosphatidylinositol-4-OH kinase, and polyadenylation specificity factor 3
(Huang et al., 2019; Hulverson et al., 2017; Lunde et al., 2019;
Manjunatha et al., 2017; Swale et al., 2019). While the targets of most of
the promising compounds have been identified, the target of the last
compound undergoing preclinical testing, MMV665917, remains
unresolved (Jumani et al., 2018; Lee et al., 2019; Stebbins et al., 2018).
Recent calls for designation of Cryptosporidium as a neglected
tropical disease (NTD) intended to attract funding to advance the
aforementioned preclinical trial candidate drugs through the development
pipeline (Choy and Huston, 2020). Designation as a NTD provides
financial incentive to drug companies advancing anti-cryptospioridial
compounds through making them eligible for the priority voucher review
program sponsored by U.S. Federal Drug Administration (FDA). The
priority voucher review promises expedited FDA review for any future
application to sponsors who provide a drug or vaccine deemed an
improvement over existing treatments for NTDs (Choy and Huston,
2020). While cryptosporidiosis has not been formally designated as an
NTD, the disease satisfies requirements for this classification by
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disproportionally impacting poor and marginalized populations and
having no significant market for therapeutics in the developed world
(Choy and Huston, 2020). Future recognition as an NTD would ascertain
drug and vaccine development efforts directed towards populations
suffering the greatest disease burden.

1.2.7 Immune response to Cryptosporidium
Innate Immunity
Innate immunity represents the first line of defense encountered by the
parasite during its passage through the digestive tract. The intestinal epithelial
cells (IEC) function as a physical barrier to invading microorganisms but is the
site of infection for intestinal dwelling Cryptosporidium species. IECs are initial
sensors of infection that subsequently initiate communication with natural killer
(NK) cells, dendritic cells (DC), macrophages, and eosinophils to mount a
coordinated immune response (Borad and Ward, 2010). Previous literature has
implicated TLRs 2, 4,5, 9 as pattern recognition receptors (PRRs) responsible for
sensing for Cryptosporidium; however, all of these experiments were carried out
in neonatal mice or cholangiocyte models of infection, which represent only a
small subset of the patient populations in which infection occurs (Barrier et al.,
2006; Costa et al., 2011; O'Hara et al., 2011). Additional experiments are
required to confirm the role of these PRRs using a new infection model system
where the immune system is intact (Sateriale et al., 2019).
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Cryptosporidium is exposed to innate defense mechanisms in the form of
secretions, mucus, bile, and stomach acid. Cryptosporidium infection increases
mucus production and secretion of antimicrobial peptides (AMPs), which is
thought to help the host promote parasite clearance (Bedi et al., 2015; Ludington
and Ward, 2015). A number of cytokines and chemokines are upregulated in
response to Cryptosporidium infection, and of them, IFNγ is the most critical in
limiting infection (Ungar et al., 1991). IFNγ produced by innate lymphoid cells
(ILCs) is critical for parasite clearance; however, the mechanism by which IFNγ
kills parasites is unknown. IL-12 and IL-18 are also important in limiting
Cryptosporidium infection, likely due to their role in inducing IFNγ production
(Bedi et al., 2015; Urban et al., 1996). The innate source of these cytokines
remained unknown until recently, when it was discovered that signaling from the
NOD-like receptor 6 (NLRP6) inflammasome during Cryptosporidium infection
leads to production of IL-18 (Bedi et al., 2015; Sateriale et al., 2021). Mice
lacking Caspase-1 and the apoptosis-associated spec-like protein (ASC) are
more susceptible to Cryptosporidium infection and administration of recombinant
IL-18 reverses this phenotype (McNair et al., 2018; Sateriale et al., 2021).
Furthermore, in vitro microarray studies and RNA sequencing from
continuous culture ex vivo model systems have helped to better characterize the
cytokine milieu during Cryptosporidium infection (Castellanos-Gonzalez et al.,
2008; Deng et al., 2004; Heo et al., 2018; Nikolaev et al., 2020b). RNA
sequencing experiments performed on Cryptosporidium infected cell culture and
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organoids have shown that infection results in a robust Type I and Type III
Interferon signaling response (Ferguson et al., 2019; Heo et al., 2018; Nikolaev
et al., 2020b). Signaling through both pathways culminates in the production of a
panel of interferon stimulated genes (ISGs) that are thought to perform antiCryptosporidial functions (Stanifer et al., 2019). While the mechanism of action of
the ISGs remains to be characterized, immunoneutralization approaches
performed within our lab as well as others, has demonstrated that Type III
interferons (IFNλ) limit Cryptosporidium infection (Ferguson et al., 2019).
Treatment with anti-IFNλ 2/3 antibody prior to infection results in a 17% reduction
of C. parvum tissue burden compared to isotype control at day 4. Furthermore,
anti-IFNλ 2/3 treatment results in a 36% reduction in C. parvum tissue burden at
the peak of infection at day 10 (Ferguson et al., 2019).
The same microarray studies and RNA sequencing also revealed changes
in ISGs, various pro-inflammatory cytokines (OPG, IL-8), chemokines (RANTES),
and prostaglandins (COX-2), and stress responses as a consequence of
Cryptosporidium infection (Castellanos-Gonzalez et al., 2008; Deng et al., 2004;
Ferguson et al., 2019; Heo et al., 2018; Nikolaev et al., 2020b). While the exact
transcripts changed due to infection varies based upon the specific experimental
method used (ie. RNA-seq vs microarray), the results universally demonstrate
that the host cell senses and responds to the presence of Cryptosporidium during
infection. In order to survive, the parasite must subvert this host immune
pressure.
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Adaptive Immunity
The importance of the adaptive immune response in resolution of
Cryptosporidium infections is highlighted by the heightened disease severity in
AIDS patients. Due to the inverse relationship between the number of CD4+ T
cells and Cryptosporidium disease severity, it was hypothesized that CD4+ T
cells perform critical effector functions in combatting Cryptosporidium infections
(Borad and Ward, 2010; Ludington and Ward, 2015). Using cytolytic and
neutralizing antibodies during infection it was shown CD4+ T cells and IFNγ are
central for control of Cryptosporidium infections (Ungar et al., 1991). Reduction in
either CD4+ T cells or IFNγ alone limits the magnitude (IFN γ) or the length (CD4+
T cells) of the infection, demonstrating the role IFNγ plays in limiting early
parasite growth and CD4+ T cells for resolution of the infection (Ungar et al.,
1991). Later work, in which SCID mice reconstituted with CD8+ T cells were able
to reduce the length and severity of C. muris infection, but to a much lesser
extent than in mice reconstituted with CD4+ T cells (Kvac et al., 2011). In
addition, both CD4+ T cells and CD8+ T cells isolated from humans previously
infected with Cryptosporidium produce IFNγ following stimulation with C. hominis
antigen, showing that CD8+ T cells aid CD4+ T cells in resolution of infection, but
that CD4+ T cells play the more important role (Preidis et al., 2007).
The contribution of humoral immunity to control and resolution of
Cryptosporidium infections remains unresolved. Epidemiological studies in
different geographical areas have established that the incidence of
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Cryptosporidium infection decreases with age, suggesting that immunity
developed over time following multiple exposures (Kabir et al., 2021; Kotloff et
al., 2013; Troeger et al., 2017). Cryptosporidium specific antibodies are detected
in patient sera upon resolution of infection (Kabir et al., 2021; Khan et al., 2004).
Passive immunization experiments utilizing hyperimmune bovine colostrum
reduced oocyst shedding and disease severity in animals; however,
administration of the same treatment to humans produced mixed results (BoulterBitzer et al., 2007). Passive immunotherapy targets have focused on surface
antigens and proteins localizing to apical secretory organelles, intending to
neutralize parasite invasion (Boulter-Bitzer et al., 2007; Riggs, 2002). More
recently, irradiated Cryptosporidium sporozoites used as a vaccination model
demonstrated protection from challenge infection, which was dependent upon
IFNγ and the presence of mature B and T cells, as IFNγ KO and Rag1 KO mice
lost protection from prior antigen exposure (Sateriale et al., 2019). Mice lacking
mature B cells (MuMT mice) showed no difference and nude mice lacking only T
cells were as susceptible as the Rag1 KO mice, suggesting that T cells are the
primary cellular effectors of the adaptive immune system contributing to
resolution of Cryptosporidium infections (Sateriale et al., 2019).
1.3 Cellular consequences of Cryptosporidium infection
1.3.1 Cryptosporidium infection induces changes in the host cell
Cryptosporidium lives in a unique intracellular, extracytoplasmic niche,
where infection is restricted to the apical periphery of epithelial cells. (Elliott and
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Clark, 2000; Lumb et al., 1988). The mechanism by which this niche is
established during invasion is debated but appears to involve the rearrangement
of the host actin cytoskeleton, the formation of tight junction-like structures
between host and parasite membranes, and organization of a dense band of
unknown origin at the host-parasite interphase (Bonnin et al., 1999; Elliott and
Clark, 2000; Lumb et al., 1988). Cryptosporidium relies heavily upon the host cell
for nutrients and metabolites due to its streamlined metabolism (Abrahamsen et
al., 2004; Xu et al., 2004). A number of specialized uptake mechanisms have
been proposed to fill this need, many of which are thought to be amino acid and
nutrient transporters that localize to the feeder organelle, a specialized, highly
invaginated structure present at the host-parasite interface (Marcial and Madara,
1986; Perkins et al., 1999). Transmission electron microscopy (TEM) and
Osmium-maceration scanning electron microscopy (OS-SEM) of the feeder
organelle in C. parvum infected cells revealed a reticulated network of tubular
membrane invaginations (Bochimoto et al., 2019). This collection of membranes
is thought to increase surface area for nutrient absorption for the parasite;
however, this hypothesis remains to be tested. To date, one protein transporter
has been localized at the host parasite interface using immunofluorescence
assay with polyclonal antisera generated against Cryptosporidium parvum ATPbinding cassette protein (CpABC) (cgd7_4510) (Perkins et al., 1999). A similar
observation was made by our lab for the localization of a sugar inositol
transporter (SIT) using immunofluorescence assay (IFA) and electron
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microscopy (EM); however, the functional role of this protein during infection
remains to be characterized. As there is an expanded number of putative amino
acid and sugar transporters in the Cryptosporidium genome (Baptista et al.,
2021), the localization of additional candidate genes remains open for
investigation.
In addition to inducing drastic morphological changes between infected
and uninfected cells, Cryptosporidium alters host cell physiology and metabolism
(Kumar et al., 2018; Ng Hublin et al., 2013). Some of the earliest observations of
experimentally infected calves and piglets revealed C. parvum infection causes
irregularities of epithelial cell surface, such as villous atrophy, elongated crypts,
and disorganization of the epithelial cell monolayer such that the nuclei no longer
aligned (Heine et al., 1984; Tzipori et al., 1982). The usually ordered columnar
epithelial cells become short and cuboidal in shape, and this perturbation has
been hypothesized to alter nutrient and electrolyte absorption, and contribute to
the diarrhea observed with the disease (Heine et al., 1984). Additionally,
Cryptosporidium infection impacts sodium and glucose transport, and that
infection disrupts paracellular permeability to substrates such as FITC-dextran
and horseradish peroxidase in flux studies (Adams et al., 1994; Kumar et al.,
2018). These changes in gut permeability do not occur when cells are infected
with heat killed parasites, indicating that they are attributable to damage caused
by parasite replication (Adams et al., 1994). More recent work indicates the
alterations in gut permeability during Cryptosporidium infection also result from
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downregulation of tight junction proteins (occludin, Cldn-4, Cldn-3 and ZO-1) and
adherens junction proteins (E-cadherin and alpha-catenin) that form cellular
junctions in the intestine critical for maintaining electrochemical gradients (Di
Genova and Tonelli, 2016; Kumar et al., 2018).
Cryptosporidium infection also influences the host metabolome.
Metabolomic analysis of fecal extracts from uninfected and C. parvum infected
mice uncovers altered metabolite profiles, highlighting the changes the host cell
undergoes as a result of nutrient scavenging by the parasite during infection (Ng
Hublin et al., 2013). Similar metabolic observations were made for human
infections. Fecal metabolite profiles of Cryptosporidium infected individuals were
distinguished from uninfected patients through shifts in amino acid, carbohydrate,
lipid, and organic acid composition (Ng et al., 2012). Together the alterations in
gut permeability and nutrient scavenging induced by the parasite have profound
consequences for nutrient availability to the host.
In summary, infected cells can be distinguished from uninfected cells at
the microscopic, transcriptional, and metabolomic levels. Cells infected with
Cryptosporidium exhibit differences in cellular morphology and physiology, and
show upregulated innate immune signaling and an adaptive response following
infection. The observed changes could be explained through three potential
hypotheses, namely, (i) the differences seen are indirect consequences of the
host response to the presence of the parasite, (ii) the changes are actively
induced by parasite factors introduced to the host cell during infection, or (iii) a
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combination host and parasite factors contributes to alterations in host cells.
Because numerous other pathogens utilize effector proteins to manipulate host
cells during infection to promote pathogen survival, I hypothesize that
Cryptosporidium has a repertoire of exported proteins to modulate the host cell
during infection. This hypothesis is consistent with previously published work
predicting Cryptosporidium proteins to be exported based upon conserved
features known from related organisms, in particular the malaria parasite
Plasmodium (Pellé et al., 2015).
1.3.2 Apicomplexan host-parasite interactions
Apicomplexa are masterful manipulators of their host cells and use
an army of subversive proteins translocated into the host cell. Over the
years, a number of species-specific host-targeted effector proteins have
been identified, all of which aid the parasites in adapting to their unique
resident niches. Exported proteins are targeted beyond the confines of the
parasite into the parasitophorous vacuole (PV) space or translocated
even beyond this additional membrane into the host cell cytoplasm
(Figure 1.5). Two broadly conserved temporal patterns have been
described for host-targeted effector proteins in Apicomplexa. Effectors
involved in early aspects of the infection are translated towards the end of
intracellular development and packaged into apical secretory organelles,
where they await injection during the invasion process (Figure 1.5)
(Cowman et al., 2017; Rastogi et al., 2019). During invasion, the contents
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of the micronemes are secreted first, as these proteins are required for
motility and host cell attachment (Hunter and Sibley, 2012; Koch and
Baum, 2016). Next, contents of the rhoptry are expelled, including rhoptry
neck (RON) and rhoptry bulb proteins (ROP) (Cowman et al., 2017;
Hunter and Sibley, 2012; Rastogi et al., 2019; Suarez et al., 2019). The
RON and ROP proteins play important roles in establishing the infection
but also act to subvert various aspects of innate immunity (Behnke et al.,
2011; Rastogi et al., 2019; Saeij et al., 2007; Saeij et al., 2006). Finally,
dense granule proteins (GRAs) exhibit variability in the timing and
localization following export, with some proteins localizing to the PV or
PVM, while others are found in the host cell. A portion of GRAs are
secreted during invasion to establish the PV and install pores for the
transport of small solutes into the infected cell, while others translocated
following the establishment of infection to rewire host transcription
(Cowman et al., 2017; Culvenor et al., 1991; Rastogi et al., 2019).
A second wave of proteins is translated and exported after the
parasite has established its intracellular niche and delivered to the host
cell by means of a translocon-based mechanism (de Koning-Ward et al.,
2009; Franco et al., 2016) (Figure 1.5). Proteins belonging to this class
often require insertion into the canonical secretory pathway and contain
species-specific host targeting motifs to direct proper trafficking beyond
the parasite (Coffey et al., 2015; Marti et al., 2004; Wickham et al., 2001).
Many of these apicomplexan effector proteins are intrinsically disordered,
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and interruption of the disorder by structured epitope tags prevents proper
localization (Marín et al., 2013; Marino et al., 2018).
Apicomplexan protein export was first studied in P. falciparum
following the identification of a number of host-targeted parasite virulence
factors (Baumeister et al., 2006; Crabb et al., 1997; Leech et al., 1984;
Maier et al., 2008). P. falciparum resides in the anucleate red blood cell
(RBC), giving the parasite much space to inhabit given the abundance of
this cell type, but few resources (Figure 1.6). Red blood cells are
terminally differentiated anucleate cells that are greatly reduced to allow
for efficient oxygen transport. To overcome this challenge, roughly 8-10%
of the P. falciparum genome (more than 300 genes) encodes exported
proteins utilized to remodel the host cell, obtain nutrients and evade the
host immune system (Matthews et al., 2019b). P. falciparum exported
effectors Erythrocyte Membrane Protein 1 (PfEMP1) and Knob
Associated Histidine Rich Protein (KAHRP) localize to the RBC
membrane and work in conjunction to form adhesive knob-like structures
on the surface of RBCs that alter tissue distribution and mechanical
properties to prevent immune clearance (Crabb et al., 1997; Leech et al.,
1984). Additional effector proteins belonging to the Ring-infected
Erythrocyte Surface Antigen (RESA) and Plasmodium helical Interspaced
Subtelomeric (PHIST) families assist by altering erythrocyte cytoskeletal
properties to promote endothelial attachment (Matthews et al., 2019b).
Insertion of the plasmodial surface anion channel (PSAC) into the RBC
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membrane results in changes to nutrient and ion uptake mechanisms in
infected cells, which then increases erythrocyte rigidity while decreasing
cell deformability (Baumeister et al., 2006; Maier et al., 2008; MundwilerPachlatko and Beck, 2013). Early observations of P. falciparum infected
cells revealed the presence of Golgi-like membranous structures in the
RBC cytoplasm, long known as Maurer’s clefts (Maurer, 1900). These
structures were since shown to be comprised of parasite proteins and are
thought to be essential components for remodeling the host cell, as
proteins destined to the erythrocyte surface, such as PfEMP1, transiently
localize to these structures during the translocation process (Matthews et
al., 2019b; Mundwiler-Pachlatko and Beck, 2013).
Following the identification of a repertoire of exported virulence
factors for P. falciparum, it was predicted that host targeted proteins also
accomplish functions during infection for other related organisms.
Toxoplasma gondii is an Apicomplexan parasite that ubiquitously infects
nucleated cells of a wide variety of hosts (Hunter and Sibley, 2012). T.
gondii lacks specific host tropism, and thus must be capable to establish
infection, acquire nutrients, and evade host immune pressure in multiple
diverse host environments (Figure 1.7). T. gondii strains isolated from
Europe and North America belong to three clonal lines (Type I, Type II
and Type III) that exhibit stark differences in a number of phenotypes, but
most strikingly virulence when used to infect mice (Hunter and Sibley,
2012). Genetic crosses between different T. gondii strains allowed the first
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identification of strain specific virulence factors (rhoptry pseudokinases
ROP16, ROP18) (Saeij et al., 2007; Saeij et al., 2006; Taylor et al., 2006).
Since then, a number of additional virulence factors (GRA24, GRA16,
TEEGR, TgIST, GRA15) have been identified using molecular
approaches, most of which were found to rewire signaling and
transcriptional networks to antagonize immune responses (Bougdour et
al., 2013; Braun et al., 2013; Braun et al., 2019; Gay et al., 2016; Olias et
al., 2016; Rosowski et al., 2011). Furthermore, an additional effector
protein (TgWIP) interacts with the WAVE regulatory complex to alter host
actin dynamics and affect morphology of dendritic cell podosomes to
enhance the motility and transmigration of infected dendritic cells
(Sangare et al., 2019). To establish access to cellular nutrients, T. gondii
utilizes the dense granules to deliver parasite proteins (GRA17 and
GRA23) to the PV to facilitate movement of small molecules between the
host and the parasite (Gold et al., 2015). Although both are Apicomplexa,
P. falciparum and T. gondii encode vastly different effector proteins, with
few to no homologous proteins conserved between their exportomes. This
is likely due to the differing demands of the cellular environments in which
they reside. In spite of differences in effector function, several aspects of
the timing of their secretion and mechanisms by which these proteins are
delivered to the host cell appear conserved among Apicomplexa.
This understanding of shared elements of apicomplexan host
targeting-pathways gave rise to hypotheses that exported proteins may
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similarly contribute to the multitude of cellular changes observed during
Cryptosporidium infection. However, the lack of continuous culture and
molecular genetic tools for Cryptosporidium complicated strategies to
formally test these ideas. Using P. falciparum as a heterologous
expression system, two C. parvum proteins (cgd2_2530 and cgd3_2690)
were shown to be exported to the RBC when their N termini were fused to
YFP (Pellé et al., 2015). The development of genetic tools (Vinayak et al.,
2015) and the availability of advanced Cryptosporidium genome
resources (Baptista et al., 2021) now provide the opportunity to address
questions surrounding export through genetic manipulation of
endogenous genes in Cryptosporidium. However, specific candidate
proteins participating in host-parasite interactions are still to be identified.

1.3.3 Cryptosporidium host parasite-interactions
There are multiple interactions likely governed by the interplay
between parasite factors and the host cell during the Cryptosporidium
lifecycle (Figure 1.8). The parasite establishes infection in the epithelial
cell niche and completes its requisite lifecycle within this intracellular
environment without host immune clearance. I hypothesize that many of
these interactions are accomplished through the use of parasite effector
proteins resulting in the modulation of host cell function to promote
parasite survival. I anticipate proteins participating in host-parasite
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interactions proteins to be divided into two classes based upon the
temporal pattern in which they are expressed during infection: namely,
those involved in invasion and the establishment of infection, and those
that are involved following the establishment of infection.
Host-parasite interactions during invasion
Despite a high degree of similarity in gene content and genome
synteny across the genus Cryptosporidium, different species exhibit
specific host tropisms, with many species being restricted to a single host
or a narrow range of related hosts (Nader et al., 2019). Pivotal hostpathogen ligand and receptor interactions for numerous bacteria, viruses,
and other apicomplexan parasites has driven the currently held
hypothesis that species-specific virulence factors determine host tropism
at the level of cell attachment and invasion (Bouzid et al., 2013). Within
Apicomplexa, it is well established that microneme proteins are some of
the initial parasite factors involved in the invasion process. Plasmodium
species exhibit specific host tropisms, as well as preferences for types of
RBC to establish infection. Studies characterizing the molecular basis of
Plasmodium’s erythrocyte invasion have implicated two families of
microneme adhesin proteins required for successful parasite invasion
through establishment of attachment by receptor-ligand interactions
(Cowman et al., 2017). The Duffy Binding like (DBL) and Reticulocyte
binding-like protein homolog (RBC or Rh) families of proteins interact with
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specific erythrocyte membrane receptors to initiate invasion events
(Cowman et al., 2017). The DBC family interacts with the Duffy
chemokine receptor (DARC), while members of the RBC family interact
with various targets, including complement receptor 1 (PfRh4) and basigin
(PfRH5) (Cowman et al., 2017). RBCs exhibit differential expression of
these surface receptors based upon host species and age, allowing for
Plasmodium species to preferentially invade cells with the matching
surface receptor complement. Experiments exploring expanding host
niches for P. knowlesi, a parasite of macaques that causes zoonotic
infection in humans, identified amplifications and deletions in DBL and
RBL families in parasites that exhibit improved infectivity and proliferation
in human erythrocytes (Cowman et al., 2017). While the DBL and RBL
families are conserved among Plasmodium, there are species specific
differences in receptor binding domains that are thought to explain the
increased affinity for various receptors (Cowman et al., 2017).
Thrombospondin-Related Adhesive Protein (TRAP) is another
protein crucial for Plasmodium invasion. TRAP is stored in the
micronemes until contact between the apical tip of the parasite and the
host cell, when it redistributes to coat the surface of the parasite (Gantt et
al., 2000; Rogers et al., 1992). Sporozoites leave residual trails of TRAP
containing material during gliding motility, and it has been shown that
antibodies generated against TRAP largely reduce parasite motility (Gantt
et al., 2000; Spaccapelo et al., 1997). A growing number of Plasmodium
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proteins harboring conserved thrombospondin repeat motifs belong to a
family of thrombospondin proteins (TSP) that participates in crucial cellcell and cell-matrix interactions during invasion (Naitza et al., 1998).
Based on this precedence, work on Cryptosporidium attachment and
invasion processes has largely focused on sporozoite surface antigens
and proteins localized to secretory organelles as the most likely
candidates to be exposed to enterocyte surface receptors (Bouzid et al.,
2013). Antisera generated from recombinant antibody production revealed
that both gp900 and TSP Related Adhesive Protein of Cryptosporidium-1
(TRAP-C1) localize to the micronemes of the infective stages of the
parasite and are also redistributed on the parasite surface (Barnes et al.,
1998; Spano et al., 1998). Similar to Plasmodium, the Cryptosporidium
genome encodes multiple proteins with TSP domains, which have drawn
much attention as candidate host determination factors at the level of
invasion; however, to date none have been confirmed to fulfill this role
(Frénal et al., 2017). Gp900 is a highly glycosylated mucin-like protein
with a size of >900 kDa that is shed in trails following gliding motility
(Barnes et al., 1998). Gp900 is thought to play a role in parasite invasion,
as treatment with an anti-gp900 neutralizing antibody disrupts invasion by
nearly 80%, but a host binding partner has not yet been identified
(Barnes et al., 1998). Apart from TRAP-C1 and gp900, other parasite
surface markers, including Cp23 and Cp15/60 have been identified, but
again, their specific function and the nature of their host interaction
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partners have not been characterized.
Because other Apicomplexa have an expanded repertoire of
proteins devoted to invasion events, I hypothesize the Cryptosporidium
genome likely encodes additional proteins involved in host-parasite
interactions during invasion that remain to be determined. An
understanding of the secretory proteins delivered by the other apical
organelles is lacking. A single rhoptry neck protein, C. parvum Putative
Rhoptry Protein 1 (CpPRP1; cgd8_2530), was previously identified based
upon putative sequence homology with Plasmodium and Toxoplasma
rhoptry proteins (Valentini et al., 2012). More recently, additional rhoptry
bulb proteins have been identified and localized within the host cell during
invasion, but most rhoptry and dense granule proteins remain to be
discovered (Guerin, in press 2021).
Predicted host-parasite interactions following establishment of
infection
Based upon transcriptional profiling of infected and uninfected cells
it is clear that the host detects Cryptosporidium infection and initiates an
immune response characterized by Type I or Type III interferons
(Ferguson et al., 2019; Heo et al., 2018; Nikolaev et al., 2020a).
Nonetheless, the parasite completes its lifecycle despite host immune
pressure. Other pathogens experience similar phenomena and have
evolved specialized mechanisms to disarm host responses through
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immune evasion strategies (Finlay and McFadden, 2006; van der Does
and Rep, 2007). While viruses, bacteria and protozoan parasites differ in
the details of their replicative mechanism and host niche, the immune
pressures they must overcome are similar, resulting in shared
immunomodulatory mechanisms across organisms. Each of the
previously mentioned pathogens modulate inflammatory pathways
through a number of different mechanisms, examples include
manipulation of cell death pathways, disruption of cytokine and
chemokine signaling, and blockade of antigen presentation (Figure 1.9)
(Finlay and McFadden, 2006; Lima and Lodoen, 2019).
Cell death pathways are homeostatic mechanisms to remove
aging, damaged, mutated, or infected cells. Cell death can limit or benefit
pathogen survival depending upon the context. Premature death of
infected cells limits the pathogen replicative niche when occurring prior to
the release of infectious stages, but induced cell death can also promote
egress at a desired moment in time or limit inflammatory response. The
host-pathogen arms race has led to the evolution of pathogen-specific
modulatory strategies to help address the complex interplay between cell
death and pathogen survival. Intracellular bacteria such as Chlamydia,
Legionella and Coxiella alter cell death at various steps in the pathways
through the injection of effector proteins into the host cell using
specialized secretion systems (Choy et al., 2012; Finlay and McFadden,
2006; Lührmann and Roy, 2007). Similarly, in viral infections, both pro42

apoptotic (ex: Vpr from HIV, HBX from hepatitis B) and anti-apoptotic (ex:
M11L from myxoma virus BHRF1 from Epstein-Barr virus) mitochondrialtargeted viral proteins have been described, as mitochondrial membrane
permeabilization is a critical step in regulating cell death by apoptosis
(Boya et al., 2004). Cells infected with Toxoplasma gondii exhibit reduced
cell death by apoptosis, which has been suggested to be a consequence
of modulation of the p53 tumor suppression pathway by the nucleartargeted dense granule protein GRA16 (Bougdour et al., 2013; Lima and
Lodoen, 2019).
To combat immune pressure, mircobe-specific immune evasion
strategies have emerged to dysregulate host cell signaling pathways that
culminate in cytokine and chemokine production. One such example
includes the Staphylococcus aureus protein A that binds to the TNFα
receptor, inducing changes in cytokine signaling that are thought to
contribute to disease (Finlay and McFadden, 2006). Similarly, Middle East
Respiratory Syndrome coronavirus (MERS) encodes the NS4a protein to
prevent phosphorylation of Protein Kinase R (PKR), an interferon induced
double-stranded RNA-activated protein kinase, and the downstream
induction of IFN and ISG expression that normally follows signaling by this
kinase (Comar et al., 2019). T. gondii combats host immune pressure
from IFNγ through repression of STAT1 protein with a nuclear targeted
effector protein called Toxoplasma Inhibitor of STAT-1 dependent
Transcription (TgIST) to impact IFNγ signaling pathways(Olias et al.,
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2016). T. gondii also modulates broader aspects of immunity through
prolonged autophosphorylation and nuclear translation of p38 (Braun et
al., 2013). The aforementioned examples of immunomodulatory
mechanisms for prokaryotic, viral and eukaryotic pathogens represent a
few selected effectors devoted to interference with cytokine and
chemokine signaling. Additional microorganisms utilize effectors which
target these same signaling pathways, highlighting the importance of
subversion of this host immune pressure to promote pathogen survival.
Antigen presentation is crucial to initiate the adaptive response to
infection and to aid in generation of a pathogen-specific response.
Therefore, in an effort to promote survival within the host environment,
pathogens target and disrupt antigen presentation pathways.
Mycobacterium tuberculosis resides within alveolar macrophages, which
can act as antigen presenting cells (APCs). To protect its replicative niche
M. tuberculosis interferes with antigen processing and presentation by
Class-I MHC. It reduces the MHC-I pool available for presentation by
sequestration of the complex inside the cell and by altering peptide
loading and decreasing IFNγ signaling (Barth et al., 2013). A similar
strategy is utilized by HIV, where a viral protein reduces MHC Class-I
presentation on the surface of infected cells by disrupting the normal
trafficking pathway of MHC-I to the cell surface (Wonderlich et al., 2011).
The decrease in MHC-I on the cell surface reduces recognition and
subsequent lysis of infected cells by Cytotoxic T Lymphocytes (CTLs)
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(Wonderlich et al., 2011). Finally, the parasitic roundworm, Ancylostoma
ceylanicum uses the effector protein Ace-MTP-2 to reduce MHC-I and
MHC-II molecules on the dendritic cell surface (Maizels et al., 2018).
Similar reductions in MHC class II gene expression and antigen
presentation were observed during T. gondii infection, but the parasite
effector responsible for performing this function has not been identified
(Lüder et al., 2001).
Many different pathogens employ immune evasion strategies to
overcome host immune pressures unique to the replicative niche they
inhabit. Cryptosporidium resides within intestinal epithelial cells, where
infection results in a robust interferon response. I hypothesize that
Cryptosporidium utilizes effector proteins to overcome host immune
pressure within this niche and predict that proteins participating in such
interactions can be identified through the selection of candidates with
similar features to proteins known to be involved in the aforementioned
immune evasion strategies. Since proteins involved in immune evasion
strategies receive selective pressure from the host, they are often found
to exhibit greater polymorphisms than the background rate of genetic
change due to the fitness consequences conferred by survival in the host
(Bouzid et al., 2013). Expanded families of highly variable genes involved
in immune evasion strategies have been well characterized for protozoan
parasites, such as Trypanosoma brucei, Trypanosoma cruzi, and
Plasmodium falciparum (Freire-de-Lima et al., 2015; Horn, 2014; Kirkman
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and Deitsch, 2012).
The bloodstream forms (BSFs) and metacyclic stages (insect host)
of Trypanosoma brucei encode an expanded gene family of proteins used
to aid in immune evasion. While both the metacyclic stages in the tsetse
fly host and the BSF in the mammalian host encode variant surface
glycoproteins (VSGs), the two differ in expression under the control of life
cycle-stage dependent promoters (Graham and Barry, 1995). The
expanded family of VSG genes allows T. brucei to escape host antibody
responses generated against the dominant surface antigen expressed on
the BSFs of the parasite by switching to a new, unrecognized surface
protein through antigenic variation (Horn, 2014). Similarly, the related
parasite T. cruzi encodes an expanded number of trans-sialidases that
help modify the parasite and host glycoproteome to promote parasite
survival. T. cruzi lacks the ability to synthesize sialic acids (SIA), so it
uses its own trans-sialidases to scavenge SIA from the host to decorate
the trypomastigote surface. This allows the parasite to utilize a trojan
horse mechanism to appear as “self” and escape immune detection while
circulating in the host bloodstream (Freire-de-Lima et al., 2015).
The Apicomplexan parasite P. falciparum also uses antigenic
variation to alter the PfEMP1 on the surface of infected erythrocytes to
prevent clearance of infected cells in the spleen (Voss et al., 2006).The P.
falciparum genome encodes 60 var genes that undergo recombination to
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produce new mosaic var products not recognized by antibodies circulating
during infection (Kirkman and Deitsch, 2012; Voss et al., 2006). In the
Plasmodium genomes, var genes often localize to the sub-telomeric
regions of the genome, which is thought to facilitate recombination by
allowing alignment of the “bouquets” of telomeres in the nuclear periphery
(Kirkman and Deitsch, 2012; Kissinger and DeBarry, 2011). Similar to
expression of VSG in T. brucei, only one var gene is expressed in
Plasmodium spp. at a given time, and the others are transcriptionally
silent (Horn, 2014; Voss et al., 2006).
The Cryptosporidium genome encodes no homologs of known
virulence factors of other protozoan parasites; however, the shared
characteristics of virulence factors of other pathogens can be used to infer
criteria to identify Cryptosporidium specific candidate genes. The
identification of additional Cryptosporidium strains and species has
allowed for comparative genomics studies to identify potential host
determining factors between species and helped uncover potential
virulence factors. Despite considerable sequence similarity between
species, interspecific genetic differences are still present, mainly in subtelomeric regions of the genomes encoding genes with signal peptides
and amino acid and nutrient transporters (Baptista et al., 2021; Bouzid et
al., 2013; Guo et al., 2015; Sateriale et al., 2019). As a result, these
regions of the genome have attracted much interest as areas that may
encode potential proteins performing crucial host-parasite interactions
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(See Chapter 3).
1.3.4 Comparative genomic studies identify candidate
Cryptosporidium host-interacting proteins
The first published analysis of the C. parvum genome sequence
revealed multiple families of paralogous proteins with N-terminal signal
peptides. These genes are often found within clusters (homologous and
heterologous), and many of them are found close to the telomeres of
multiple chromosomes across the genome (Abrahamsen et al., 2004).
While the subtelomeric localization and multiple homologous family
members is reminiscent of the P. falciparum var gene family and the T.
brucei VSG genes, the gene families of Cryptosporidium parvum are
greatly reduced in size and contain no more than 9 genes in a given
family (Abrahamsen et al., 2004; Horn, 2014; Kirkman and Deitsch,
2012). The gene families of C. parvum share repeated amino acid repeat
sequence motifs among family members, which give rise to their family
names: SKSR, WYLE, FLGN, WYLE, MEDLE, GGC, Cp LSP, and
mucin-like (Abrahamsen et al., 2004; Templeton and Pain, 2016).
Interestingly, genes of the predicted secreted protein families are
highly polymorphic and vary in copy number when compared across
strains and species (Baptista et al., 2021; Guo et al., 2015; Nader et al.,
2019; Sateriale et al., 2019; Widmer et al., 2012; Xu et al., 2019).This
has been interpreted as sign of rapid evolution driven by speculated
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roles in pathogenesis, invasion, or host cell specificity. When comparing
the C. parvum to the C. hominis and C. tyzzeri genomes, the genomes
are 95-97% identical in nucleotide sequence; however, many of the
interspecies differences arise within regions of the genome that encode
members of the predicted secreted protein family members in the
subtelomeric regions of the genome (Baptista et al., 2021; Guo et al.,
2015). The C. hominis genome has only one member of the mucin-like
family (cgd5_4600), lacks two subtelomeric insulinase proteins
(cgd6_5510 and cgd6_5520), and is missing all but one member of the
MEDLE gene family (cgd5_4600) (Guo et al., 2015). Similarly, when
comparing the C. parvum genome to the Cryptosporidium Chipmunk I
genome, differences in the number of MEDLE genes were observed (2
genes compared to 6) and a Chipmunk I-specific insulinase-like gene
was identified (Xu et al., 2019). A BLAST search of the C. tyzzeri
genome published by our lab, which shares 95% and 96% identical
nucleotide sequences with C. hominis and C. parvum, respectively,
reveals the presence of only 2 MEDLE gene family members
(CTYZ_00003166 and CTYZ_00002702) (Sateriale et al., 2019).
Comparative genomics studies led to the hypothesis that these
Cryptosporidium specific gene families are responsible for determining
virulence and host specificity. Due to the differences in copy number
observed between C. parvum and C. hominis, recent work has
characterized the expression profiles of the MEDLE and predicted
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insulinase gene families by qPCR. The results revealed differences in
the temporal patterns for various family members across the life cycle of
the parasite (Fei et al., 2018; Li et al., 2017; Su et al., 2019; Zhang et al.,
2019a). Using recombinant antisera generated to characterize
localization patterns as neutralizing antibodies on sporozoites treated
prior to invasion, neutralization of MEDLE1, MEDLE2, and MEDLE3 with
polyclonal antibodies reduced the efficiency of invasion by roughly 50%,
40%, and 56%, respectively at dilutions of 1: 100 or 1:200 (Fei et al.,
2018; Li et al., 2017; Su et al., 2019; Zhang et al., 2019a). Similarly,
treatment of sporozoites with an anti-insulinase 19 (cgd6_5510)
polyclonal antibody reduced efficiency of invasion by 38% (Zhang et al.,
2019a).
While comparative genomics analyses have highlighted genes that
vary interspecies, the presence of variation alone is not sufficient to
demonstrate participation in host-parasite interactions and a potential
role in virulence. While eukaryotic, prokaryotic, and viral pathogens have
distinctive effector repertoires, common pathogenic mechanisms are
shared among them, namely interfering with the host cytoskeleton to
promote attachment and invasion, altering cellular trafficking, cytotoxicity
and barrier dysfunction, and participation in subversion of the immune
system (Coburn et al., 2007; Finlay and McFadden, 2006). To
accomplish these goals, the effector must interact with the host cell or
external environment in some capacity to perform functions to enhance
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pathogen survival.
1.4 Dissertation aims and questions
The main objective of my dissertation project is to investigate
protein export of Cryptosporidium parvum. I will use newly available
genetic approaches to assess export status of candidate effector proteins
in a homologous system, focusing on candidate proteins from expanded
gene families of predicted secreted proteins encoded in highly
polymorphic regions of the genome. The goals of my project center about
exploring 2 primary questions: what are the host targeted effector proteins
utilized during Cryptosporidium infection (Chapter 3) and what is the
mechanism by which these proteins are delivered to the epithelial host
cell (Chapter 4)?
1.4.1 What are the host targeted effector proteins utilized during
Cryptosporidium infection?
Morphological, physiological and transcriptional differences are
observed as a consequence of Cryptosporidium infection, suggesting the
parasite modifies the host cell in some way during infection. Because
other pathogens utilize effector proteins to induce each of these changes,
I hypothesize that Cryptosporidium encodes effector proteins to
manipulate its host cell. I used the CRISPR/Cas9 system that permits
efficient genetic modification of Cryptosporidium (Vinayak et al., 2015) to
generate transgenic parasites with epitope tagged candidate proteins to
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assess export status using immunofluorescence assays (IFA). The
localization pattern of candidate proteins was characterized across the
parasite lifecycle, as there are multiple host-parasite interactions required
for completion of the lifecycle in which secreted effectors could be used. I
focused on candidate proteins belonging to highly polymorphic expanded
gene families of predicted secreted proteins, since host interacting
effector proteins of other eukaryotic pathogens often exhibit similar
characteristics. These approaches aid in preliminary identification of the
C. parvum exportome.
1.4.2 What is the mechanism by which exported proteins are
targeted to the epithelial host cell?
While the molecular components involved in protein export vary,
the overall mechanism of export is partially conserved across genetically
tractable Apicomplexa. Secreted effector proteins are injected into the
host cell at the time of invasion or processed and delivered to the host cell
by passage through a translocon made of parasite proteins following the
establishment of infection. Although the Cryptosporidium genome
encodes putative homologs of components of export machines, study of
the mechanism of export was hindered due to the lack of known host
targeted effector proteins. With the identification of MEDLE2 and other
exported proteins of C. parvum, I use molecular, cell biological, and
pharmacological tools to characterize the mechanism of export for
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Cryptosporidium, focusing on the attributes of MEDLE2 that promote
export. These findings were then applied in a targeted approach to
identify additional exported proteins of Cryptosporidium. The results of
these experiments inform how Cryptosporidium export relates to other
Apicomplexa and direct approaches to perturb the export process.

53

Figure1.1. A schematic representation an apicomplexan invasive
stage. The T. gondii tachyzoite is shown as a representative model of
apicomplexan invasive stages. The parasite is polarized with secretory
organelles (micronemes, rhoptries, and dense granules) localized to the
apical end of the parasite for contact with the host cell during invasion.
The inset depicts the apical tip containing the molecular machinery for the
invasion process, namely the conoid, polar ring and inner membrane
complex (IMC).
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Figure1.2. The anatomy of a Cryptosporidium sporozoite. The
molecular machinery involved in invasion (see inset) and the presence of
apical secretory organelles is conserved among Apicomplexa, but the
conoid is shorter. Note, in contrast to other apicomplexa, the
Cryptosporidium sporozoite has only a single rhoptry, a degenerate
mitochondrion-like organelle known as the mitsome, and lacks the
apicoplast.
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Figure1.3. A Cryptosporidium infected cell. Cryptosporidium infects
epithelial cells in a unique intracellular but extracytoplasmic localization.
The parasite resides within the parasitophorous vacuole (PV) and
establishes an elaborate membranous collection at the host-parasite
interphase called the feeder organelle. The PV containing the parasite sits
upon a dense band constructed following infection, separating it from the
remainder of the host cell.

56

Figure1.4. The Cryptosporidium Lifecycle. The lifecycle begins with
ingestion of oocysts containing infective sporozoites. Upon invasion, the
trophozoites grow and undergo multiple rounds of nuclear divisions by
asexual replication (merogony) to produce 8 merozoites, which
subsequently egress and reinvade nearby cells for additional cycles of
merogony. After 3 cycles of merogony, the population commits to
differentiation of sexual life stages (gametogony) from merozoites
egressing from a Type II meront. Microgametes (♂) egress to find and
fertilize an intracellular macrogamete (♀), leading to the production of new
oocysts to allow the lifecycle to continue through reinfection of the same
host or being shed to the external environment in to infect additional
hosts.
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Figure 1.5. Host targeted effector proteins of Apicomplexa.
Apicomplexan parasites such as Plasmodium falciparum and Toxoplasma
gondii utilize effector proteins to manipulate their resident host cells. Two
broadly conserved temporal patterns have been described for hosttargeted effector proteins: (i) effectors packaged into apical secretory
organelles which are injected during the invasion process or (ii) those that
are made after infection has been established and delivered to the host
cell by means of a translocon based mechanism. Exported proteins
adhering to each of the temporal patterns, the export mechanism, and
molecular export machines involved have been identified for P. falciparum
and T. gondii (see inserts); however, while it is hypothesized
Cryptosporidium also delivers effectors to the epithelial host cell, no such
proteins have been identified.
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Figure 1.6. The mechanism of protein export in Plasmodium
falciparum. Trafficking of host-targeted effectors begins with cotranslational processing of a subset of export-motif containing proteins.
The ER-resident aspartyl protease Plasmepsin V (PMV) processes
exported proteins containing the Plasmodium Export Element (PEXEL)
motif, which licenses the proteins for travel beyond the parasite.
Processed proteins reach the parasite plasma membrane through
vesicular trafficking and are released into the PV. Proteins destined for
the host cell are unfolded by HSP101 and are threaded through the
additional components of the Plasmodium Translocon of Exported
Proteins (PTEX), which bridges the PV and RBC cytoplasm. Additional
solutes and ions pass from the RBC to the PV and the reverse through
surface channels created by EXP1 and EXP2.
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Figure 1.7. Export mechanism of Toxoplasma gondii. Exported
effector proteins of Toxoplasma gondii are translated on ribosomes and
inserted into the secretory pathway. The Golgi-resident aspartyl protease
Asp5 processes exported proteins containing the Toxoplasma Export
Element (TEXEL) motif. The new N-terminus of the processed proteins is
acetylated, and vesicular trafficking continues to the parasite cell
membrane, where the proteins are thought to be released into the PV by
exocytosis. Proteins targeted to the host cell cross the PV by means of
the MYR export machine, a complex of proteins creating a channel
between the PV and host cell. The complete effector repertoire, the
molecular components of the machine, and energy source powering this
transport (if any) are still being identified. Additionally, the dense granule
proteins GRA17 and GRA23 dimerize to create a small pore in the
membrane of the PV (PVM) to facilitate the movement of small molecules
between the PV and the host cell.
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Figure 1.8. Hypothetical functions of exported proteins during the
Cryptosporidium life cycle. Exported proteins are hypothesized to
participate in a number of interactions with the host cell during the
Cryptosporidium life cycle. Proteins injected by sporozoites may aid in the
accomplishment of events required for the establishment of infection such
as attachment, invasion, construction of the host/parasite interface, and
reorganization of the actin cytoskeleton. Effectors delivered after infection
has been established are predicted to require a translocon-based method
of delivery and may perform roles in immune evasion, nutrient acquisition,
reprogramming of host transcription and alteration of cell death pathways.
Regardless of the temporal expression pattern, the exported protein
repertoire is thought to promote parasite survival within the novel
intracellular environment.
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Figure 1.9. A summary of immune evasion strategies. The immune
evasion strategies utilized by various bacterial (blue), viral (green) and
parasitic (red) pathogens to promote survival within the context of host
immunity are shown. While the replicative niche and obligate life cycles of
the pathogens vary, strategies for host manipulation and the pathways
targeted remain conserved. Pathogens utilize repertoires of effector
proteins both in the extracellular environment (orange) and delivered into
the host cell (yellow) to accomplish disruption of immune signaling and
modulation of host cell biology for benefit in the host-pathogen arms race.
Adapted from (Finlay and McFadden, 2006).
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Chapter 2: Materials and Methods
Mouse models of infection
Ifng-/- (stock no:002287) mice were purchased from Jackson Laboratory and
maintained as a breeding colony at the University of Pennsylvania. The age of all
mice used in this study ranged from 4 – 12 weeks. Both male and female Ifng-/mice were used to generate and propagate C. parvum transgenic parasite lines,
without a difference being noted in parasite shedding. All protocols for animal
care were approved by the Institutional Animal Care and Use Committee of the
University of Georgia (protocol A2016 01-028-Y1-A4) and the Institutional Animal
Care and Use Committee of the University of Pennsylvania (protocol #806292).

Parasite strains
Cryptosporidium parvum transgenic strains were generated and propagated in
Ifng-/- mice (stock no:002287). Oocysts were purified from collected feces using
sucrose flotation followed by a cesium chloride gradient (Pawlowic et al., 2017).
All Cryptosporidium parvum oocysts used in this study as WT controls, as well as
to generate transgenic strains, are on the IOWAII strain background, purchased
from Bunchgrass Farms (Dreary, ID).

Plasmid construction
Guide oligonucleotides (Sigma-Aldrich, St. Louis. MO) were introduced into the
C. parvum Cas9/U6 plasmid by restriction cloning, as detailed in (Pawlowic et al.,
63

2017). All plasmids encoding epitope tags and ectopically expressed MEDLE2
were constructed by Gibson assembly using NEB Gibson Assembly Master Mix
(New England Biolabs, Ipswich. MA). A linear repair template was generated by
PCR. See Supplementary Table 1 for a complete list of primers used for this
study.

Generation of transgenic parasites
Transgenic parasites were derived as previously described (Sateriale et al.,
2020). Briefly, 5 X 107 C. parvum oocysts were bleached on ice, washed in 1X
PBS and incubated in sodium taurodeoxycholate. Excysted sporozoites were
resuspended in transfection buffer supplemented with a total of 100 µg DNA
(comprising 50 µg of Cas9/gRNA plasmid and 50 µg of repair template generated
by PCR) and nucleofected using an Amaxa 4D nucleofector (Lonza, Basel,
Switzerland). Transfected parasites were resuspended in PBS and administered
to Ifng-/- mice by oral gavage. Mice were pretreated with antibiotics for 1 week
preceding infection and with sodium bicarbonate immediately before parasite
administration (Sateriale et al., 2020). Mice received 16mg/mL Paromomycin in
drinking water for selection. Transgenic parasites were detected by measuring
fecal nanoluciferase activity and purified from feces using sucrose flotation
followed by a cesium chloride gradient and stored in PBS at 4°C (Sateriale et al.,
2020).
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Nanoluciferase Assay to monitor parasite shedding
20 mg of fecal material was dissolved in nanoluciferase lysis buffer and mixed
1:1 with nanoluciferase substrate/nanoluciferase Assay Buffer (1:50) in a white
bottom plate. Relative luminescence was read using a Promega GloMax Plate
Reader.

Integration PCR to confirm generation of transgenic parasites
DNA was purified from excysted sporozoites using the Qiagen DNeasy Blood
and Tissue kit (Qiagen 69504). PCR primers were designed to anneal outside of
the 5’ and 3’ homology arms used to direct homologous recombination and
matched with primers annealing to the nanoluciferase reporter gene or the
Neomycin selection marker respectively. Primers for the thymidine kinase gene
served as control, unless otherwise noted. Where indicated, amplicons were
cloned using the ZeroBlunt TopoTA kit (Invitrogen 450245) and transformed into
One ShotTM Topo10 Chemically Competent E. coli (Invitrogen C404003).
Individual colonies were miniprepped and sequenced.

In vitro infection and Immunofluorescence Assay
Coverslips seeded with human ileocecal adenocarcinoma cells (HCT8)
(ATCC® CCL-244™) were infected when 80% confluent with 200,000 purified
oocysts (bleached, washed, and resuspended in RPMI medium containing 1%
serum). For time course infections, parasites were allowed to invade for 3h, then
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medium was removed, and the cells were washed with PBS to remove
unexcysted oocysts and replaced with fresh RPMI medium with 1% serum. At
indicated time points, cells were washed with PBS, and successively fixed and
permeabilized with PBS supplemented with 4% paraformaldehyde or 0.1% Triton
X-100 for 10 min each (Sigma St. Louis, MO). Coverslips were blocked with 1%
Bovine Serum Albumin (BSA) (Sigma St. Louis, MO). Antibodies were diluted in
blocking solution. The rat monoclonal anti-HA (Millpore Sigma, Burlington, MA,
USA) was used as primary antibody (1:500) and goat-anti-rat polyclonal Alexa
Fluor 594 (Thermofisher, Waltham, MA) as secondary along with Vicia villosa
lectin (Vector Labs Burlingame, CA, USA). Host and parasite nuclei were stained
with Hoechst 33342 (Thermofisher, Waltham, MA). Slides were imaged using a
Zeiss LSM710 Confocal microscope or a Leica Widefield microscope. For all
experiments utilizing both Myc and HA antibodies simultanelously, the mouse
anti-myc primary antibody (1:500) was used (Millpore Sigma, Burlington, MA,
USA), with a goat-anti-mouse 594 antibody (Thermofisher, Waltham, MA) and a
rabbit anti-HA antibody (1:500) was used (Cell Signaling Technologies, Danvers,
MA) with a goat-anti-rabbit 488 secondary antibody (Thermofisher, Waltham,
MA).

Immunohistochemistry on infected intestine
Infected Ifng-/- mice were euthanized at day 12 during peak infection, and the
distal 1/3 of the small intestine was dissected. The tissue was washed with PBS
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and ‘swiss-rolled’ and fixed overnight in 4% Paraformaldehyde at 4°C, placed in
30% sucrose in PBS for cryoprotection, and mounted with OCT compound
(Tissue-Tek, Sakura Finetek, Japan) and frozen. Cryomicrotome sections were
permeabilized and blocked and labeled as described above (Alexa Fluor 647
Phalloidin (Thermofisher, Waltham, MA) was used in addition). Sections were
imaged using a Zeiss LSM710 Confocal Microscope.

Poly-L-Lysine treatment of coverslips and sporozoite IFA
Sterile coverslips were treated with Poly-L-Lysine (Sigma, St Louis, MO, USA),
washed with water for 5 min and airdried. Sporozoites suspended in PBS were
allowed to settle on treated coverslip for 1h prior to fixing and IFA. Primary
antibodies used were mouse anti- Cp23 (1:100) (LS Bio Seattle, WA) and rat
monoclonal anti-HA (1:500). Secondary antibodies include: goat-anti-rat
polyclonal Alexa Fluor and goat-anti-mouse polyclonal Alexa Fluor 488 (both
1:1000, Thermofisher, Waltham, MA).

Brefeldin A (BFA) treatment during C. parvum infection
Excysted oocysts were allowed to invade HCT-8 coverslip cultures for 3h,
unexcysted oocysts were removed by PBS wash, and cultures we replaced with
medium supplemented with 1% serum and 10 µg/mL BFA from a 1000X stock in
DMSO. Medium supplemented with carrier alone served as control. Cultures
were fixed and processed 10h post infection.
67

OT-1 transfer and flow cytometry
10,000 OT-I (OVA-specific CD8+ T cells) cells were transferred to 4 Ifng-/- KO
mice 24 hours prior to infection. 2 mice were infected with 10,000 MEDLE2-OVA
oocysts by oral gavage, while the remaining 2 mice were used as an uninfected
control. 10 days post infection, IELs, MLNs, and spleens were isolated, prepared
for flow cytometry and stained for viability, with antibodies recognizing CD19,
NK1.1, CD3, CD8a, CD4, CD45.1, CD45.2, SIINFEKL-tetramer, EpCAM, and
mNeon. Side scatter (SSC) and forward scatter (FSC) were used to identify
single cells. CD19+NK1.1+CD3+ cells were selected to identify the CD+4 and
CD8+ T cells, which were subsequently distinguished based upon staining with
their respective antibodies. Staining with the SIINFEKL tetramer and CD45.1
antibody were used as an indication of CD8+ T cells with OVA antigen
experience.

Generation of MEDLE2 mutant plasmids for host cell transfection
Human codon optimized MEDLE2 lacking the N terminal signal peptide (aa 21209) was synthesized by Integrated DNA Technologies (IDT, Coralville, IA) and
cloned into the mEGFP-Lifeact-7 mammalian expression plasmid (Addgene
#54610), replacing Lifeact and appending a 3x HA tag. Point mutations were
engineered by Gibson cloning. HEK293T cells (ATCC®CRL-3216TM) were
transfected with 5 µg of each plasmid using Lipofectamine®P3000
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(ThermoFisher Scientific Waltham, MA). 24h post transfection, cells were
harvested and processed for Western Blot analysis.

Flow Cytometric analysis of transfected cells
HEK293T cells were subjected to lipofection with 25 µg GFP only plasmid or
MEDLE2-GFP plasmid, grown for 24h, trypsinized, washed and resuspended in
PBS with DAPI and passed through a 40 µM filter (BD Biosciences San Jose,
CA). Cell viability was gated based upon DAPI staining. Untransfected HEK293T
cells served as negative controls and GFP expressing HEK293T cells as positive
controls to establish gates. 10,000 green, single cells were double sorted using
an Aria C flow cytometer first into PBS then into lysis buffer (3 biological
replicates for each condition).

RNA extraction sequencing and data analysis
Total RNA was extracted using the Qiagen RNeasy Microkit (Qiagen,
Germantown, MD) and input RNA was quality controled and quantified using a
Tape Station 4200 (Aglient Technologies Santa Clara, CA). cDNA synthesis was
performed following the clonTechSMART-seq cDNA synthesis protocol (15
cycles). Following DNA cleanup, a Nextera library was prepared and nucleic acid
was quantified using the Qubit 3 Fluorometer (Thermo Fisher Scientific Waltham,
MA). Samples were pooled for RNAsequencing of 4 nM of total cDNA and
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sequencing was performed using a NextSeq 500 Instrument (Illumina Inc San
Diego, CA).
RNAseq reads were pseudo-aligned to the Ensembl Homo sapiens
reference transcriptome v86 using kallisto v0.44.0 (Bray et al., 2016). In R,
transcripts were collapsed to genes using Bioconductor tximport (Robinson et al.,
2010) and differentially expressed genes were identified using Limma-Voom
(Law et al., 2014; Ritchie et al., 2015). The MEDLE2 transcription response data
set can be found under GEO accession number GSE174117. Gene set
enrichment analysis (GSEA) was performed using the GSEA software and the
annotated gene sets of the Molecular Signatures Database (MSigDB) (Mootha et
al., 2003; Subramanian et al., 2005). The MEDLE2 signature was generated from
the differentially expressed genes and read into GSEA to evaluate its presence in
published datasets of C. parvum infection (Nikolaev et al., 2020b; Saxena et al.,
2017).

qPCR for MEDLE2 response genes
Ifng-/- mice were infected with 10,000 C. parvum oocysts and the infection was
tracked by fecal nanoluciferase activity. Mice were euthanized after 10 days and
the distal 1/3 of the small intestine was removed. The tissue was washed with 1X
PBS until clear of fecal material and then cut longitudinally. 5 mm diameter gut
punches were made and preserved in RNAlaterTM solution (Thermo Fisher
Scientific Waltham, MA). RNA was extracted from tissue samples using the
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Qiagen RNeasy MiniKit (Qiagen, Germantown, MD) following homogenization
with a bead beater and passage through a QIAshredder (Qiagen, Germantown,
MD). 5 µg of cDNA was reverse transcribed using the SuperScriptTM First Strand
Synthesis kit following the manufacturer’s instructions for use with OligoDT
(Thermo Fisher Scientific Waltham, MA). qPCR was performed using a ViiaTM7
Real-time PCR System (Thermo Fisher Scientific Waltham, MA) and relative
gene expression was determined using the DDCT method.

Live imaging of Beta-Lactamase Reporter Assay
1 X106 WT and MEDLE2-BLA oocysts were used to infect HCT8 cells in a 35 mm
glass bottom dish (MatTek Life Sciences Ashland, MA). After 24h, the medium
was replaced with RPMI medium containing CCF4-AM substrate from the
LiveBLAzerTM FRET-B/G Loading Kit (ThermoFisher Scientific Waltham, MA).
Cells were incubated in the dark at 37°C for 1h, washed with PBS 3 times and
live imaged using a Leica SP5 Confocal Microscope using a water immersion
lens.

Cre recombinase reporter assay by flow cytometry
Pre-made lentivirus was used to transform HCT8 cells with a loxP GFP/RFP
color switch cassette (GenTarget Inc San Diego, CA). Cells were selected with
400 mg/mL Neomycin (Millpore Sigma, Burlington, MA) for 14 days and validated
by transfection with 5 µg Cre recombinase plasmid using LipofectamineP3000
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(ThermoFisher Scinetific Waltham, MA). After 24h and 48h, cells were
trypsinized and flow sorted using a LSRFortessa (BD Biosciences) and data
were analyzed with FlowJo v10 software (TreeStar).
1 X 106 WT and MEDLE2- Cre oocysts were used to infect 6 well cultures
of Lox GFP/RFP color switch cells. After 48h, cells were trypsinized and
resuspended in 1 mL PBS. 300 µL were used for Nanoluciferase assay and 700
µL cells for flow cytometry. Forward and side scatter was used to gate viability,
untransfected uninfected cells to establish the green gate, and Cre recombinase
transfected cells for the red gate.

In vitro parasite growth assay
Transgenic parasites containing the nanoluciferase reporter gene were excysted
as previously described (Pawlowic et al., 2017) and used to infect HCT8 cells
(10,000 parasites/well). At the indicated timepoints post infection, the medium
was removed from the infected cells and replaced by the nanoluciferase cell lysis
buffer (Pawlowic et al., 2017). Cells were incubated for 5 min at 37°C before
transferring the lysate and mixing 1:1 with nanoluciferase
substrate/nanoluciferase Assay Buffer (1:50) in a white bottom plate. Relative
luminescence was read using a Promega GloMax Plate Reader.

72

In vivo competition assay
8-week-old Ifng-/- mice were infected with 3,500 trpBMEDLE2 parasites and
3,500 dominant negative parasites. At the time of infection, fecal samples were
collected as the uninfected starting control. Furthermore, 7,000 oocysts (3,500
trpBMEDLE2 and 3,500 dominant negative) were saved as the initial allele
frequencies at day 0. Feces were collected from the infected mice every other
day for the duration of the 14-day infection. Genomic DNA was extracted from
the samples for qPCR analysis. Dominant negative parasites were serially diluted
for gDNA extraction to generate a standard curve from which quantification of
allele frequencies could be performed. gDNA isolated from fecal material was
diluted 1:200 and used for qPCR with a ViiaTM7 Real-time PCR System (Thermo
Fisher Scientific Waltham, MA). Allele frequencies for genes of interest (TK,
mDHFR) were calculated using the standard curve method.

Western Blot on C. parvum Infected Cells
HCT8 cultures were infected with 5 x 106 oocysts were for 48h and then were
treated with Trypsin- 0.25% EDTA (ThermoFisher Scientific, Waltham, MA),
pelleted, and flash frozen in liquid nitrogen. Cell pellets were lysed in PierceTM IP
Lysis Buffer (ThermoFisher Scientific, Waltham, MA), supplemented 1:100 with
both protease inhibitor cocktail (Sigma St. Louis, MO) and benzonase nuclease
(Millpore Sigma Burlington, MA). Lysates were incubated on ice for 15 min,
sonicated (80% amplitude, 10 second pulses, rest on ice for 1 min between 3
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times) cleared by centrifugation (20,000 g, 10 min, 4°C), mixed with freshly
prepared Lamelli Sample buffer (Millpore Sigma Burlington, MA) + bMercaptoethanaol (1:20) (Sigma St. Louis, MO), boiled and loaded on a 12%
Mini-PROTEAN® TGX™ Precast Protein Gel (BioRad Hercules, CA) run at 70 V
for 2.5h. Gels were transferred to 0.45 µm pore size Nitrocellulose membrane
(ThermoFisher Scientific Waltham, MA) overnight at 0.02 A at 4°C. The
membrane was blocked for 1h with Intercept (TBS) Protein-Free Blocking Buffer
(LI-COR Lincoln, NE), antibodies we diluted in blocking solution with 0.01%
Tween®20 (Sigma, St. Louis, MO) using rat monoclonal anti-HA 1:500 (Millpore
Sigma, Burlington, MA) and rabbit anti-neomycin phosphotransferase II 1:1000
(Millpore Sigma, Burlington, MA) as primary and IRDye® 800CW Goat anti-Rat
IgG and IRDye® 680RD Goat anti-Rabbit IgG (both 1:10,000, LI-COR, Lincoln,
NE) as secondary antibody. Washed membranes were imaged using a Odyssey
Infrared Imaging System v3.0 (LICOR, Lincoln, NE).

Treatment of parasites with peptidomimetic compounds
10,000 MEDLE2-HA-tdNeon parasites were bleached, washed, and incubated
for 10 minutes in 0.8% sodium taurodeoxycholate to induce excystation, as
previously described (Pawlowic et al., 2017). Following excystation, parasites
were resuspended in RPMI medium supplemented with 1% serum containing
each of peptidomimetic compounds resembling the KDVSLI motif (synthesized
by Brad Sleebs at WEHI) to a final concentration of 10 µM and placed at 37°C to
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continue excystation for 1h. The parasites were resuspended and used to infect
a HCT8 cells in a 96 well clear bottom plate (6 wells/drug treatment). Parasites
excysted in the presence of DMSO vehicle were used as a control. 10h post
infection, the cells were fixed and prepared for IFA. The plate was imaged with a
scanning function, using the 60x objective on an ImageXpress Confocal
Microscope (Molecular Devices, San Jose, CA) and image quantification of
average fluorescence intensity was performed with MetaMorph software.

Rapamycin Inducible DiCre Knockdown of gene expression In vitro
PMV2 flox parasites were excysted as previously described (Pawlowic et al.,
2017) and used to infect HCT8 cells in the presence (+ 100 nM Rapamycin ) and
absence of rapamycin added to the medium at the time of infection. At 12h
intervals across a 72h infection, gDNA was extracted from the infected cells
using the Qiagen Blood and Tissue kit (Qiagen 69504). gDNA samples were
diluted 1:10 and used for PCR with primers designed to anneal within the PMV1
gene (5’) and after the loxP sites (3’). The resulting PCR products were run on a
3% agarose gel to distinguish between the small size fragments.

Quantification and Statistical Methods
GraphPad PRISM was used for all statistical analyses. When measuring the
difference between two populations, a standard t-test was used. For data sets
with 3 or more experimental groups, a one-way ANOVA with Dunnett’s multiple
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comparison’s test was used. Simple Linear Regression was used to determine
the goodness of fit curve for the number of MEDLE2 expressing cells and
intracellular parasites. Quantification of imaging experiments was performed
using ImageJ macros programmed to count both parasites and host cell nuclei in
blinded images that were captured using a scanning function to avoid bias during
acquisition. The MetaMorph imaging software was used to quantify the average
fluorescence intensity of MEDLE2 expressing cells.
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Chapter 3: Cryptosporidium parvum translocates the MEDLE2 effector
protein into the cytoplasm of the host cell
Parts of the content of this chapter were submitted for publication in eLife.
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3.1 Abstract
The parasite Cryptosporidium is responsible for diarrheal disease in young
children causing death, malnutrition, and growth delay. Cryptosporidium invades
enterocytes where it develops in a unique intracellular niche. Infected cells
exhibit profound changes in morphology, physiology and transcriptional activity.
How the parasite effects these changes is poorly understood, but we hypothesize
Cryptosporidium accomplishes these host modifications through the use of
exported effector proteins during infection. We used genetic approaches to
explore the localization of highly polymorphic proteins and found members of the
C. parvum MEDLE protein family to be translocated into the cytoplasm of
infected cells. One such protein, MEDLE2, is constitutively exported in high
abundance across the lifecycle of the parasite. All intracellular life stages engage
in MEDLE2 export following initial invasion events and the establishment of
infection. Proper host targeting of MEDLE2 required trafficking through the
canonical secretory pathway of the parasite and chemical inhibition of this
transport resulted in ablation of export. The host cytoplasmic localization of
MEDLE2 could be used to deliver model antigens to the host cell establishing
tools to interrogate host-pathogen interactions. Direct expression of MEDLE2 in
mammalian cells triggered an ER stress response, which was similarly observed
during infection. Taken together, our studies reveal the presence of a
Cryptosporidium secretion system capable of delivering exported proteins into
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the infected enterocyte and indicate the first functional consequence of the
introduction of such factors into the host cells.
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3.2 Introduction
The Apicomplexan parasite Cryptosporidium is a leading cause of
diarrheal disease worldwide. Young children are highly susceptible to infection
and cryptosporidiosis is an important contributor to child mortality (Khalil et al.,
2018; Kotloff et al., 2013). Children in resource poor settings carry a
disproportionate burden of severe disease (Choy and Huston, 2020). Malnutrition
enhances the risk of severe cryptosporidiosis, and at the same time, the disease
impacts the nutritional state of children, which can lead to impaired growth (Costa
et al., 2011; Mondal et al., 2009). Infection with the parasite results in protective
immunity, but this immunity is not sterile and may require multiple exposures to
develop (Chappell et al., 1999; Okhuysen et al., 1998). Most human disease is
due to infection with C. hominis, which only infects humans, and C. parvum,
which can be zoonotically transmitted (Feng et al., 2018; Nader et al., 2019). The
emergence of Cryptosporidium species is driven by host adaptation resulting in
specialization and narrowing host specificity; however, the sexual lifecycle of the
parasite allows for recombination and can lead to rapid convergent evolution of
host specificity (Guo et al., 2015; Nader et al., 2019).
Cryptosporidium infects the epithelium of the small intestine, where it lives
in a unique intracellular, but extracytoplasmic niche (Elliott and Clark, 2000). The
mechanism by which this niche is established during invasion is still debated but
involves the rearrangement of the host actin cytoskeleton, the formation of tight
junction-like structures between host and parasite membranes, and a dense
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band of unknown composition at the host-parasite interphase (Bonnin et al.,
1999; Elliott and Clark, 2000). Cryptosporidium has severely reduced metabolic
capabilities and relies heavily upon the host cell for nutrients and metabolites
(Abrahamsen et al., 2004; Xu et al., 2004). A number of specialized uptake
mechanisms have been proposed to fill this need, many of which are believed to
be localized to the so-called feeder organelle at the host parasite interface
(Perkins et al., 1999). Cryptosporidium infection remodels the host cell in
numerous ways, including its cytoskeleton (Bonnin et al., 1999; Elliott and Clark,
2000), cellular physiology and metabolism (Argenzio et al., 1990; Kumar et al.,
2018), as well as aspects of immune restriction and regulation (Laurent and
Lacroix-Lamandé, 2017).
Bacterial, protozoan and fungal pathogens use translocated effectors to
manipulate their hosts, to secure nutrients, and to block host immunity. In
Plasmodium falciparum, exported effectors form adhesive structures on the
surface of red blood cells to alter tissue distribution and mechanical properties to
prevent clearance (Crabb et al., 1997; Leech et al., 1984) and install new nutrient
and ion uptake mechanisms (Baumeister et al., 2006). In Toxoplasma gondii,
translocated effectors disarm critical elements of interferon induced cellular
restriction (Gay et al., 2016; Olias et al., 2016), establish access to cellular
nutrients, and rewire signaling and transcriptional networks to antagonize
immune responses to promote a favorable environment for parasite growth
(Bougdour et al., 2013; Braun et al., 2013; Braun et al., 2019; Gold et al., 2015).
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Cryptosporidium has been hypothesized to use exported effector proteins to
ensure its survival (Pellé et al., 2015); however, to date, no such factors have
been identified. Here we focused upon expanded families of polymorphic
proteins and report that members of the MEDLE protein family are exported to
the host cell cytoplasm. The protein MEDLE2 is robustly exported by all stages of
the C. parvum lifecycle in vitro and in vivo. This protein is not injected during
invasion, but rather is transported into the host cell following the initial
establishment of infection for the duration of the parasite lifecycle. Due to its host
cell cytoplasmic localization, MEDLE2 can be used as a tool to deliver model
antigens to infected cells for characterization of the anti-Cryptosporidium immune
response. The kinetics of MEDLE2 export revealed the presence of a
translocation mechanism established by intracellular parasites and we found that
this system requires transit through the canonical secretory pathway. Finally, we
explored putative functions of MEDLE2 during C. parvum infection and
uncovered a potential role in inducing an ER stress response.
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3.3 Results
The Cryptosporidium parvum protein MEDLE2 is exported into the host
cell.
The genome of Cryptosporidium parvum encodes multiple families of
paralogous proteins which carry N-terminal signal peptides and share conserved
amino acid repeat motifs among family members (Abrahamsen et al., 2004).
These genes are often found within clusters (homologous and heterologous),
many of which are located proximal to the telomeres of multiple chromosomes
(Figure 3.1A). Comparing strains and species, these genes are highly
polymorphic and vary in copy number, which has been interpreted as sign of
rapid evolution driven by their roles in invasion, pathogenesis, and host cell
specificity (Guo et al., 2015; Nader et al., 2019; Xu et al., 2019). We
hypothesized that such roles might be reflected in the targeting of presumptive
effectors to the host cell and selected representatives from each polymorphic
gene family for initial localization studies (Supplementary Table 1). Selected loci
were modified in the C. parvum IOWAII isolate using CRISPR/Cas9 driven
homologous recombination (Vinayak et al., 2015) to append three hemagglutinin
epitopes (3XHA) in translational fusion to the C-terminus (Figure 3.1B). Drug
resistant parasites were recovered for four of six initial candidates and successful
genomic insertion was mapped by PCR (Figure 3.1C and Supplementary Figure
3.1). We next infected human ileocecal colorectal adenocarcinoma cell cultures
(HCT-8) with transgenic parasites and assessed the localization of the tagged
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proteins by immunofluorescence assay (IFA, Figure 3.1D & E). For most
candidates, the tagged protein (red) appeared to coincide with the parasite
and/or the parasitophorous vacuole (cgd8_3560, Figure 3.1D, Supplementary
Figure 3.1). In contrast, upon infection with parasites tagged in the MEDLE2
locus (cgd5_4590), HCT-8 cells showed HA staining in the cytosol (Figure 3.1E).
We note that the cells that stain for HA (red) were those that were infected with
parasites, labeled with Vicia villosa lectin (VVL, green), and conclude that
MEDLE2-HA is exported by the parasite into the host cell during or following
invasion.
We investigated whether other members of the MEDLE gene family are
similarly exported and selected MEDLE1 (cgd5_4580) and MEDLE6
(cgd6_5490) for epitope tagging. In IFAs, both tagged MEDLE1 and MEDLE6
localized around the parasite, as well as to the host cell cytoplasm, but
expression and export was reduced when compared with MEDLE2
(Supplementary Figure 3.3). To explore this difference, we engineered a chimeric
mutant carrying an extra copy of MEDLE1-HA driven by the MEDLE2 promoter.
Upon infection with these parasites, we observed increased MEDLE1 expression
making export into the host cell easier to appreciate (Supplementary Figure 3.3).
We conclude that multiple members of the MEDLE family are host targeted
proteins. Of these, MEDLE2 was expressed and exported most robustly and was
selected for further study.
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MEDLE2 is exported across the C. parvum lifecycle in culture and infected
animals
To better understand export of MEDLE2 to the host cell, we next
engineered a reporter parasite in which the endogenous locus of MEDLE2 was
3XHA epitope tagged, and these parasites expressed a tandem mNeon green
fluorescent protein in their cytoplasm to allow for identification and quantification
of parasites (MEDLE2-HA-tdNeon, Supplementary Figure 3.4). These parasites
were then used in time course experiments across the 72 hours of infection
afforded by the HCT-8 culture model. Following inoculation with sporozoites,
cultures were fixed in 12-hour increments and processed for IFA. MEDLE2 was
observed at all timepoints (Figure 3.2A) and quantification showed that the
number of HA positive host cells (red, Figure 3.2B) increased over time, closely
matching the increase in the number of parasites (blue). 94 % ± 1.83 (Mean ±
SD, n= 3695) of the cells showing HA staining also showed parasite infection.
Importantly, this high level of correlation between host cell HA expression and
infection (r2 = 0.9) remained constant over 72 hours. Previous work has shown
synchronous lifecycle progression over this time span. Initially, all parasites
represent asexual stages replicating by merogony followed by a dramatic
development switch at 40 hours, and later cultures are dominated by male and
female gametes (Tandel et al., 2019). We staged parasites at 48 hours and
identified female gametes and male gamonts using antibodies for the markers

85

COWP1 and tubulin, respectively. We found the host cells infected with all of
these stages to be positive for MEDLE2-HA (Figure 3.2D).
We also tested whether MEDLE2 export occurs in vivo. Susceptible Ifng-/mice were infected with 10,000 oocysts of the reporter strain, and after 12 days,
mice were euthanized, the ileum was resected, fixed, and processed for
histology. As shown by immunohistochemistry of sections of infected intestines in
Figure 3.2E, MEDLE2 was exported to infected cells in vivo and exhibited
cytoplasmic localization.

MEDLE2 is expressed and exported by trophozoites once infection has
been established
Two broadly conserved temporal patterns have been described for hosttargeted effectors in Apicomplexa (Figure 3.3A). Those involved in early aspects
of the infection are packaged into the rhoptry organelle and injected during
invasion (Rastogi et al., 2019). A second wave of proteins is translated and
exported after the parasite has established its intracellular niche and they are
delivered to the host cell by a translocon-based mechanism (de Koning-Ward et
al., 2009; Franco et al., 2016) . For this reason, we next determined the timing of
MEDLE2 expression using IFA of wild type (WT) and transgenic sporozoites
mounted to cover glass with poly-lysine. We readily observed labeling for the
sporozoite antigen Cp23 but did not detect any HA staining in transgenic
sporozoites, indicating that MEDLE2 is not pre-packaged into secretory
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organelles (Figure 3.3B). We then stained intracellular stages at different
timepoints following invasion to determine the kinetics of MEDLE2 expression
and export. At 4 hours, HA is first detectable, with labeling being associated with
the parasite (parasite nuclei stained with Hoechst highlighted by white
arrowheads). Beginning at 5.5 hours, MEDLE2-HA staining was observed
throughout the host cell cytoplasm and continued to accumulate over time
(Figure 3.3C).
MEDLE2 is predicted to be a 209 amino acid protein with a putative Nterminal signal peptide suggesting trafficking through the parasite’s secretory
pathway. To test this, we used Brefeldin A (BFA) which blocks passage through
the secretory pathway between the ER and Golgi. Cells were infected with
MEDLE2-HA parasites, treated with BFA beginning 3 hours post-infection, and
fixed for IFA after 10 hours to assess MEDLE2 localization. BFA treatment
initiated after invasion ablated export and resulted in the accumulation of
MEDLE2-HA within the parasite (Figure 3.3D). Image analysis and quantification
showed this reduction in export to be significant when comparing treated (red) to
untreated cells (blue) (n = 98 treated; n = 198 untreated; p < 0.0001; unpaired t
test with Welch’s correction; Figure 3.3E). We conclude that MEDLE2 is not
injected by the sporozoite during invasion; rather, it is expressed and exported by
the trophozoite and arrives in the host cell about 5 hours post infection (note that
the length of the intracellular lytic cycle of asexual stages is 11.5 hours (Guerin,
in press 2021).
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MEDLE2 can be used to deliver model antigens to the host cell
Model antigens have been utilized to evaluate antigen-specific cellular
responses to vaccine delivery systems and a variety of pathogens, as well
characterized reagents, cell lines and animals facilitate their use to probe hostpathogen interactions for otherwise intractable systems (Garg et al., 1997; Gregg
et al., 2011; Gubbels et al., 2005; Lin et al., 2014). Ovalbumin (OVA), the major
protein component of chicken egg-white, is a model antigen that relies upon
processing and presentation of the SIINFEKL peptide by Class I MHC to CD8+ T
cells. We hypothesized that MEDLE2, as a protein exported to the host cell, is
subject to immune surveillance and recognition. To test this, we used a model
antigen, which also afforded the first opportunity to develop Cryptosporidiumspecific tools to probe immunity. We engineered a construct in which an HA tag
and the 12 aa SIINFEKL peptide of the ovalbumin protein were appended to the
C-terminus of MEDLE2 (Figure 3.4A). PCR mapping of the MEDLE2 locus
revealed proper integration of both the HA and OVA tags, as well as the
presence of the nanoluciferase reporter and the neomycin selection marker
(Figure 3.4B). MEDLE2-OVA parasites were then used to infect HCT8 cells for
24h before fixation and preparation of cells for IFA. Visualization by microscopy
indicated MEDLE2-OVA was exported to the host cell cytoplasm of infected cells,
similar to the previously observed localization of the MEDLE2-HA tagged protein
(Figure 3.4C). Because MHC-I surveys and presents antigens from intracellular
derived proteins, we next tested whether the MEDLE2 protein was processed
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and recognized by the corresponding CD8+ T cells. 10,000 T cells from OT-1
mice, which have transgenic T cell receptors specific for ovalbumin in the context
of MHC Class I were transferred to Ifng-/- KO mice 24h prior to infection with
MEDLE2-OVA parasites. 10 days post infection, intraepithelial lymphocytes
(IELs), mesenteric lymph nodes (MLNs), and spleens were isolated, stained, and
flow sorted for live CD8+ T cells specific for the OVA peptide (SIINFEKL)
according to the gating strategy shown in Supplementary Figure 3.5. An
expansion of OVA-specific CD8+ T cells was detected in all tissue types
compared to no expansion in the uninfected controls(Figure 3.4D). Quantification
of the OVA specific-CD8+ T cells revealed the expansion cells was most enriched
in IEL population compared to cells taken from uninfected controls, with 5.9% of
the CD8+ T cells in this compartment being OT-1 cells (Figure 3.4E).
Furthermore, transfer of OT-1 cells prior to infection with MEDLE2-OVA parasites
reduced the magnitude of infection (Figure 3.4F). We conclude that MEDLE2 can
be used as a tool to deliver model antigens to the host cell and that the immune
system responds vigorously to this antigen with a CD8+ T cell response in
particular in the IEL compartment and that this response affords partial protection
against Cryptosporidium infection.

MEDLE2 induces an ER stress response in the host cell
To begin to understand the consequence of MEDLE2 export on the host
cell, we expressed the protein in human cells. MEDLE2 omitting the N terminal
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signal peptide (aa 2-20) was codon optimized for human cell expression,
appended to the N-terminus of GFP, and the resulting plasmid introduced into
HEK293T cells by lipofectamine transfection. The GFP-only parent plasmid
served as control. Transfection with both constructs resulted in cytoplasmatic
green fluorescence in roughly 40% of cells 24 hours post transfection (Figure
3.5A). At this time point, GFP positive cells were enriched by flow cytometry and
the resulting populations were subjected to mRNA sequencing (3 biological
repeats for each sample, Figure 3.5B). Differential gene expression analysis
revealed 413 upregulated genes and 487 genes with lower transcript abundance
in MEDLE2-GFP expressing cells compared to cells expressing GFP alone, with
an adjusted p-value less than 0.05 (Figure 3.5C). Gene set enrichment analysis
showed upregulation in the response to ER stress, including changes in genes
linked to the unfolded protein response (UPR). Genes that are part of the core
enrichment of the ER stress response are highlighted (red) in the volcano plot
and the most upregulated genes are identified by name (Figure 3.5D). Genes
that were differentially expressed at an adjusted p-value less than 0.01 were
used to derive a MEDLE2 response signature from the transfected cell dataset
(234 genes). Using a published mRNA sequencing dataset generated from C.
parvum infection of a homeostatic mini-intestine model (Nikolaev et al., 2020b),
we found enrichment for this MEDLE2 response signature with 51 genes of the
MEDLE2 response present, and 22 of them contributing to the core enrichment
of this response (Figure 3.5E). To test whether this ER stress response also
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occurs during in vivo infection, we performed qPCR on ileal segments resected
from mice infected with C. parvum or those that were uninfected. We measured
the RNA abundance for the four genes highlighted in the volcano plot and found
three to be upregulated in infected mice compared to uninfected controls
(NUPR1, CHAC1, DDIT3, Figure 3.5F). We conclude that an ER stress response
triggered by ectopic expression of MEDLE2 in mammalian cells is also observed
during parasite infection in culture and mice.
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Figure 3.1. MEDLE2 is exported to the host cell cytoplasm.
(A) Schematic overview of the chromosomal location for polymorphic gene
families in the C. parvum genome.
(B) Map of the MEDLE2 locus targeted in C. parvum for insertion of a 3X
hemagglutinin epitope tag (HA), a nanoluciferase reporter gene (Nluc), and
neomycin phosphotransferase selection marker (Neo).
(C) PCR mapping of the MEDLE2 locus using genomic DNA from wild type (WT)
and transgenic (MEDLE2-HA) sporozoites, corresponding primer pairs are shown
in B, and thymidine kinase (TK) gene used as a control. Note, the presence of
two bands in the 5’ – 3’ amplification, indicating the presence of a transgene
(3081 bp) and persistence of an unmodified copy (1174 bp), suggesting multiple
copies of MEDLE2 in the C. parvum genome, also see Supplementary Figure
3.2.
(D-E) HCT-8 cultures were infected with WYLE4-HA (D) or MEDLE2-HA (E)
transgenic parasites and fixed after 24h for IFA. Red, antibody to HA; green,
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Vicia villosa lectin stain, VVL (Gut and Nelson, 1999); blue, Hoechst DNA dye.
Additional genes targeted and the localizations of their products are summarized
in Supplemental Table 1 and Supplementary Figures 3.1.
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Figure 3.2. Infected cells express MEDLE2-HA across the parasite lifecycle.
(A) 200,000 MEDLE2-HA-tdNeon transgenic parasites were used to infect HCT8
cells and fixed at intervals across a 72h time period. Data shown are
representative images from triplicate coverslips processed for IFA. Red, HA
tagged protein; green, parasites (mNeon); blue, Hoechst.
(B-C) Quantification of MEDLE2 expressing cells (red) versus intracellular
parasites (blue) for 3695 host cells evaluated across a 72h time course. 20 fields
of view quantified using ImageJ to identify host cells and parasites (B). The
percentage of cell exhibiting MEDLE2-HA and mNeon staining is constant across
the time course with a cumulative 94 % ± 1.83 (Mean ± SD) (C).
(D) HCT-8 cultures infected with MEDLE2-HA parasites were fixed for IFA at 48h
when sexual life stages were present. Cells were stained with stage specific
antibodies for female (COWP1) and male (α- tubulin) demonstrating MEDLE2 is
exported across the parasite lifecycle. Red, HA tagged protein; green, parasites
(stage specific antibody); blue, Hoechst.
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(E) IFA of cryosections from the small intestine of Ifng-/- mice infected with
MEDLE2-HA-tdNeon C. parvum (images representative of samples from 3 mice).
Red, HA tagged protein; green, parasites (tdNeon); blue, Hoechst; grey,
Phalloidin (actin).
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Figure 3.3. MEDLE2 is expressed by trophozoites and passes through the
secretory pathway.
(A) Schematic representation of hypothetical patterns of MEDLE2 export in C.
parvum.
(B) IFA of WT and MEDLE2-HA sporozoites fixed on Poly-L-Lysine treated
coverslips. We note that MEDLE2-HA is not observed in sporozoites. Red, HA
tagged protein; green, sporozoite antigen Cp23; blue, Hoechst.
(C) HCT-8 cells infected with MEDLE2-HA parasites were fixed in 30 min
increments and processed for IFA. Data shown are representative images from a
time course bridging 3h (no observed MEDLE2-HA) and 6h (MEDLE2-HA
abundant in host cell). White arrowheads denote parasite nuclei. Red, HA tagged
protein; blue, Hoechst.
(D) MEDLE2-HA parasites were excysted and used to infect HCT8 and after 3h
media were supplemented with BFA (10 ug/mL). 10h post infection, cells were
96

fixed and processed for IFA. Red, HA tagged protein; green, parasites (VVL);
blue, Hoechst.
(E) The impact of BFA treatment on MEDLE2-HA export was quantified showing
a significant reduction in MEDLE2 export when comparing BFA treated (red) and
untreated cells (blue), (n = 191 untreated, n = 98 treated; mean ± SEM; p <
0.0001; unpaired t test with Welch’s correction).
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Figure 3.4 MEDLE2 can be used to deliver model antigens to the host cell
for interrogation of host-parasite interactions.
(A) Map of the MEDLE2 locus targeted for insertion of a 3X HA epitope tag and
an OVA (SIINFEKL) peptide on the C-terminus of the gene. Also introduced were
the nanoluciferase reporter gene (Nluc), and neomycin phosphotransferase
selection marker (Neo).
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(B) PCR mapping of the MEDLE2 locus using genomic DNA isolated from wild
type (WT) and transgenic (MEDLE2-OVA) sporozoites. Primer pairs are shown in
A, and thymidine kinase (TK) gene used as a control. Note, the presence of two
bands in the 5’ – 3’ amplification, indicating the presence of a transgene (2787
bp) and persistence of an unmodified copy (1174 bp), which supports previous
observations that there are multiple copies of MEDLE2 in the C. parvum genome.
(C) MEDLE2-OVA transgenic parasites were used to infect HCT8 cells. After 24
hours, cells were fixed and prepared for IFA. MEDLE2-OVA is exported to the
cytoplasm of infected host cells. Red, HA tagged protein; green, parasites; blue,
Hoechst.
(D-E) 10,000 OT-I cells were transferred to Ifng-/- KO mice 24h prior to infection
with MEDLE2-OVA oocysts by oral gavage. 10 days post infection, intraepithelial
lymphocytes (IELs), mesenteric lymph nodes (MLNs), and spleens were isolated,
stained, and separated by flow cytometry to identify live, OVA-experienced CD8+
T cells according to the gating strategy outlined in Supplemental Figure 3.5. An
expansion of OVA peptide- specific CD8+ T cells was detected following infection
with MEDLE2-OVA parasites in all tissue types compared to uninfected controls,
indicating recognition of the OVA antigen drove CD8+ T cell division and
expansion (D). The OVA specific CD8+ T cells were most enriched in IEL
population compared to uninfected controls, with 5.9% of the total CD8+ T cells in
this compartment being OVA specific following their expansion (E).
(F) 1e6 OT-I cells were transferred to Ifng-/- KO mice 24 hours prior to challenge
infection with MEDLE2-OVA oocysts by oral gavage. Relative luminescence of
fecal samples was used as a measure of infection. Transfer of OT-I cells prior to
infection provided partial protection and reduced the magnitude of infection.
*Note the data in panels 3.4D-3.4F were generated by experiments carried out
by Breanne Haskins and Jodi Gullicksrud.
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Figure 3.5. MEDLE2 expressing cells exhibit upregulation of genes
involved in the unfolded protein response.
(A) HEK293T cells were transfected with plasmids encoding MEDLE2-GFP or
GFP alone. After 24h, cells were fixed and processed for IFA. GFP is shown in
green, Hoechst in blue.
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(B) 24h post transection, HEK293T cells were trypsinized and double sorted for
live, GFP+ singlets directly into RNA lysis buffer and subjected to RNA
sequencing.
(C) Heat map depicting the differential gene expression between MEDLE2-GFP
(top panel) and GFP control expressing cells (bottom panel). Upregulated gene
expression is shown in red (row Z score > 0), while blue shows genes that are
downregulated in expression (row Z score < 0).
(D) Volcano plot representing the differentially expressed genes found in
MEDLE2-GFP expressing cells compared to GFP control cells. 413 transcripts
showed upregulation in MEDLE2-GFP expressing cells (right) and 487 genes
had lower transcript abundance (left). The horizontal dashed line indicates pvalue equal to 0.05. GSEA performed on the 900 differentially expressed genes
from the MEDLE2 transfection dataset identifies core enrichment of 20 genes
that belong to ER stress response signaling pathways, which are indicated on the
volcano plot in red. The most upregulated genes are identified by their gene ID.
(E) The 234 genes with the greatest differential expression (p <0.01, log fold
change absolute value > 1.5) were used to define a MEDLE2 gene set from the
MEDLE2-GFP transfection dataset. This signature was used to perform gene set
enrichment analysis using data from single cell RNA sequencing on C.parvum
infected organoid derived cultures, which showed enrichment of 51 genes with
22 genes in the core enrichment for the MEDLE2 response set highlighted in
solid red. We note that we did not detect the MEDLE2 response signature in
datasets from other enteric infections including Rotavirus (Figure 6-figure
supplement 1).
(F) Ileal sections were removed from C. parvum infected Ifng-/- mice and
uninfected controls (each n = 3) and expression levels for the four differentially
upregulated genes in the MEDLE2 response set (NUPR1, CHAC1, DDIT3 and
TRIB3) were measured by qPCR.
*Note the flow cytometry required for this experiment was performed in
collaboration with Joseph Clark and the RNA sequencing analysis that generated
Figures 3.5C – 3.5E was performed by Alexis Gibson.
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Supplemental Table 3.1: Members of multigene families for which
localization of protein product was initially attempted in this study
Gene family
MEDLE

Gene ID
cgd5_4590

Result
Exported to host cell

FLGN

cgd4_4470

Transgenic unsuccessful

GGC
SKSR
SKSR
WYLE

cgd5_3570
cgd8_30
cgd8_40
cgd8_3560

Transgenic unsuccessful
Not in host cell
Not in host cell
Not in host cell
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Supplementary Figure 3.1. Additional secretory proteins tested in this
study.
(A-C) Schematic depicting the generation of in locus gene fusion transgenic
parasite strains for WYLE4 (A), and SKSR7 (B). In each case, the C terminus of
the gene was targeted for integration of a repair construct containing an HA
epitope tag, a Nanoluciferase reporter gene (Nluc) and a Neomycin
phosphotransferase (Neo) selectable marker. Individual primer pairs used to map
integration in WT and transgenic strains are shown. (C) SKSR7-HA does not
localize to the host cell; rather, the protein (red) exhibits expression in the
parasite (green).
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Supplementary Figure 3.2. Knockout of MEDLE2 reveals multiple copies of
the gene in the genome.
(A) Schematic representation for the strategy used to generate a MEDLE2 KO
line, in which the entire locus of MEDLE2 is replaced with a nanoluciferase
reporter gene (Nluc) and the neomycin phosphotransferase (Neo) selection
marker fused to a 2A peptide, and tdTomato, such that the parasites express a
red fluorescent protein in their cytoplasm. The solid black arrow indicates the
position of the Cas9 induced double-stranded break in the middle of the gene.
Note, this is a different guide from the one used for C terminal tagging. (B) PCR
mapping modification of the MEDLE2 locus using genomic DNA from wild type
(WT) and transgenic (MEDLE2 KO) sporozoites using the primer pairs shown in
A and the Thymidine kinase (TK) gene as a control. Note the persistence of a
WT band (1392 bp) in the 5’ – 3’ amplification product, despite the presence of
the transgene (3524 bp).
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(C) HCT-8 cultures were fixed 24h after being infected with MEDLE2 KO
transgenic parasites. MEDLE2 KO parasites exhibit red fluorescence in their
cytoplasm as expected (Red, tdTomato, parasite cytoplasm; green, parasites
VVL; blue, Hoechst).
(D) The full gene PCR products from WT (1392 bp) and MEDLE2 KO parasites
(3524 bp) were used for restriction digest with ScaI. A single ScaI restriction site
is found in the C terminus of WT MEDLE2; however, integration of the repair
cassette disrupts this site. ScaI digested WT PCR product results in 2 digest
products: 331 bp and 1061 bp. Undigested MEDLE2 KO full gene product has
the expected 3524 bp fragment, as well as a persisting 1392 bp WT band. ScaI
digested MEDLE2 KO, shows the 3525 bp repair cassette resistant to ScaI
digest, as well as the 331 bp and 1061 bp fragments produced from digest of the
unmodified MEDLE2 locus. As a result, there are multiple copies of MEDLE2 in
the genome and we have only targeted one for knockout.
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Supplementary Figure 3.3. Other members of the MEDLE gene family are
exported to the host cell.
(A) Schematic representation depicting the generation of a MEDLE6-HA
transgenic parasite line, in which the endogenous locus of MEDLE6 (cgd6_5490)
is HA epitope tagged at the C terminus. Proper integration at the desired locus
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was confirmed using PCR mapping with gDNA isolated from MEDLE6 transgenic
parasites (M6) and a wild type control (WT).
(B) MEDLE6-HA parasites were used to infect HCT8 cells for an
immunofluorescence assay. Cells were fixed every 12h and stained for IFA.
Shown as a representative image, at 24h post infection, MEDLE6 (red) localizes
in/around the parasite (green), as well as slightly in the host cell. Host cell
expression is more apparent in multiply infected cells.
(C) The MEDLE1 (cgd5_4580) locus was targeted for integration of an HA
epitope tag at the C terminus.
(D) MEDLE1-HA parasites were used to infect HCT8 cells for a time course
infection and IFA was performed on cells fixed every 12h. Shown as a
representative image, at 12h post infection, MEDLE1 (red) localizes in/around
the parasite (green), as well as at very low levels in the host cell.
(E) Schematic representation for the strategy used to engineer a MEDLE1
overexpression line. The MEDLE2 promoter was used to drive expression of an
ectopic copy of MEDLE1-HA expressed in the TK locus. Proper integration was
assessed using PCR mapping with gDNA isolated from Medle2MEDLE1-HA
(M2- M1 HA) and WT control (WT) parasites.
(F) M2-M1 HA parasites were used to infect HCT8 cells for IFA. At 24h post
infection, MEDLE1-HA (red) can be seen in/around the parasite (green), as well
as in the host cell when expression is driven by the MEDLE2 promoter.
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Supplementary figure 3.4. Construction of a MEDLE2-HA cytoplasmic
tdNeon reporter parasite.
(A) Schematic representation of the strategy to derive reporter parasite line in
which MEDLE2 is 3X HA epitope tagged and the parasite cytoplasm expresses a
tandem mNeon green tag (tdNeon). The solid black arrow indicates the position
of the Cas9 induced double-stranded break at the C terminus of the gene, which
is the same guide used in Figure 1B to generate the MEDLE2-HA transgenic
parasites.
(B) PCR mapping modification of the MEDLE2 locus using genomic DNA from
wild type (WT) and transgenic (MEDLE2-HA-tdNeon) sporozoites using the
primer pairs shown in A and the Thymidine kinase (TK) gene as a control. Note
the presence of both a 1174 bp WT gene and a 4557 bp transgene.
(C) HCT-8 cultures were infected with and MEDLE2-HA-tdNeon transgenic
parasites and fixed at 24h. Red, HA tagged protein; green, parasites (tdNeon);
blue, Hoechst.
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Supplementary figure 3.5. The gating strategy used to sort the OVA
(SIINFEKL) specific CD8+ T-cells from intraepithelial lymphocytes (IELs),
mesenteric lymphnode (MLNs) and spleen.
10,000 OT-I cells were transferred to 4 Ifng-/- KO mice. 2 mice were infected with
10,000 MEDLE2-OVA oocysts by oral gavage, while the remaining 2 mice were
used as an uninfected control. 10 days post infection, IELs, MLNs, and spleens
were isolated, prepared for flow cytometry and stained for viability, CD19, NK1.1,
CD3, CD8a, CD4, CD45.1, CD45.2, SIINFEKL-tetramer, EpCAM, and mNeon.
The gating strategy first identified lymphocytes within the population based upon
side scatter (SSC) and forward scatter (FSC). Single cells were identified by FSC
and SSC and then live cells were selected for inclusion. CD19+NK1.1+CD3+ cells
were selected to identify the CD+4 and CD8+ T cells, which were subsequently
distinguished based upon staining with their respective antibodies. We gated on
CD8a+ cells and focused upon those that stain with the SIINFEKL tetramer and
express CD45.1 as an indication of antigen experience.
*Note, the flow cytometry performed above was carried out by Breanne Haskins
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Supplementary Figure 3.6. MEDLE2 response signature is absent from
intestinal epithelial cells infected with human Rotavirus.
Genes with the greatest differential expression (p <0.01, log fold change absolute
value > 1.5) were used to define a MEDLE2 gene set from the MEDLE2-GFP
transfected cells. RNA sequencing from small intestinal enteroid cultures infected
with human rotavirus shows an absence of the MEDLE2 signature created from
the MEDLE2 transfection dataset, evidenced by the negative enrichment score
resulting from GSEA.
*Note the bioinformatics analysis shown in this figure was performed by Alexis
Gibson.
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3.4 Discussion
Intestinal cryptosporidiosis in animals and humans is caused by parasites
that are morphologically indistinguishable, and therefore were initially described
as a single taxon, C. parvum. Extensive population genetic studies have since
replaced C. parvum with a multitude of species, sub species, and strains
(Checkley et al., 2015; Xiao et al., 1999). The genomes of these parasites reflect
the overall high degree of similarity in their conservation of gene content and
synteny; nonetheless, these parasites show pronounced differences in their host
specificity (Feng et al., 2017; Feng et al., 2018; Nader et al., 2019). The genomic
differences observed are focused on families of predicted secretory proteins that
have been proposed to contribute to host specificity, prominently among them
the MEDLE family (Fei et al., 2018; Li et al., 2017; Su et al., 2019). Previous
studies found that treatment of sporozoites with antisera raised against
recombinant MEDLE1 or MEDLE2 diminished the efficiency of infection by 40%.
This led the authors to consider that MEDLE proteins may play a role in invasion
and that host specificity is rooted in receptor specificity (Fei et al., 2018; Li et al.,
2017). In this study, we screened polymorphic genes for the localization of the
proteins they encode by epitope tagging the endogenous loci. We found that C.
parvum exports multiple members of the MEDLE protein family into the
cytoplasm of the host cell. This is particularly robust for the highly expressed
MEDLE2 protein, where the observation is based on more than 15 independent
transgenic strains using different epitope tags and antibodies, in locus and
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ectopic tagging, and held true in cultured cells and infected animals, thereby
highlighting the specificity of the reagents used.
Apicomplexa have evolved multiple mechanisms to deliver proteins to
their host cells during and following invasion. The timing of MEDLE2 expression
and export and its sensitivity to BFA treatment argues for a mechanism that
becomes active after the parasite has established its intracellular niche, in
contrast to injection during invasion from organelles already poised to secrete. In
P. falciparum such export relies on the translocon complex PTEX (de KoningWard et al., 2009), which uses the ATPase activity of a heat shock protein to
unfold and then extrude cargo through a transmembrane channel into the red
blood cell (Ho et al., 2018b; Matthews et al., 2019a). Genetic ablation of this
complex results in loss of export and loss of parasite viability (Beck et al., 2014;
Elsworth et al., 2014). In T. gondii proteins are exported during intracellular
growth via the MYR complex, which is independent of ATP hydrolysis and
requires intrinsically disordered cargo (Hakimi et al., 2017). Translocon and
export are dispensable for growth of this parasite in culture, but loss profoundly
impacts virulence in vivo (Hakimi et al., 2017; Marino et al., 2018). With the
exception of a putative HSP101 chaperone, genome searches do not readily
identify C. parvum homologs of the components that make up these two
previously characterized translocons (Pellé et al., 2015). Nonetheless there are
important parallels that suggest conserved features of Apicomplexan export and
warrant future investigation into the mechanism by which MEDLE2 reaches the
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host cell. Similar to the export requirements for both P. falciparum and T. gondii,
MEDLE2 contains a signal peptide and relies upon insertion into the canonical
secretory pathway for export to the host cell to occur. Conservation of this
mechanistic feature suggests there may be additional sequence specific
information apart from the signal peptide to direct trafficking of MEDLE2 beyond
the parasite. The presence and identity of a Cryptosporidium-specific sequence
directing export remains to be determined.
Pathogens inject a wide array of factors into the cells of their hosts to
remodel cellular architecture, hijack death and survival pathways, change cell
physiology and metabolism, rewire transcriptional networks. Many of them aid
immune evasion and the evolutionary arms race between host and pathogen
(Long et al., 2019; van der Does and Rep, 2007). Here we have identified the
first examples of host-targeted effector proteins for intracellular stages of C.
parvum and investigated the functional role of MEDLE2 during infection. Efforts
using co-precipitation or yeast-two-hybrid assays failed to identify host proteins
that physically interact with MEDLE2, thereby suggesting MEDLE2 does not
have a protein binding partner within the host cell (data not shown). However,
introduction of the protein into its target compartment, the mammalian cytoplasm,
by transient transfection and mRNA sequencing revealed a transcriptional
signature of ER stress and unfolded protein response (UPR) upon expression of
MEDLE2, but not in matched control transfections. The MEDLE2 signature is
also detectable when cells or mice are infected with C. parvum but is absent from
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published datasets involving infection with other enteric pathogens, such as
Salmonella and human rotavirus, suggesting the UPR response initiated in the
intestinal epithelial host cell is specific to C. parvum infection and not a general
intestinal epithelial innate immune response initiated due to infection (Saxena et
al., 2017; Schulte et al., 2020).
The UPR is a signal transduction pathway initiated in response to ER
stress, which is a consequence of infection with a number of different pathogens.
ER stress results from accumulation of unfolded or misfolded proteins due to
changes in ER function from physiological or environmental challenges to the cell
(Alshareef et al., 2021). This signaling axis functions as cell intrinsic mechanism
to restore homeostatic conditions in the ER, but if left unresolved, apoptotic cell
death results following the canonical mitochondrial pathway (Alshareef et al.,
2021; Hetz et al., 2020). The UPR pathway first involves activation of the sensor
proteins in the ER membrane including inisotol-requiring protein 1 (IRE1), protein
kinase RNA-like ER kinase (PERK) and activating transcription factor 6 (ATF6).
Sensor-specific downstream signaling cascades follow, ultimately leading to
transcriptional and posttranscriptional responses which alter global protein
translation, protein folding, ER biogenesis, ER-associated degradation (ERAD),
autophagy, and progression through the secretory pathway (Alshareef et al.,
2021; Hetz et al., 2020). Crosstalk with pathways controlling lipid and energy
metabolism, innate immunity, and programs for cell differentiation are also
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functional consequences of an ER stress response, indicating the global nature
of the response (Hetz et al., 2020).
ER stress is a common feature of intracellular infection that greatly
modulates host cell survival and inflammatory response. Bacteria, viruses and
protozoa alike have evolved strategies to trigger or block the UPR during
infection suggesting the response not to be a byproduct of infection, but rather an
active participant (Abhishek et al., 2018; Alshareef et al., 2021; Perera et al.,
2017). This relationship is complex and depending on cellular context, the UPR
can aid pathogens or restrict them. T. gondii hijacks the IRE1 branch of the UPR
to enhance infected host cell migration and dissemination though a noncanonical
role the pathway plays in actin remodeling (Augusto et al., 2020). Modulating the
UPR is pivotal for intracellular bacteria that reside in vacuoles, including
Chlamydia, Brucella, Listeria, and Mycobacterium, to build their intracellular
niche and to acquire nutrients (Celli and Tsolis, 2015). Cryptosporidium lost the
ability to synthesize most required metabolites and depends on an elaborate
membranous feeder organelle at the host-parasite interface. This reduction
includes biosynthesis of many lipids (Coppens, 2013) and we note modulation of
lipid synthesis and mobilization as one important consequence of the UPR
(Moncan et al., 2021). There is a bidirectional relationship between the UPR
response and lipid regulation, with some stimuli promoting lipogenesis and others
resulting in lipolysis (Moncan et al., 2021). As a result, future studies are required
to uncover changes in lipid availability within the context of the UPR induced with
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Cryptosporidium infection. The UPR is also important in the context of
recognition of intracellular pathogens and the subsequent cytokine-mediated
immune responses. Cryptosporidium triggers an enterocyte intrinsic
inflammasome leading to the release of IL-18 from the infected cell (McNair et
al., 2018) and infection also results in pronounced production of IFNλ (Ferguson
et al., 2019). It remains to be determined whether the UPR is a byproduct of host
detection of the disordered protein MEDLE2 following its translocation during C.
parvum infection, or if it is an active process deliberately triggered to promote
parasite survival. This may be explored with future studies where mice lacking
signaling components of UPR pathways are infected with C. parvum and the
infection is followed over time.
The MEDLE genes are highly polymorphic and encoded by multiple loci,
but our current view of the family likely underestimates its true plasticity. The
recent reannotation of the C. parvum genome using long read sequencing found
evidence for multiple ‘alternative’ telomeres carrying different MEDLE gene
clusters (Baptista et al., 2021). Our experimental observations support this, as
when we ablated the MEDLE2 gene by homologous recombination, additional
MEDLE2 copies remained in the genome (Supplementary Figure 3.2). Similar
observations were made when tagging the gene (Fig3.C, Supplementary Figure
3.4). It is important to note that Cryptosporidium has a single host lifecycle and
undergoes sexual exchange throughout the infection, providing near constant
opportunity for recombination (Tandel et al., 2019). This is reminiscent of the
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importance of chromosomal position and recombination for the antigenically
varied VSG and var genes in Trypanosoma brucei and P. falciparum,
respectively (Dreesen et al., 2007; Zhang et al., 2019b). The fact that MEDLE
proteins are delivered into the host cell makes them prime targets for immunity,
and immune evasion may drive chromosomal organization, expression and
evolution of these genes.
The polymorphism of the MEDLE gene family may be a consequence of
interaction with host immunity and subsequent selective pressure mounted
against these antigens during infection. However, because no Cryptosporidiumspecific reagents or tools exist, interrogation of this hypothesis has been
hindered. Identification of MEDLE2 as a host-targeted protein affords the
opportunity to develop tools to study host-Cryptosporidium interactions at the
molecular level. Towards this goal, an ovalbumin (OVA) CD8-model antigen was
appended to the C-terminus of MEDLE2, allowing for export of the protein and
model antigen to the host cell cytoplasm in an infection-dependent fashion. OVA
driven expansion of OT1 CD8+ T cells during infection was observed in IEL and
mesenteric lymph node cell populations. This CD8+ T cell expansion was partially
protective during infection, highlighting the utility of this newly developed tool for
characterizing cell populations participating in host-parasite interactions.
MEDLE2 is constitutively exported to the host cell cytoplasm across the lifecycle
of the parasite, where it is visible to the host immune system. This presents the
opportunity to exploit its cellular localization to engineer tools to characterize cell
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type-specific host-pathogen interactions, similar to what has been accomplished
within other model systems (Garg et al., 1997; Gubbels et al., 2005; Pepper et
al., 2004). Currently, there is no vaccine to prevent Cryptosporidium infection.
The lack of a vaccine can be attributed to multiple factors, including no known
targets participating in host-parasite interactions, as well as an incomplete
understanding of the cellular players contributing to the anti-Cryptosporidium
response. Future studies involving MEDLE proteins as prime targets for immunity
within the host cell environment may help to overcome these long-held hurdles
and advance the field towards the development of a vaccine.
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Chapter 4: Defining the mechanism of export of Cryptosporidium parvum
host targeted proteins.
Partial contents of this chapter were submitted for publication in eLife with the
large majority of Chapter 3.
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4.1 Abstract
Cryptosporidium is an obligate intracellular pathogen causing diarrheal disease
worldwide. Intracellular pathogens often manipulate the host cell in order to
promote survival, so the changes in cell morphology, physiology, and
transcription observed during Cryptosporidium infection were predicted to be
functional consequences of effector proteins within the host cell. No such effector
proteins had been identified until recent work identified MEDLE2 as the first
exported protein of C. parvum. Because MEDLE2 is exported to the host cell
cytoplasm following the establishment of infection, we hypothesize that
Cryptosporidium utilizes an export mechanism to deliver proteins requiring time
for translation and assembly. We used genetic approaches to define the
mechanistic requirements for export of MEDLE2. The intrinsic disorder of
MEDLE2 is critical for its export status, as the addition of ordered domains
ablated translocation to the host cell cytoplasm. Disruption of MEDLE2 export
with folded epitope tags reduced translocation of additional effector proteins,
indicating protein export requires passage through a putative export machine.
Proper targeting of MEDLE2 within the host cell required an N terminal signal
sequence which was found to contain a proteolytic cleavage site. We verified the
involvement of the host targeting motif in directing export using peptidomimetic
compounds synthesized to resemble the sequence. Finally, we demonstrated
that exported proteins are processed before being sent to the host cell and
identified candidate enzymes that may perform this function. Taken together, our
studies uncover the mechanistic requirements for the delivery of Cryptosporidium
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effector proteins to infected host cells using MEDLE2 as a model exported
protein.
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4.2 Introduction
Host-pathogen interactions are complex relationships that govern the
establishment, replication, and dissemination of infection with diverse microbial
agents. Throughout all stages of infection, the innate immune system of the host
detects and responds to pathogen associated molecular patterns (PAMPs) to
initiate antimicrobial signaling responses (Jo, 2019). The interplay between host
and pathogens has evolved into a dynamic arms race, pressuring pathogens to
employ strategies to evade, manipulate or hijack host cellular processes to
escape host immune pressure and promote their own survival (Long et al., 2019;
van der Does and Rep, 2007). Intracellular bacteria, viruses, fungi, and parasite
species have all developed extensive repertoires of effector proteins for
manipulation of the host cell despite differing replicative niches and requisite
lifecycles (Feltcher et al., 2010; Finlay and McFadden, 2006; Hakimi et al., 2017;
Long et al., 2019; Selin et al., 2016). To accomplish this, pathogens utilize
delivery mechanisms to translocate effector proteins into the infected cells. While
the mechanistic details of delivery vary between organisms, one conserved
feature is the presence of sequence signals directing trafficking towards export
(Bhattacharjee et al., 2006; Coffey et al., 2015; Green and Mecsas, 2016;
Krampen et al., 2018; Marti et al., 2004).
Gram-positive and gram-negative bacteria have developed multiple
secretion apparatuses to direct secretion across cytoplasmic membranes (Green
and Mecsas, 2016). The Sec, Tat, and the Type I – Type VII Secretion
Apparatuses rely upon N-terminal or C- terminal secretion signals to direct proper
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trafficking of effectors to the host cell (Green and Mecsas, 2016). Pathogenesis
factors are threaded through the needle-like Type III and Type IV secretion
systems that span from the bacterial cytoplasm to the host cell, either requiring
an unfolding step for transport or relying upon intrinsic disorder for passage
(Coburn et al., 2007; Green and Mecsas, 2016; Wallden et al., 2010).
In a similar strategy, apicomplexan parasites Plasmodium falciparum and
Toxoplasma gondii have evolved complex export machines to deliver effectors
with specific host targeting motifs to infected cells. P. falciparum relies upon
recognition of the pentameric Plasmodium Export Element (PEXEL) consisting of
the amino acid residues RxLxE/D/Q to target proteins to the host cell. This motif
is co-translationally processed after the leucine residue by Plasmepsin V, an
essential ER-resident aspartyl protease to direct transport of the protein beyond
the parasite to the PV (Boddey et al., 2010; Marti et al., 2004; Russo et al.,
2010). Proteins are then translocated across the PVM by the Plasmodium
Translocon of Exported proteins (PTEX), a protein complex made and
assembled in a specific stoichiometric ratio during infection (Ho et al., 2018a).
The PTEX machine consists of a protein-unfolding motor, heat shock protein 101
(HSP101), a membrane spanning pore protein exported protein 2 (EXP2) and
additional accessory proteins (PTEX150, PTEX88, and Thioredoxin 2 TRX2) (de
Koning-Ward et al., 2009; Ho et al., 2018a). A small subset of exported proteins
lacks the canonical PEXEL motif and are consequently referred to as PEXELNegative Exported Proteins (PNEPs). The mechanism surrounding PNEP export
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remains to be elucidated but is hypothesized to require a second signal
sequence to direct export through the PTEX machinery (Beck et al., 2014; Marti
and Spielmann, 2013).
T.gondii effectors cross the PVM to the host cell by an analogous
mechanism, with the Toxoplasma Export Element (TEXEL) being processed by
the Golgi-resident aspartyl protease ASP5 to direct protein transport to the PV
(Coffey et al., 2015; Hammoudi et al., 2015). The TEXEL motif exhibits more
stringent sequence requirements, with a RRLxx amino acid motif being required
to direct export (Coffey et al., 2015). Proteins then transverse the PVM through
the MYR translocon, whose molecular components and mechanism of transport
are still being resolved (Franco et al., 2016; Marino et al., 2018). The RxL motif
shared by host-targeted proteins of P.falciparum and T. gondii is also conserved
among effectors of the fungal pathogen Phytophthora infestans, indicating the
importance of signal sequences in directing access to host cells for diverse
eukaryotic organisms (Bhattacharjee et al., 2006).
Recent work has identified MEDLE2 as the first exported protein of
Cryptosporidium. The temporal expression pattern of export of MEDLE2
suggests an export mechanism established following infection, consistent with
the mechanistic features of translocon-based delivery of effectors. However,
BLAST searches of the Cryptosporidium genome reveal little homology to
components of bacterial and parasite export machines, with only a putative
HSP101 homolog being discovered. Here we explore the mechanistic elements
124

required for protein export of MEDLE2 in Cryptosporidium using both genetic and
pharmacological approaches. The intrinsic disorder of MEDLE2 was crucial for its
export status, as introduction of ordered domains prevented translocation to the
host cell cytoplasm. Disruption of MEDLE2 export with the addition of folded
epitope tags reduced host targeting of additional effector proteins, demonstrating
a putative export machine was required for proper host targeting. We carefully
mapped the requirements for export and found a signal sequence that includes a
proteolytic cleavage site. We demonstrated that Cryptosporidium pathogenesis
factors undergo processing before being sent to the host enterocyte and have
identified candidate aspartyl protease homologs that may perform this function.
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4.3 Results
MEDLE2 is an intrinsically disordered protein and its export is blocked by
ordered reporters
MEDLE2 (cgd5_4590) is a C. parvum host-targeted effector protein with
an N-terminal signal peptide that has been demonstrated to be important for
proper localization in the host cell cytoplasm. The lack of predicted structural
domains, as well as requisite insertion into the canonical secretory pathway
suggest an export mechanism consistent with features of translocon-based
export for other Apicomplexa. To investigate the mechanism by which MEDLE2
reaches the host cell, we sought to develop a reporter assay to follow trafficking
using three previously established systems (Bichsel et al., 2011; Lodoen et al.,
2010; Pedelacq and Cabantous, 2019). First, we fused the fluorescent reporter
mScarlet to the C-terminus of MEDLE2 in its endogenous locus such that export
could be followed by live imaging microscopy (Figure 4.1A and Supplementary
Figure 4.1). Transgenic parasites showed robust expression of the reporter when
used to infect HCT-8 cultures. However, this fluorescence (red) was associated
with parasites, highlighted by staining with VVL (green, Figure 4.1B), suggesting
that MEDLE2-mScarlet remained trapped within or close to the parasite instead
of being trafficked to the host cell cytoplasm. We considered that export may
occur, but that we lack the sensitivity to detect it. Thus, we engineered two highly
sensitive assays that employ enzymes to amplify the signal.
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We tagged MEDLE2 with beta lactamase, which has been used to reveal
effector export in bacteria and protozoa (Charpentier and Oswald, 2004; Lodoen
et al., 2010). These parasites also expressed a cytoplasmic red fluorescent
protein (Supplementary Figure 4.1). Cells infected with MEDLE2-BLA
sporozoites were incubated with CCF4-AM, a cell-permeable substrate of beta
lactamase and imaged by live microscopy. Infected and uninfected cells
accumulated CCF4-AM (green, Figure 4.1C); however, we did not detect
substrate cleavage resulting in blue fluorescence (Figure 4.1C). This could be
due to the lack of MEDLE-BLA expression or export. To visualize localization of
the MEDLE2-BLA fusion protein during infection, we performed IFA on MEDLE2BLA infected cells using a BLA antibody and observed that MEDLE2-BLA (green)
was expressed but remained with the parasite (red, Supplementary Figure 4.1).
Finally, we generated a MEDLE2 fusion with Cre recombinase and used these
parasites to infect an HCT-8 host cell line we engineered to carry a floxed
GFP/RFP color switch reporter (see Supplementary Figure 4.2 for detail). After
48 hours, cells were subjected to flow cytometry (Figure 4.1D). Using a gate for
live, single cells, uninfected cells showed green (95.1%) but not red fluorescence
(2.51%). Transfection of host cells with a Cre recombinase expression plasmid
resulted in a pronounced shift to red fluorescence (+control, 32%, Figure 4.1D).
Cells infected with either WT parasites or MEDLE2-Cre parasites remained
green, despite robust infection (Supplementary Figure 4.2). Therefore, we tested
three reporters, none of which resulted in detectable export to the host cell. We
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note that multiple algorithms predict MEDLE2 to be a highly disordered protein
due to multiple low complexity regions with single amino acid repeat sequences.
We conclude that protein disorder is important for MEDLE2 export and that
introduction of structure with folded reporters blocks translocation to the host cell.

Blockade of MEDLE2 export impacts translocation of additional exported
protein
Apicomplexan effectors sent from intracellular parasites rely upon
translocon machines to unfold and thread proteins through parasite-protein
comprised channels spanning the PV to the host cell for proper targeting (de
Koning-Ward et al., 2009; Franco et al., 2016). In T. gondii, blockade of the MYR
export machine through fusion of an ordered dihydrofolate reductase (DHFR)
reporter to a normally host-targeted effector protein reduces translocation of
additional effectors to the host cell nucleus, demonstrating the requirement for
translocon-based export for proper targeting of these effectors (Marino et al.,
2018). Similarly, we wanted to explore the role an export machine may play in
translocation of Cryptosporidium host targeted proteins to the host cell. We
engineered a dominant negative reporter strain in which the endogenous
MEDLE2 locus was modified to express a DHFR reporter with a Myc epitope tag
at the C terminus of the gene, as well as an additional recodonized copy of
MEDLE2 appended to an HA tag (Figure 4.2A, B). The tryptophan B synthase
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promoter (trpB) was selected to drive the expression of the recodonized copy of
MEDLE2, as its timing and strength of expression match that of the MEDLE2
promoter. A control strain (trpBMEDLE2) with an identical insert, but lacking the
DHFR reporter, was used to confirm export of recodonized MEDLE2 when driven
by the trpB promoter (Supplementary Figure 4.3). Both MEDLE2 Myc and
recodMEDLE2 HA were exported to the host cell by IFA for the control strain,
demonstrating the trpB promoter was sufficient to use within this context
(Supplementary Figure 4.3). Addition of the ordered DHFR tag in the dominant
negative strain disrupted MEDLE2-myc (red) translocation to host cell, and
instead the protein remained trapped with the parasite (Figure 4.2C). Ablation of
MEDLE2 export with the DHFR epitope tag reduced but did not fully block
recodonized MEDLE2-HA (green) export to the host cell, indicating transport of
additional effectors is impacted but not prevented with physical blockade of an
export machine (Figure 4.2D, E). This suggests that export of MEDLE2 is
consistent with the translocon-based mechanisms of other Apicomplexa and
depends upon an export machine for proper host targeting.

Protein export is dispensable for parasite growth in vitro and in
immunocompromised mice
We next wanted to investigate the impact of reduced export on parasite
fitness. The trpBMEDLE2 and dominant negative parasite strains were used to
infect HCT8 cells and parasite growth was measured by nanoluciferase assay
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every 12 hours, with parasite growth being a proxy for fitness. While the relative
luminescence measured in cells infected with the dominant negative strain was
lower than that of those infected with the trpBMEDLE2 control strain at all tested
timepoints, there was no statistically significant difference in in vitro growth
between the two strains (Supplementary Figure 4.4A, B). The lack of a growth
phenotype could be attributed to protein export being dispensable for in vitro
growth. To explore this, we assessed the consequences of reduced protein
export on parasite fitness in vivo. Susceptible Ifng-/- mice were infected with 7,000
oocysts (3,500 trpBMEDLE2 control and 3,500 dominant negative oocysts) and
qPCR was performed using parasite gDNA isolated from feces every other day
for the duration of infection (Supplementary Figure 4.4 C, D). The allele
frequency of the thymidine kinase control gene increases over the course of
infection, following the increase in parasite burden (Supplementary Figure 4.4E).
In contrast, the allele frequency of the DHFR tag decreases in the parasite
population over the 14-day time course (Supplementary Figure 4.4F). Although
the allele frequency of DHFR is reduced, it does not disappear completely. We
interpret the reduction to be driven by the partial loss of export of additional
effectors resulting from blockade of a putative translocon with the DHFR reporter.
This suggests that protein export may be dispensable for parasite growth both in
vitro and in an immunocompromised mouse model but do note one significant
caveat. Export is not fully ablated when using mDHFR for physical obstruction of
an export machine, which may account for the lack of a significant growth
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phenotype. Low levels of export may be sufficient to drive parasite survival both
in vitro and in vivo, but future experiments are needed to fully explore this
hypothesis.

MEDLE2 export depends upon N-terminal sequence features
Export of C. parvum MEDLE2 depends on trafficking through the secretory
pathway of the parasite. The export mechanisms of both P. falciparum and T.
gondii require a signal peptide followed by additional sequence information to
direct proteins for host-targeting (Coffey et al., 2015; Marti et al., 2004). We next
wanted to determine whether MEDLE2 contains any other sequence information
targeting the protein for export. Using previously established host targeting motifs
from P. falciparum and T. gondii as models (Coffey et al., 2015; Marti et al.,
2004), we searched the MEDLE2 amino acid sequence to identify candidate
export motifs. Preference was given to regions with a basic amino acid, followed
by one or two random amino acids, and a leucine residue (Pellé et al., 2015).
While Plasmodium host targeting motifs are typically found in close proximity to
the signal peptide, T. gondii exhibits less rigid distance requirements (Coffey et
al., 2015). We identified 4 motifs, three sites in proximity to the N-terminus and
one C-terminal candidate for mutational analysis (Figure 4.3A). As folded
reporters are not tolerated, we engineered parasite lines to express an ectopic
copy of MEDLE2 marked by a HA tag. A cassette driven by the MEDLE2
promoter was inserted into the locus of the dispensable thymidine kinase gene
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(TK, Figure 4.3B) and expression level and export of ectopic WT protein was
indistinguishable from protein tagged within the native locus.
In support of previous observations, removal of the sequence encoding
the N-terminal signal peptide (DSP) prevented MEDLE2-HA export, and the
resulting protein accumulated within the parasite (Figure 4.3C). Next, we
constructed a series of parasite strains in which each of the candidate motifs was
replaced by a matching number of alanine residues (all mutants were confirmed
by PCR mapping and Sanger sequencing, Supplemental Figure 4.5).
Mutagenesis of three of these candidate motifs had no impact on MEDLE2
translocation to the host cell (Figure 4.3C; Supplemental Figure 4.5). In contrast,
when the most N-terminal sequence KDVSLI was changed to six alanines, HA
staining accumulated in the parasite and host cell staining was lost (Figure 4.3C).
We conclude that in this mutant, MEDLE2-HA is made but export is ablated.
Next, we constructed six additional strains using the same strategy to change
each amino acid position of the KDVSLI motif to alanine one residue at a time
(Supplemental Figure 4.5). Mutation of residue leucine 35 to alanine (L35A)
ablated export and instead, MEDLE2-HA remained with the parasite (Figure
4.3D). Changing the remaining five amino acids individually did not alter
MEDLE2 localization in the host cell (Figure 4.3D). We conclude leucine 35 to be
crucial for export.
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MEDLE2 export is linked to proteolytic processing
Leucine residues serve as crucial sites for proteolytic processing events
that license exported proteins to leave the parasite and enter the host cell for
both P. falciparum and T. gondii (Coffey et al., 2015; Hiller et al., 2004; Marti et
al., 2004). To test whether such processing occurs during export of MEDLE2 in
C. parvum, we performed Western Blot analysis on whole cell lysates of infected
cell cultures using antibodies to HA (MEDLE2-HA, green) and the drug
resistance marker Neo (loading control, red). For WT MEDLE2-HA we observed
a single band with an apparent molecular weight of 31 kDa (Figure 4.3E, the
predicted molecular weight for full length MEDLE2-HA is 26.9 kDA but the
abundance of positive charges is likely to result in reduced electrophoretic
mobility). Protein KPVLKN/6A, carrying a mutation that did not affect trafficking to
the host cell cytoplasm, was of identical size to WT MEDLE2-HA. In contrast, the
KDVSLI/6A mutant, which is no longer exported, appeared to be of a larger
molecular weight (Figure 4.3E). The mutant lacking the 22 amino acid signal
peptide (DSP) produced an intermediate size band larger than the exported WT
but smaller than the retained KDVSLI/6A mutant. We found a very similar pattern
when analyzing the single amino acid mutants, where the L35A change caused
the mutant protein to migrate more slowly when compared to WT or the DSP
mutant (Figure 4.3F). To ensure the observed differences in apparent molecular
weight were due to processing by the parasite and not the consequence of
folding or subsequent host processing, we also expressed WT and mutants in
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mammalian cells (see Material and Methods for detail). In this context, the
proteins are the same size (Supplemental Figure 4.6). Overall, we interpret the
relative sizes of the mutated proteins to indicate processing of MEDLE2 at a
point beyond the signal peptide, a position that would be consistent with leucine
35. We note that this processing appears to require translocation into the ER, as
it does not occur in mutants lacking a signal peptide. Furthermore, the L35A
mutation apparently prevented removal of the signal peptide, suggesting that
processing at L35 could replace the canonical signal peptidase activity.

Amino acids surrounding the KDVSLI sequence provide information for
export
Proteolytic processing after the leucine residue in the P. falciparum host
targeting motif generates a new N-terminus that is acetylated to direct trafficking
to the red blood cell (Boddey et al., 2009). Western Blot analysis suggests the
KDVSLI sequence of MEDLE2 is similarly processed at L35 during export, so we
next wanted to engineer a reporter assay to functionally demonstrate cleavage.
Towards this, we generated parasite lines to express an ectopic copy of MEDLE2
with an HA tag appended to the C terminus. MEDLE2 was also engineered to
express internal Myc epitope tags immediately preceding the KDVSLI sequence
(N terminal, before K31) or following the sequence (C terminal, following I36)
(Supplemental Figure 4.7A). The cassette driven by the MEDLE2 promoter was
inserted into the locus of the dispensable TK gene as previously described
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(Figure 4.3B). Despite 4 attempts, insertion of the N terminal Myc tag after the
signal peptide but before K31 was unsuccessful, suggesting the spatial
positioning of the KDVSLI sequence with respect to the signal peptide may be
important for recognition and processing. Parasites were recovered with
introduction of an internal C-terminal Myc tag immediately following the KDVSLI
sequence; however, insertion of the Myc tag at this site prevented export to the
host cell cytoplasm, and instead, both the internal Myc tag (red) and the Cterminal HA tag (green) were observed together in punctate dots in the parasite
(Supplemental figure 4.7B). Generation of an additional parasite line in which the
internal Myc tag was moved an additional 10 amino acids downstream of the
KDVSLI sequence (after G46) restored MEDLE2 export to the host cytoplasm
(Supplemental figure 4.7C). In both cases, engineering internal Myc tags Cterminal of the KDVSLI sequence (I36 or G46) resulted in a peptide that was still
intact with original C-terminus of MEDLE2 tagged with HA. From this we
conclude that proteolytic processing of MEDLE2 occurs at a site upstream of I36
and G46, consistent with previous findings. Furthermore, this suggests the 10
amino acids downstream of the KDVSLI sequence may be involved in events
subsequent to proteolytic processing that contribute to targeting MEDLE2 to the
host cell.
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Peptidomimetic compounds resembling the KDVSLI sequence reduce
MEDLE2 export
Genetic approaches demonstrated a role for the KDVSLI sequence in
directing MEDLE2 export beyond the parasite, but to better understand this
requirement, we wanted to investigate the sequence using pharmacological
approaches. Peptidomimetic compounds resembling the KDVSLI sequence were
synthesized and used to treat MEDLE2-HA-tdNeon expressing parasites during
excystation and in infection in HCT8 cells (Figure 4.4A, B see Supplemental
Table 4.1 for specificity). Following 10 hours of infection, MEDLE2 localization
was assessed by IFA. Treatment of parasites with peptidomimetics resembling
N-terminal acetyl groups followed by serine and phenylalanine residues
(WEHI1002, 407, 720) resulted in accumulated MEDLE2 in puncta within the
parasite and a reduction of MEDLE2 in the host cytoplasm compared to the
DMSO control (Figure 4.4C). The average fluorescence intensity of
MEDLE2 in the cytoplasm of infected cells was quantified and used as a
measure to assess the impact of each compound on protein export. Parasites
treated with WEHI1002 exhibited a 23% decrease in MEDLE2 fluorescence in
the host cell cytoplasm compared to the DMSO control (Figure 4.4D).
Furthermore, the average fluorescence intensity of MEDLE2 accumulated in the
parasite cytoplasm was also quantified and used to calculate a ratio between
accumulated MEDLE2 and exported MEDLE2. Treatment with WEHI1002
resulted in the highest ratio of Accumulated MEDLE2: Exported MEDLE2, with a
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ratio of 1.97 being observed compared to a 1.36 ratio being observed for the
DMSO vehicle control (Figure 4.4E). We next wanted to determine whether the
reduction in MEDLE2 export was linked to changes in proteolytic processing
events as a consequence of drug treatment. Due to its impact on export, we
selected compound 1002 for further analysis and performed Western Blot on
whole cell lysates of cultures infected in the presence of drug using antibodies to
HA (MEDLE2-HA, green) and the drug resistance marker Neo (loading control,
red). There was no difference in size of MEDLE2 between 1002, vehicle-treated
conditions, and compounds that did not impact export (091, 586) (Figure 4.4F).
We note that although 1002 reduced MEDLE2 export, the effect was not a total
blockade, which may complicate the interpretation of the results. Overall, we
conclude that the KDVSLI sequence provides information to direct export to the
host cell and that genetic approaches to disrupt protein export are a more
promising strategy than pharmacology to modulate protein export in
Cryptosporidium.

Cryptosporidium aspartyl protease cgd1_3690 is essential for parasite
survival
Aspartyl proteases recognize and cleave downstream of leucine residues
in the species-specific host targeting motifs of P. falciparum and T. gondii
(Boddey et al., 2010; Coffey et al., 2015; Hammoudi et al., 2015; Russo et al.,
2010). The Cryptosporidium genome encodes 3 putative aspartyl proteases with
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homology to the Plasmepsin V (PMV) and Aspartyl protease 5 (ASP5) enzymes
known to be involved in export (Supplementary Table 4.2). Subcellular
localization and essentiality of these enzyme differ, but both process host
targeting motifs during passage of proteins through the secretory pathway of the
parasite. We established that the KDVSLI sequence of Cryptosporidium is
processed at L35 and next wanted to characterize the enzyme responsible for
proteolytic processing of MEDLE2 for export. We focused upon the
Cryptosporidium aspartyl protease homologs and sought to generate parasite
strains that lack each putative aspartyl protease candidate. Knockout parasite
lines were generated for aspartyl protease homologs PMV1 (cgd4_2190) and
PMV3 (cgd1_2240) and confirmed by PCR mapping of the loci, demonstrating
these enzymes are not essential for parasite survival (Figure 4.5A, B;
Supplementary Figure 4.8 A, B). In contrast, 4 independent attempts with
multiple guides targeting PMV2 (cgd1_3690) were unsuccessful in recovering
parasites (Supplementary Figure 4.8C). This result could reflect the essentiality
of the gene being targeted or could be due to difficulty in accessing this region of
the genome. To investigate this, we attempted to modify the PMV2 locus to
append an HA epitope tag to the C-terminus of the gene but leave the gene
otherwise intact. PMV2-HA parasites were recovered, and integration PCR
confirmed proper modification of the locus (Figure 4.5C). The localization of the
PMV2-HA protein was established across a time course of the infection by IFA.
We found PMV2 absent from sporozoites but expressed in intracellular parasites
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at 12h, 24h, 36h, and 48h post infection (Figure 4.5E, Supplemental Figure 4.8
D-G). Super resolution microscopy revealed prominent puncta of PMV2-HA
protein in proximity to the parasite nuclei (Figure 4.5F). This pattern differed
slightly between stages of different size and age suggesting localization to an
organelle that develops over the intracellular growth phase. The fact that we
were able to engineer the PMV2 locus with an HA tag but failed to target the
gene for knock out suggests that PMV2 is essential for parasite growth.

The rapamycin inducible Di-Cre system allows for conditional knockdown
of PMV2 (cgd1_3690).
Adaptation of conditional knockdown systems for use in Cryptosporidium
has afforded an alternative approach to investigate the role PMV2 may play in
protein export (Choudhary et al., 2020; Tandel, in prep 2021). We next
engineered transgenic parasites for use of the rapamycin inducible DiCre system
to conditionally knockdown expression of PMV2 (Figure 4.6A). PMV2
(cgd1_3690) is a 792 amino acid protein with a C-terminal transmembrane
domain. We introduced loxP sites flanking the C-terminal transmembrane domain
of PMV2, such that administration of rapamycin would result in recombination at
the loxP sites and subsequent removal of the transmembrane domain to alter
protein localization and potentially activity (Figure 4.6B, C). HCT8 cells were
infected with PMV2-flox parasites in the presence and absence of rapamycin;
genomic DNA was extracted from infected cultures every 12 hours, and PCR
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was carried out using the isolated gDNA. Addition of rapamycin resulted in a shift
in fragment size from 554 bp (-Rap) to 207 bp (+Rap), indicating excision of the
DNA fragment encoding the transmembrane domain between the loxP sites
(Figure 4.6C). We next wanted to observe changes in protein localization and
expression as a consequence of rapamycin treatment. Coverslips prepared with
HCT8 cells were infected with PMV2-flox parasites and stained for IFA. 24 hours
post infection, PMV2-HA was visualized in the parasite (red) in the absence of
rapamycin; however, at the same time point, administration of rapamycin to the
culture ablated PMV2-HA expression (Figure 4.6D). Quantification of PMV2-HA
protein expression by IFA revealed rapamycin treatment of cultures significantly
reduced HA expressing parasites from 83.5% of parasites to 24.5% at 12 hours
and 90.9% of parasites to 5.23% at 24 hours (12h: n = 56 untreated, n = 50
treated; 24h: n = 194 untreated, n = 149 treated; mean% HA expression; p <
0.0001; unpaired t test with Welch’s correction). From this we conclude that
rapamycin-induced disruption of the transmembrane domain altered protein
localization as desired. We next wanted to measure the impact of PMV2
mislocalization on parasite growth across a 72-hour in vitro infection. HCT8 cells
were infected with PMV2-flox parasites in the presence and absence of
rapamycin, and nanoluciferase activity was determined every 12 hours as a
measure of parasite growth. Excision of the transmembrane domain of PMV2
reduced parasite growth at all timepoints in vitro (Figure 4.6F). Taken together,
we conclude PMV2 is a gene critical for survival of the parasite both in vitro and
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in vivo and that the transmembrane domain of this protein is critical for its
function. The subcellular localization of the protein provides clues about potential
functions and highlights the importance of further studies to assess its
involvement in protein export. The PMV2 staining pattern changed size across
the parasite lifecycle, suggesting localization within an organelle that develops
across the intracellular growth phase. The proximity of this staining pattern to the
parasite nucleus is consistent with localization within the parasite secretory
pathway; however future experiments are required to confirm this hypothesis.
The overall proposed mechanism for Cryptosporidium protein export is depicted
in Figure 4.7.
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Figure 4.1. Ordered reporters disrupt MEDLE2 export.
(A) Schematic map of the MEDLE2 locus targeted for insertion of three different
reporter genes (mScarlet, Beta-lactamase, or Cre recombinase), nanoluciferase
(Nluc), and the selection marker (Neo). The guide RNA and flanking sequences
used here were the same as those employed to generate MEDLE2-HA
transgenic parasites (see Figure 2-figure supplement 1, Figure 4-figure
supplement 1 for more detail).
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(B) MEDLE2-mScarlet parasites were used to infect HCT8 cells and fixed for IFA
across a time course. Data shown are from 10h post-infection, which is
representative of the MEDLE2 localization observed at all time points. Red,
Medle2-mScarlet; green, parasites (VVL); blue, Hoechst.
(C) HCT8 cells were infected with MEDLE2-BLA C. parvum for 24h before
incubation with the CCF4-AM Beta-lactamase substrate and visualization by live
microscopy. This experiment was repeated 3 times. Red, parasites (tdTomato);
green, uncleaved CC4F-AM; blue, cleaved CCF4-AM; grey, DIC. We attribute
lack of CCF4-AM cleavage to failure of MEDLE2-BLA to export (Figure 4-figure
supplement 1).
(D) MEDLE2-Cre parasites were used to infect loxGFP/RFP color switch HCT8
cells (Figure4-figure supplement 2) for schematic representation). After 48h, cells
were subjected to flow cytometry. Live, single cells were gated based upon
forward and side scatter, and green fluorescence (GFP) and red fluorescence
(RFP) were measured to detect Cre recombinase activity. Despite robust
infection, MEDLE2-Cre infected cultures did not express RFP (Figure 4-figure
supplement 2), compared to the positive control which was transiently
transfected to express Cre recombinase.
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Figure 4.2. Blockade of export reduces translocation of additional effectors.
(A) Schematic representation of the construct for engineering dominant negative
strain to assess modulation of export impacts translocation of other effectors.
The MEDLE2 locus was targeted for insertion of a murine DHFR gene (mDHFR)
and a myc tag on the C-terminus of the gene. The nanoluciferase reporter (Nluc)
and Neomycin (Neo) selection markers were also inserted, along with an extra
copy of recodonized MEDLE2 (recodMEDLE2) appended to an HA tag, being
driven by the tryptophan B synthase (trp) promoter. The guide RNA and flanking
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sequences used here were the same as those employed to generate MEDLE2HA transgenic parasites (see Figure 3.1B, Supplementary Figure 3.4 for more
detail).
(B) PCR mapping of the MEDLE2 locus using genomic DNA from wild type (WT)
and transgenic (dominant negative) sporozoites, corresponding primer pairs are
shown in B, and thymidine kinase (TK) gene used as a control. The 5’ – Nluc
fragment (1676 bp) and the Neo – 3’ fragment (1480 bp) demonstrate proper
integration. Note the presence of a persisting unmodified copy (677 bp),
supporting multiple copies of MEDLE2 in the C. parvum genome.
(C) HCT8 cells were infected with the dominant negative C. parvum strain for 10h
before fixation, IFA and visualization by super resolution microscopy. Export of
endogenous MEDLE2 is ablated with the addition of the mDHFR-myc tag. Red,
MEDLE2-mDHFR-myc; blue, Hoechst. Note, the addition of a C-terminal myc tag
alone does not impact MEDLE2 export (See supplementary Figure 4.4 for more
detail).
(D) The dominant negative strain was used to infect HCT8 cells for 24 hours
before IFA and confocal microscopy. Blockade of export with the mDHFR tag
results in variable levels of export of recodMEDLE2 in infected cells, representing
translocation status for additional effectors Red, MEDLE2-mDHFR-myc; green,
RecodMEDLE2-HA; blue, Hoechst (D). The varied level of recodMEDLE2-HA
export is attributed to mDHFR blockade of export, as the trpBMEDLE2 control
strain exports MEDLE2-myc and RecodMEDLE2-HA at similar levels (See
supplementary Figure 4.4 for more detail).
(E) HCT8 cells were infected with trpBMEDLE2 and dominant negative parasite
lines for 24h before IFA and visualization by microscopy to capture images for
quantification of mean fluorescence intensity of RecodMEDLE2-HA (green). The
mDHFR tag in the dominant negative strain significantly reduces the mean
fluorescence intensity of RecodMEDLE2-HA exported to the host cell (n = 18
trpBMEDLE2, n = 22 dominant negative; p = 0.02; unpaired t test with Welch’s
correction).
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Figure 4.3. MEDLE2 contains a host targeting motif that is processed
during export.
(A) Map showing the strategy used to engineer an ectopic copy of MEDLE2-HA
in the thymidine kinase (TK) locus. Expression of an ectopic copy of MEDLE2-HA
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was driven the MEDLE2 promoter. All point mutations were confirmed by Sanger
sequencing (Supplemental Figure 4.5).
(B) Schematic representation of the MEDLE2 mutants generated using the
strategy outlined in A. The signal peptide (SP) is represented by dark blue and
low complexity regions are shown in light blue. Candidate motifs targeted for
mutagenesis are indicated with black triangles and mutagenized amino acids are
shown in red for two representative mutants.
(C-D) Mutant parasites were used to infect HCT8 cells and fixed for IFA after
24h. For mutants shown in (C) the entire candidate motif was replaced with a
matching number of alanine residues (ex: KDVSLI/6A à AAAAAA). For mutants
shown in (D) each individual amino acid in the KDVSLI sequence was changed
to alanine. Red, HA tagged protein; green, parasites (VVL); blue, Hoechst. We
note that signal peptide and leucine 35 within the KDVSLI sequence are required
for MEDLE2 export.
(E-F) 5 x 106 transgenic oocysts were used to infect HCT8 cells for 48h before
preparation of whole cell lysates. Proteins were separated by for SDS PAGE and
analyzed by Western Blot. The resulting blots for infections with whole motif
mutants (E) and individual amino acid point mutants (F) are shown. Red,
Neomycin; green, HA. Note that when mutants are expressed in mammalian
cells and not C. parvum the resulting proteins do not show any size differences
(Supplemental Figure 4.6).
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Figure 4.4. Peptidomimetic compounds resembling the KDVSLI sequence
reduce MEDLE2 export
(A) Schematic representation of the KDVSLI sequence used to inform chemical
synthesis of peptidomimetic compounds. The arrow represents a putative
proteolytic processing site following the leucine residue (L). The positioning of
each residue with respect to the cleavage site (P1) is represented numerically,
counting up from this site both N-terminally (P2, P3, P4) and C terminally (P’1).
(B) The chemical structure of the WEHI1002 peptidomimetic compound is
shown. While the chemical structure of the backbone is conserved, the individual
residues mimicked by each compound vary. See Supplementary Table 4.1 for
complete details on structure and specificity for each compound.
(C) MEDLE2-HA parasites were used to infect HCT8 cells in the presence of the
peptidomimetic compounds and fixed for IFA 10 hours post infection. Treatment
results in variable MEDLE2 export compared to the DMSO control. Treatment
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with 1002, 720 and 661 leads to accumulation of MEDLE2 in puncta in the
parasite. Red, HA tagged protein.
(D-E) A Quantification of the average fluorescence intensity of MEDLE2 in the
host cell cytoplasm of infected cells (n = 170, 186, 180, 117, 180, 173, 164, 126,
150 for DMSO, 842, 91, 1002, 407, 720, 660, 661, 662 respectively) for 96 fields
of view determined using MetaMorph are shown. Data are represented as the %
fluorescence intensity compared to the DMSO control. The dotted line at 100%
represents the expectation for the DMSO control. Treatment with 1002 reduces
the host cytoplasmic MEDLE2 by 23% (D). The average fluorescence intensity of
accumulated MEDLE2 in the parasite was quantified and used to calculate a ratio
(average fluorescence intensity accumulated MEDLE2: average fluorescence
intensity host cytoplasmic MEDLE2). The data are shown in relationship to the
DMSO control, represented with the dotted line at 1.36. 1002 results in a 1.97
ratio of accumulated MEDLE2: host cytoplasmic MEDLE2 (E).
(F) 5 x 106 transgenic oocysts were excysted in the presence of drug and used to
infect HCT8 cells for 10h before preparation of whole cell lysates. Proteins were
separated by for SDS PAGE and analyzed by Western Blot. The resulting blots
for the infections are shown. Red, Neomycin; green, HA. Despite partial blockade
of MEDLE2 export, there is no detectable change in protein size for 1002. DMSO
is the vehicle control and compounds 91 and 586 were used as controls for no
impact on export.
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Figure 4.5. C. parvum aspartyl protease homologs emerge as candidate
enzymes for processing the KDVSLI sequence of MEDLE2.
(A) The strategy for targeting each of the putative C. parvum aspartyl protease
homologs for knockout is shown. The arrow indicates the Cas9 cut site targeted
in the middle of each gene. Homology directed repair replaces the entire locus
with the Nanoluciferase (Nluc) and Neomycin (Neo) selection marker.
(B) C. parvum infection was monitored by relative luminescence of fecal samples
collected over the time course of infection. Parasites with PMV1 and PMV3
knocked out were successfully recovered and verified by integration PCR (See
150

Supplemental Figure 4.8A, B). In contrast, parasites could not be recovered
when targeting PMV2 for knockout despite multiple attempts (Supplemental
Figure 4C).
(C) Schematic map depicting the construct used to engineer an HA epitope tag at
the C- terminus of the PMV2 locus. Also inserted were the Nluc reporter gene
and Neo selection marker.
(D) PCR demonstrating the successful integration of an HA epitope tag in the
PMV2 locus using WT and PMV2-HA gDNA isolated from sporozoites.
Corresponding primer pairs are shown in Figure 4.5C. The TK gene was used as
a control.
(E-F) PMV2-HA transgenic parasites were used to infect HCT8 cells over a time
course of infection before fixation and preparation for immunofluorescence
assay, and visualization by microscopy. PMV2-HA localizes within the parasite
and this staining pattern changes across the lifecycle of the parasite (E,
Supplemental Figure 4.8 F, G). PMV2-HA, red; VVL, green; Hoechst, blue. Super
resolution microscopy reveals punctate staining of PMV2-HA around the parasite
nuclei 36 hours post infection (F).
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Figure 4.6. The Rapamycin inducible Di-Cre system allows for conditional
knockdown of PMV1 (cgd1_3690).
(A) Schematic model depicting the Rapamycin inducible Di-Cre system adapted
for use in Cryptosporidium. Cre recombinase is split into inactive polypeptides
fused to the FRB and FKBP rapamycin binding domains, which dimerize and
become active following the addition of Rapamycin. The active Cre recombinase
recognizes loxP sites that have been engineered to flank a portion of the gene of
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interest (GOI) desired for knockdown, resulting in excision of the DNA sequence
between the loxP sites.
(B) PCR mapping of the PMV2 locus engineered for conditional knockdown with
the Rapamycin inducible DiCre system using genomic DNA isolated from WT
and PMV2 flox sporozoites. The TK gene is used as a control. Note the absence
of the 5’ – 3’ fragment in the PMV2-flox due to the size of the transgenic
construct (expected size is 4944 bp for transgene and 686 bp for WT). The
absence of the 686 bp WT fragment for the PMV2-flox parasites, together with
proper integration at the 5’ – Nluc (610 bp) and Neo – 3’ (1121 bp) indicates
PMV2-flox were engineered as desired.
(C) Depiction of the conditional knockdown strategy engineered in the PMV2
locus. The C-terminal transmembrane domain (tm) of PMV2 was modified to
encode an HA epitope tag, with loxP sites flanking the tm, and an intron between
the two. Furthermore, the FRB and FKBP domains of Di-Cre separated by a T2A
peptide were inserted under control of the α-tubulin promoter (tub). The Nluc
reporter gene and Neo selection marker were also integrated within the locus.
Before addition of Rapamycin (-Rap), PCR primers spanning the transmembrane
and recognizing the tub promoter result in a 554 bp fragment. Following addition
of rapamycin (+Rap), the same primer pair results in a 207 bp fragment, due to
the fragment of DNA lost following recombination at the loxP sites.
(D) PMV2-flox parasites were used to infect HCT8 cells across the 72-hour life
cycle afforded by in vitro growth. Genomic DNA was extracted every 12 hours
from cells infected in the presence (+Rap) and absence (-Rap) of Rapamycin
treatment for PCR using the primer pairs shown in Figure 4.6C. Addition of 100
nM rapamycin to cultures during infection resulted in an increase in the 207 bp
fragment across the infection, indicating excision of the DNA fragment between
the loxP sites.
(E) HCT8 cells were infected with PMV2-flox parasites and grown in the
presence (+Rap) or absence of Rapamycin (-Rap) for 12h or 24h before fixation
and preparation for IFA. Rapamycin treatment significantly reduced PMV2-HA
protein expression when comparing Rap treated (black) and untreated cells
(gray), (12h: n = 56 untreated, n = 50 treated; 24h: n = 194 untreated, n = 149
treated; mean% HA expression; p < 0.0001; unpaired t test with Welch’s
correction). Shown is a representative image of PMV2-HA knockdown at 24
hours post infection; PMV2-HA, red; VVL, green, Hoechst, Blue.
(F) Induction of PMV2 knockdown with rapamycin treatment (black) reduced the
growth of PMV2-flox parasites at all timepoints of in vitro growth compared to the
untreated control (gray), as determined by nanoluciferase assay performed on
the infected cell cultures. The data shown are representative of 3 biological
replicates.
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Figure 4.7. Proposed model of the export mechanism of MEDLE2 in C.
parvum.
MEDLE2 is translated following the establishment of infection. The N terminal
signal peptide directs insertion of the protein into the canonical secretory
pathway of the parasite following its initial translation. MEDLE2 is processed at
L35 (red arrow) in the KDVSLI sequence during passage through the secretory
pathway. Putative aspartyl protease homologs (green; cgd4_2190, cgd1_3690,
or cgd1_2240) may perform this processing event; however, the involvement and
localization of any of these enzymes remains to be confirmed. We propose the
aspartyl protease involved in processing exported proteins localizes within the
secretory pathway of the parasite. The newly generated N terminus of MEDLE2
following proteolytic processing is likely post-translationally modified to further
inform proper trafficking and localization. Vesicular trafficking delivers MEDLE2
to the parasite surface, where it is released into the PV. A predicted export
machine (purple) is hypothesized to translocate MEDLE2 across the PV to the
host cell, but the localization of the translocon, as well as the molecular
components of the machine remain to be determined. We hypothesize a
repurposed family of SbmA/BacA-like amino acid transporters (cgd5_3590,
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cgd5_3590, cgd7_1380, or cgd7_1390) may function in this role based upon
temporal expression profiles of these genes in relationship to MEDLE2 export
kinetics. Nonetheless, the Cryptosporidium genome encodes an expanded
number of putative amino acid transporters, and a number of other gene
candidates may also perform this function.
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Supplemental Table 4.1. BLASTp searches identify three putative C.
parvum aspartyl proteases with similarity to the Plasmepsin V
(P.falciparum) and ASP5 (T. gondii) enzymes known to process proteins for
export.
C. parvum
putative aspartyl
proteases
cgd1_2240

Plasmepsin V BLASTp Pvalue

Asp5 BLASTp P-value

1.00E-33

4.00E-40

cgd1_3690

3.00E-29

7.00E-33

cgd3_2190
cgd4_2190
cgd6_3820
cgd6_660

N/A
5.00E-27
1.00E-03
4.80E+00

N/A
4.00E-40
5.00E-04
N/A
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Supplemental Table 4.2. Chemical structures and the substrate identities
for the peptidomimetic compounds synthesized to resemble the KDVSLI
sequence present in MEDLE2.

FORMATTED_ID

P4

P3

P2

P1 P'1

N-terminal
acetyl group

S

F

C-terminal
hydrophobic
group

N-terminal
hydrophobic
group

S

F

C-terminal
hydrophobic
group

I

S

F

C-terminal
hydrophobic
group

N-terminal
hydrophobic
group

S

L

C-terminal
hydrophobic
group

V

S

L

C-terminal
hydrophobic
group

WEHI-16209 91

WEHI-1621002

WEHI-1621407

N-terminal
acetyl group

WEHI-1653720

WEHI-1655660

N-terminal
hydrophobic
group
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FORMATTED_ID

P4

P3

P2

P1 P'1

N-terminal
hydrophobic
group

V

S

L*

N-terminal
hydrophobic
group

K

D

V

WEHI-1655661

C-terminal
hydrophobic
group

*Less active stereoisomer
WEHI-1655662
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C-terminal
hydrophobic
group

-

Supplementary Figure 4.1. MEDLE2-BLA is not exported.
(A) Schematic representation of the strategy used to generate a MEDLE2mScarlet parasite line, in which the MEDLE2 is C terminally tagged with the
fluorescent protein mScarlet, as well as engineered to express a nanoluciferase
reporter gene (Nluc) and the neomycin phosphotransferase (Neo) selection
marker. The solid black guide hit sequence is the same as used in Figure 1B to
generate the MEDLE2-HA transgenic parasites. Integration PCR using MEDLE2mScarlet and WT gDNA confirms proper integration.
(B) The C terminus of MEDLE2 was targeted for insertion of a construct encoding
Beta-lactamase (BLA), a nanoluciferase reporter gene (Nluc) and the neomycin
phosphotransferase (Neo) selection marker fused to a 2A peptide and a
tdTomato reporter gene, using the same tagging strategy previously utilized for
this locus. Integration PCR mapping the MEDLE2 locus using genomic DNA from
wild type (WT) and transgenic (MEDLE2-BLA) sporozoites with the
corresponding primer pairs shown in A and the Thymidine kinase (TK) gene as a
control shows the locus was successfully modified.
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(C) MEDLE2-BLA transgenic parasites were used to infect HCT8 cells and fixed
at 24h for IFA. Red, parasites (tdtomato); green, Beta-lactamse (Beta-lactamase
antibody); blue, Hoechst.
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Supplementary Figure 4.2. MEDLE2-Cre parasites infect loxGFP/RFP color
switch cells.
(A) MEDLE2-Cre expressing parasites were generated by targeting the MEDLE2
locus for insertion of a construct encoding Cre recombinase (Cre), a
nanoluciferase reporter gene (Nluc) and the neomycin phosphotransferase (Neo)
selection marker. The solid black arrow indicates the guide hit sequence, which
is the same guide used in Figure 1B to generate the MEDLE2-HA transgenic
parasites.
(B) Integration PCR mapping the MEDLE2 locus using genomic DNA from wild
type (WT) and transgenic (MEDLE2-Cre) sporozoites using the primer pairs
shown in A and the Thymidine kinase (TK) gene as a control.
(C) Schematic of the LoxGFP/RFP color switch HCT8. Introduction of Cre into
these cells induces a color switch from green to red by recombinase directed
removal of the GFP coding sequence along with a stop codon preventing
translation of RFP.
(D) 1 x 106 transgenic MEDLE2-Cre oocyts were used to infect LoxGFP/RFP
color switch HCT8 cells for 48h before preparation of the sample for flow
cytometry. 400,000 cells were removed from the sample preparation for
nanoluciferase assay to determine infection in the culture. Mean nanoluciferase
(relative luminescence) ± SEM is shown for three replicates
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(p < 0.0001; one-way ANOVA with Dunnett’s Multiple Comparison test).
Uninfected cells were used as a negative control and Cre recombinase
transfected cells were used as a positive control.
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Supplementary figure 4.3. A recodonized copy of MEDLE2 driven by the
trpB promoter (trpBMEDLE2) exports to the host cell.
(A) Schematic representation of the strategy used to generate the trpBMEDLE2
control parasite line. MEDLE2 is C-terminally tagged with a myc tag, as well as
engineered to encode a second, Recodonized copy of MEDLE2 (recodMEDLE2)
appended to an HA tag, with expression being driven by the tryptophan B
synthase (trpB) promoter. The repair construct also encodes a nanoluciferase
reporter gene (Nluc) and the neomycin phosphotransferase (Neo) selection
marker. The small black arrow indicates the guide hit sequence, which is the
same as used in Figure 3.1B to generate the MEDLE2-HA transgenic parasites.
(B) Integration PCR using trpBMEDLE2 and WT gDNA confirms proper
integration. 5’ – Nluc (1115 bp) and Neo – 3’ (1490 bp).
(C) trpBMEDLE2 transgenic parasites were used to infect HCT8 cells and fixed
at 24h for IFA. Both endogenous MEDLE2-myc (red) and the extra copy of
Recodonized MEDLE2-HA driven by the trpB promoter (green) localize to the
host cell cytoplasm. Nuclei can be seen in blue.
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Supplementary Figure 4.4. Protein export is dispensable for parasite
growth in vitro and in immunocompromised mice
(A-B) 10,000 TrpBMEDLE2 (control) and dominant negative oocysts were used
to infect HCT8 cells. Nanoluciferase assay was performed on cell lysates every
12 hours as a measurement of in vitro parasite growth. While the dominant
negative strain (gray) showed slightly less growth than the TrpBMEDLE2 control
strain (black) at all timepoints, this difference was not statistically significant (A).
The area under the curve for the nanoluciferase readings reveals the same
finding (B).
(C) Schematic representation of the qPCR assay developed to assess parasite
fitness in an in vivo competition assay. 8-week-old Ifng-/- mice were infected with
3,500 trpBMEDLE2 parasites and 3,500 dominant negative parasites. Feces
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were collected from the infected mice every other day for the duration of the 14day infection. Genomic DNA was extracted from the fecal samples for qPCR
analysis.
(D) Nanoluciferase assay was used to determine the relative luminescence of
fecal material collected during the in vivo competition assay between the
TrpBMEDLE2 and dominant negative strains. The infection exhibits typical
kinetics and peaks around days 8-10 before resolution of infection in an IFN
gamma dependent mechanism.
(E-F) Genomic DNA was extracted from fecal samples collected during the in
vivo infection and used for quantitative PCR to determine allele frequencies of
the Thymidine kinase (TK) gene, a control allele (E) and the mDHFR gene (F).
Cryptosporidium beta-actin was used as a normalization control. The allele
frequency of TK gene increases during infection, while the allele frequency of
mDHFR decreases in the population over the course of the infection.
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Supplementary Figure 4.5. Sanger sequencing confirming the generation of
MEDLE2 mutants.
100,000 sporozoites were used from each mutant strain for genomic DNA
extraction. The resulting gDNA was used for PCR mapping of the TK locus to
verify the desired mutagenesis. 5’ TK – Nluc PCR products were used for
TopoTA cloning and the resulting colonies were grown, and Sanger sequenced.
3 colonies were sequenced for each strain using the M13 forward, M13 reverse,
and an internal MEDLE2-specific primer to confirm targeted mutagenesis. An
alignment of the Sanger sequencing result (transgene) to the reference
sequence is shown. The black box highlights the mutation engineered in each
strain.
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Supplementary Figure 4.6. MEDLE2 mutants are of the same size as WT
MEDLE2 when expressed in HEK293T cells.
Plasmids encoding human codon optimized MEDLE2 with the N terminal signal
peptide removed (aa 2-20) (WT) or encoding the desired point mutations
(denoted residues were replaced with alanines) were transfected into HEK293T
cells. After 24h, whole cell lysates were prepared, and proteins separated by for
SDS PAGE for Western Blot analysis. MEDLE2 mutants were indistinguishable
in size from WT MEDLE2. Red, Neomycin; green, HA.
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Supplementary Figure 4.7. Insertion of an internal myc tag immediately
following the KDVSLI sequence disrupts MEDLE2 to the host cell.
(A) Schematic map of the Thymidine kinase (TK) locus targeted for insertion of
an extra copy of MEDLE2 with internal myc tags to make 3 different reporter lines
to assess functional cleavage of the KDVSLI sequence. MEDLE2 was expressed
as an extra copy under control of its own promoter and with a C terminal-HA
epitope tag appended. An internal myc tag was placed immediately preceding
K31 of the KDVSLI sequence (int N term myc), following I36 of the KDVSLI
sequence (int C term myc) or 10 amino acids downstream of the KDVSLI
sequence after G46 (10aa int C term myc). In addition, each construct also
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expressed the nanoluciferase (Nluc) reporter gene and the selection marker
(Neo). This is the same strategy was used to express extra copies of MEDLE2
for the mutagenesis studies in Figure 4.3.
(B) Int C term myc parasites were generated and used to infect HCT8 cells for
24h before fixation for IFA and visualization by microscopy. Introduction of the
myc tag following I36 prevented MEDLE2 export to the host cell. The internal
myc tag (red) and the HA tag on the C terminus of MEDLE2 (green) localize in
puncta within the parasite.
(C) HCT8 cells were infected with 10 aa int C term myc C. parvum for 24h before
fixation and IFA. Both the internal myc tag (red) and the C terminal HA tag
(green) localize to the host cell cytoplasm.
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Supplementary Figure 4.8. PMV2 (cgd1_3690) is an essential gene of
Cryptosporidium parvum.
(A-B) PCR mapping of the PMV1 (cgd4_2190) and PMV3 (cgd1_2240) loci
demonstrate knockout of the intended genes. Genomic DNA was isolated from
oocysts from the transgenic PMV1 or PMV3 parasites or wild type (WT) control.
Primer pairs indicate 5’ – Nluc (NR), full gene (5’ – 3’), or Neo NF) – 3’.
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(C-D) The relative luminescence of fecal material collected from attempts to
generate PMV2 (cgd1_3690) KO parasites. Shown are independent experiments
representing knockouts attempted with 2 different guide RNA (C). In total, 4
attempts with 3 different guide RNA sequences were unsuccessful in targeting
PMV2 for knockout. In contrast, engineering a C-terminal HA epitope tag on
PMV2 resulted in detectable fecal nanoluciferase activity (D).
(E) IFA of WT and PMV2-HA sporozoites fixed on Poly-L-Lysine treated
coverslips. We note that PMV2-HA is not observed in sporozoites. Red, PMV2HA; green, sporozoite antigen Cp23; blue, Hoechst.
(F) 100,000 PMV2-HA transgenic parasites were used to infect HCT8 cells and
fixed at 12-hour intervals across a time course of infection. Data shown are
representative images from triplicate coverslips processed for IFA. Red, HA
tagged protein; green, parasites (VVL); blue, Hoechst.
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Supplementary Figure 4.9. A schematic representation of the predicted
localization of putative export machines in Cryptosporidium.
Exported proteins (yellow) of Cryptosporidium are delivered to the PV (gray),
where they must then traverse across the PVM to reach a final destination within
the infected host cell. C. parvum infects in a unique intracellular, but
extracytoplasmic localization separated from the host cell cytoplasm by a dense
band of actin under the site of infection. There are two models for how
cytoplasmic-localized proteins may be delivered to the host cell. In Model 1, the
proposed export machine is spatially restricted to the host-parasite interface near
the parasite feeder organelle. Such a localization may facilitate access to the
host cytoplasmic compartment; however, it is unknown if this site provides direct
access to the host cytoplasm or how proteins may travel through the dense band
of actin. For Model 2, the proposed export machine may localize ubiquitously
around the PV. Exported proteins delivered according to this model would then
be restricted to the apical side of the cell and then diffuse down into the host
cytoplasm bypassing the confines of the dense band of actin. With this model it
again is unknown if the dense band of actin provides a barrier to protein transport
or if it is permeable to parasite proteins. The localization of MEDLE2 when export
is disrupted by the addition of ordered reporters suggests a PV localization;
however, until molecular components of the machine are identified, it remains to
be determined which model explains Cryptosporidium protein export.
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Discussion 4.4
Delivery of effector proteins to the host cell equips pathogens with tools to
rewire immune signaling and to manipulate biological processes to promote their
own survival. In an arms race with the host, pathogenesis factors provide a
selective advantage for survival. In addition to effectors, pathogens also evolved
strategies for delivery of these proteins to the host cell. Large repertoires of
exported effectors have been identified for bacterial, viral and parasite pathogens
alike, but the mechanisms by which these proteins are targeted to the host cell
vary. Bacterial pathogenesis factors are injected into the host cell through
elaborate secretion apparatuses often originally derived from bacterial flagella
and pili (Green and Mecsas, 2016). The signal sequences directing secretion,
number of steps involved in the secretion process and the particular structural
requirements allowing cargo proteins to pass through secretion apparatuses vary
by secretion system type (Green and Mecsas, 2016). Similarly, the protozoan
parasites P. falciparum and T. gondii have evolved specialized export machines
to deliver an expanded collection of host-targeted proteins to modify the cell and
support their metabolic needs (Beck and Ho, 2021; de Koning-Ward et al., 2009;
Franco et al., 2016; Hakimi et al., 2017). In both parasite species export requires
trafficking of effector proteins through the secretory pathway to reach the host
parasite-interface where export machines are localized (Marino et al., 2018;
Wickham et al., 2001). Threading of effector proteins through translocon export
machines has specific folding requirements, relying on the intrinsic disorder of
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the exported substrates for the T. gondii GRA proteins or the activity of the
HSP101 chaperone component of the P. falciparum PTEX machine (Hakimi et
al., 2017; Ho et al., 2018a; Matthews et al., 2019a) .
Identification of MEDLE2 as the first host-targeted protein of
Cryptosporidium introduced the possibility to explore the requirements for export
in this organism. Here we have established that disorder is critical for MEDLE2
export, as fusion of well folded domains potently blocked export to the host cell
cytoplasm. This observation was highly reproducible using five different ordered
reporters of varying sizes, structure and origin (mScarlet, Beta Lactamase, Cre
Recombinase, mDHFR and turboID), and is consistent with studies carried out in
other apicomplexans where the introduction of ordered reporters ablated protein
export (Gehde et al., 2009; Marino et al., 2018). Furthermore, this suggests
Cryptosporidium has an export mechanism that is unable to unfold proteins as
proposed for T. gondii and Plasmodium liver stages (Beck and Ho, 2021; Gehde
et al., 2009; Marino et al., 2018). Instead, the parasite likely relies upon the
disordered nature of the effector proteins themselves to allow passage through a
putative export machine. As a result, intrinsic disorder may be used as a defining
characteristic to predict export status of additional Cryptosporidium effector
proteins.
Fusion of the well folded murine DHFR (mDHFR) domain to the GRA16
protein of T. gondii prevented proper host targeting and significantly reduced
export of additional effector proteins (GRA24), thereby uncovering the translocon
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function of the MYR complex (Marino et al., 2018). Similarly, appending the
mDHFR domain to MEDLE2 prevented its export and reduced the translocation
of an additional differentially tagged copy of MEDLE2, representative of the
export status of other effector proteins. These findings suggest the presence of
an export machine to accomplish trafficking of Cryptosporidium exported proteins
beyond the parasite and into the host cell. C. parvum drastically remodels the
host enterocyte during infection to establish a unique intracellular, but
extracytoplasmic localization that is separated from remainder of the host cell by
a complex structure of membranes and proteins. The unique intracellular
environment poses the question as to how exported proteins gain access to the
host cell cytoplasm. It is unclear where the putative export machine is localized
but we envision two alternative models. The first proposes that the localization of
the translocon is polarized and restricted beneath the site of infection at the hostparasite interface, a structure known as the feeder organelle (Supplementary
Figure 4.9). It is hypothesized that the parasite gains access to host nutrients
through the feeder organelle, but it is undetermined whether the parasite has
direct access to the host cell cytoplasm or faces a portioning host membrane
(Guérin and Striepen, 2020; Perkins et al., 1999). Nonetheless, this site provides
an already established contact point between the host and parasite that can be
repurposed for the delivery of effector proteins. Alternatively, the export machine
may localize uniformly around the PV, allowing proteins that are exported into the
host cell to be translocated into the space adjacent to the PV, and then diffuse
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down to fill the host cell cytosol (Supplementary Figure 4.9). This would be
similar to the localization of the PTEX and MYR complexes of Plasmodium and
T. gondii, respectively (Bullen et al., 2012; Ho et al., 2018a). The localization of
MEDLE2 observed when export has been ablated may suggest the latter;
however, future studies to address this question with higher subcellular resolution
are required to fully settle this question (Figure 4.1B, Supplementary Figures 4.1,
4.2).
Export of proteins in P. falciparum and T. gondii requires a host targeting
motif (Coffey et al., 2015; Hiller et al., 2004; Marti et al., 2004). While the
sequence of the motif varies between species, there is a shared requirement for
a leucine residue that has been linked to processing by an aspartyl protease to
license export (Boddey et al., 2010; Coffey et al., 2015; Hammoudi et al., 2015;
Russo et al., 2010). We demonstrate that MEDLE2 export depends on an Nterminal signal peptide and a leucine residue at position 35. Point mutation of this
residue ablates export and results in a higher apparent molecular weight of the
protein, which we interpret as a lack of processing at the mutated site. We
hypothesize that similar to the established mechanism of Plasmodium, both the
signal peptide and the host targeting sequence are processed in a single
cleavage event; however, due to technical limitations surrounding generation of
enough parasite material for MALDI-TOF mass spectrometry, we have been
unable to utilize this approach to characterize the N terminal residues following
processing.
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Attempts to generate a reporter to functionally demonstrate cleavage have
been unsuccessful to date; however, these challenges have provided critical
clues about the amino acid residues surrounding the KDVSLI sequence that may
help direct export. Integration of an extra copy of MEDLE2 containing an internal
myc tag at the N terminus between the signal peptide and K31 was ineffective
despite multiple attempts with the same gRNA targeting the TK locus used for all
the ectopic expression constructs. This suggests the spatial positioning of the
KDVSLI sequence from the signal peptide is important for proper recognition and
processing, aligning with the mechanism of export in Plasmodium where the
PEXEL motif serves as a recessed signal sequence for a single proteolytic
processing event of both host-targeting sequence and the signal peptide
(Marapana et al., 2018). Our mutational analysis in C. parvum and the inability to
introduce a myc tag N terminal of the KDVSLI sequence together suggest that
cleavage of L35 could replace the activity of signal peptidase similar to P.
falciparum.
During export of both PEXEL containing proteins and PNEPs, it has been
hypothesized that acetylation of the newly generated N terminus following
processing by Plasmepsin V contributes to proper cargo selection by the PTEX
machine for translocation to the RBC (Boddey et al., 2009; Chang et al., 2008;
Schulze et al., 2015). Introduction of an internal myc tag immediately following
I36 in the KDVSLI sequence prevented MEDLE2 export to the host cell.
However, shifting the position of the myc tag to fall after G46 restored MEDLE2
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export and host cytoplasmic localization. We interpret this to suggest that the 10
amino acids following the KDVSLI sequence may provide additional information
to aid in proper host-targeting.
The PEXEL and TEXEL host targeting motifs are processed by aspartyl
proteases. In both organisms, the responsible enzymes possess a core aspartyl
protease domain with dual catalytic triads consisting of DTG and DSG residues
and C-terminal transmembrane domains (Coffey et al., 2015; Hodder et al.,
2015). The C. parvum genome encodes six putative aspartyl proteases, three of
which share significant similarity with Plasmepsin V/ASP5. (cgd4_2190,
cgd1_3690, cgd1_2240). Of the candidates, two possess C-terminal
transmembrane domains and core aspartyl protease domains with dual catalytic
triads (cgd1_3690 and cgd4_2190); however, only cgd1_3690 has both the DTG
and DSG residues present, while the cgd4_2190 has double DTG catalytic triads.
Candidate cgd1_2240 possesses a single DSG catalytic triad and lacks the Cterminal transmembrane domain. Mutation of the aspartic acid residue to alanine
in the DSG catalytic triad of Plasmepsin V (DSG>ASG) rendered the enzyme
functionally inactive, and this mutant was unable to process PEXEL substrates
similar to a mutant in which both catalytic triads were changed (DSG>ASG and
DTG>ATG) (Sleebs et al., 2014). How the dual catalytic triads process substrates
remains unsolved, but it appears that the DSG catalytic triad is crucial for
Plasmepsin V activity. For this reason, we anticipate that a Cryptosporidium
aspartyl protease involved in export likely also possesses such a DSG triad.
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MEDLE2 export relies upon the signal peptide for insertion of the protein into the
secretory pathway of the parasite. Proteolytic processing of an N terminal host
targeting motif (KDVSLI) at L35 licenses the protein to travel beyond the parasite.
Based upon the requisite insertion of MEDLE2 in the secretory pathway of the
parasite, it is likely that the aspartyl protease involved in processing exported
proteins localizes to the ER or the Golgi. We propose that the putative translocon
in the membrane of the PV recognizes the newly generated N- terminus following
aspartyl protease processing of the KDVSLI sequence and allows for passage of
the cargo into the host cell. The intrinsic disorder of MEDLE2 is critical for the
translocation process, which we postulate to occur independently of chaperone
and ATPase involvement.
Genetic approaches revealed two of the putative Cryptosporidium aspartyl
protease candidates (cgd4_2190 and cgd1_2240) to be dispensable for parasite
survival, while cgd1_3690 was essential for parasite growth in vitro and in vivo.
Plasmepsin V and Asp5 differ in their requirement across the lifecycles of their
respective parasite species, thus indicating essentiality may not be a firm
indicator of involvement in protein export. Given the presence of multiple aspartyl
protease homologs in the Cryptosporidium genome, it is also possible that more
than one enzyme can be used to process exported proteins; however, such
redundancy was not observed in other apicomplexans thus far. Introduction of an
internal myc tag at I36 prevented MEDLE2 export to the host cell and resulted in
accumulation of the tagged protein in puncta within the parasite. Interestingly, the
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localization pattern of MEDLE2 accumulated within this mutant resembles the
localization of PMV2 with an HA tag appended at 48 hours, highlighting the
importance of further studies with this mutant. Future work is required to
determine which aspartyl protease, if any, processes MEDLE2 for export.
MEDLE2 is a highly polymorphic protein that is constitutively exported
across the Cryptosporidium lifecycle. Export of MEDLE2 to the host cell begins
following the establishment of infection, suggesting a translocation mechanism
for effector proteins that takes time to be established. Here we provide
experimental evidence in support of the existence of such a machine; however,
the molecular composition and localization of the apparatus remains to be
determined. Apart from a putative HSP101 chaperone (cgd7_2620), genome
searches do not identify C. parvum homologs for the components of the PTEX or
MYR translocons. As a result, we hypothesize Cryptosporidium has evolved a
unique taxon-specific export machine to meet the requirements of the parasite in
its unique intracellular niche. Ongoing investigations in the lab have focused on
amino acid transporters predicted to localize to the feeder organelle that may
have been repurposed to aid in protein transport across the PV (cgd7_1380,
cgd7_1390, cgd5_3580, cgd5_3590). However, the role of any of these
candidates remains to be tested.
Our efforts disrupt protein export in Cryptosporidium have resulted in an
incomplete block thus far. Physical obstruction of a putative export machine by
addition of ordered reporters to MEDLE2 reduced but did not fully ablate export
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of additional effectors. Introduction of point mutations (DSP and L35) prevented
MEDLE2 export to the host cell, but these strains were engineered with ectopic
copies expressed in the TK locus and likely have little impact on the trafficking of
additional proteins. Use of KDVSLI peptidomimetics for pharmacological
inhibition of protein export partially reduced MEDLE2 in the host cell cytoplasm,
which is consistent with the moderately reduced processing of PEXEL motif
containing substrates observed upon treatment with PEXEL motif
peptidomimetics 916 and 842 (Coffey et al., 2015; Hodder et al., 2015; Sleebs et
al., 2014). Chemical inhibition is a useful strategy to manipulate protein export for
mechanistic studies in the laboratory but likely has limited therapeutic potential
unless the impact on export can be considerably improved. Identification of the
critical molecular components of the export machine could provide a strategy to
ablate protein export and explore its consequence. The strength of this approach
is underscored by the advances that have resulted from functional MYR
translocon knockout strains in T. gondii, including functional characterization of
other exported dense granule proteins and identification of the molecular
components of the export machine (Cygan et al., 2020; Franco et al., 2016;
Marino et al., 2018; Young et al., 2019). Members of the Cryptosporidium
MEDLE protein family are exported to the host cell cytoplasm, but little else is
known about the effector repertoire of Cryptosporidium. Identification and
characterization of Cryptosporidium host-interacting proteins is important to our
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understanding of this infection and will also inform vaccine and drug development
for this important human pathogen.
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Chapter 5: Conclusion and Future Directions
5.1.1 Investigate the role additional immune cell populations play in antiCryptosporidium defense
Our experiments have demonstrated that MEDLE2 can be used to deliver
model antigens to the host cell cytoplasm (Chapter 3). Importantly, the OVA
derived SIINFEKL tag could be used to induce and study parasite-specific antiCryptosporidium CD8+ T cells and that these cells provide partial protection to
infection (Chapter 3). While these observations have provided a powerful tool to
begin to dissect host-parasite interactions, previous work has shown that CD8+ T
cells may be not the most important cell type for resolution of Cryptosporidium
infection. SCID mice reconstituted with CD8+ T cells reduced C. muris infection
length and severity, but to a much lesser extent than in mice reconstituted with
CD4+ T cells (Kváč et al., 2011). Additionally, experiments carried out with
cytolytic and neutralizing antibodies implicated CD4+ T cells and IFN γ as most
critical components needed for control of Cryptosporidium infection (Ungar et al.,
1991). Reduction in either CD4s or IFNγ alone limits the magnitude (IFN γ) or the
length (CD4+) of the infection (Ungar et al., 1991). This presents an interesting
paradigm given the fact that Cryptosporidium is an intracellular pathogen and
suggests that the cytotoxic effect of CD8+ T cells is not the primary mechanism of
clearance.
Because CD4+ T cells are likely of great importance to the resolution of
Cryptosporidium infection, a similar approach using MEDLE2 to deliver CD4
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model antigens to the host cell would greatly advance our understanding of this
critical cell subset role in the anti-Cryptosporidium immune response. Canonically
CD4+ T cells recognize peptides presented by MHC II molecules of antigen
presenting cells and subsequently help to initiate an adaptive immune response.
IFNγ produced by CD4+ T cells helps to recruit CD8+ T cells to mucosal sites
during challenge infection with influenza and Leishmania major infections
(Laidlaw et al., 2016). The lymphocytic choriomeningitis virus (LCMV) gp61-80
peptide and 2W1S, a variant of peptide 55–68 of the alpha chain of the mouse
MHC class II molecule, are model antigens applicable for the study of CD4+ T
cells (De Boer et al., 2003; Moon et al., 2011). Engineering transgenic C. parvum
parasite lines with MEDLE2 epitope tagged with the gp61 or 2W1S peptides will
provide tools to be used within this context to study Cryptosporidium-specific
CD4+ T cells for the first time. Transfer of gp61-specific SMARTA CD4+ T cells to
Ifng-/- KO mice prior to challenge with MEDLE2- gp61 parasites could provide
important insights into the contribution of CD4+ T cells to immune mediated
resolution and protection of cryptosporidiosis. The response to 2W1S relies on
the natural high frequency of responsive CD4+ T cells in BL6 mice. While a
specific T cell clone is not available for this particular antigen a response can
nonetheless be detected.
Alternatively, in lieu of making multiple transgenic parasite strains in which
MEDLE2 is tagged with model antigens, a MHCII tetramer could be generated
that recognizes MEDLE2. This approach would require screening MEDLE2
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peptide sequences to determine which the MHC complex binds with the greatest
affinity; however, the resulting tool could then be used to characterize the antiCryptosporidium CD4+ T cell response without requiring additional cell lines or
resources. Currently there is no vaccine for the prevention of Cryptosporidium
infection. This is partly due to a lack of understanding of the critical hostpathogen interactions governing the progression and resolution of infection. The
future experiments proposed here will provide a basic understanding of how the
T cell repertoire combats Cryptosporidium infection and inform about specific cell
types that must be stimulated by vaccination strategies.

5.1.2 Characterize how protein localization impacts antigen presentation
The development of Cryptosporidium-specific tools to probe hostpathogen interactions also affords the opportunity to explore antigen
presentation, which was previously hindered by a lack of pathogen specific
reagents. Introduction of exogenous model antigens has been useful in
characterizing the immune responses to several different pathogens, including T.
gondii, T. cruzi, Salmonella enterica serovar Typhimurium, and Listeria (Garg et
al., 1997; Pepper et al., 2004; Pope et al., 2001; Yrlid et al., 2001). MEDLE2model antigen expressing parasite strains now permit similar studies to be
conducted with Cryptosporidium. Introduction of the exogenous antigen tags in
the MEDLE2 locus will allow for constitutive expression and export to the host
cell across the life cycle of the parasite (Chapter 3). Our previous findings
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underscore the importance of the signal peptide and L35 amino acid in directing
translocation of MEDLE2 to the host cell, as mutagenesis of either of these
motifs ablated export (Chapter 4). These observations can be used to design
future experiments to dissect the importance of host compartmentalization in
induction of an anti-Cryptosporidium immune response. Transgenic parasite
strains in which the signal peptide is removed from an extra copy of MEDLE2
(ex: DSP MEDLE2-OVA, DSP-gp61, DSP-2W1S) will be generated to represent
conditions in which export does not occur. This approach allows the same protein
to be utilized for model antigen expression, thereby controlling for variation in
quantity or temporal expression across the parasite lifecycle that would be
introduced if using different proteins to deliver tags to cellular compartments.
Currently it is unknown where the DSP and L35A mutant MEDLE2-HA
proteins localize within the parasite; however, future immuno-EM studies
performed on these strains will provide insight into their subcellular localizations
within the parasite. Based upon our observations from IFA of these parasite
strains, we hypothesize that the protein localization patterns for the DSP and L35
mutants will be different within the parasite (Chapter 4). We hypothesize the DSP
mutant likely localizes to the parasite cytoplasm, as removal of the canonical
signal peptide would prevent insertion into the secretory pathway. Because the
MEDLE2 protein from the L35A exhibited the largest molecular weight by
Western Blot, we predict that the localization of the L35A mutant is within the
secretory pathway, as the N terminal signal peptide is still present but is not
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processed (Chapter 4). Once distinct localization patterns are confirmed, DSP
and L35 mutant parasite strains tagged with model antigens will be engineered to
direct presentation of antigens in the parasite cytosol and sequestered within the
secretory system. Immuno-electron microscopy on mutant strains in which
MEDLE2 fails to export (ex: MEDLE2-mScarlet or MEDLE2-mDHFR) may
provide alternative compartments that may be included in the same studies, such
as the PV.
C. parvum infection is restricted to the apical pole of epithelial cells, where
it exhibits an intracellular but extracytoplasmic localization separated from the
rest of the cell by multiple structures (Elliott and Clark, 2000; Elliott et al., 2001).
This localization prompts questions about the accessibility of parasite proteins to
antigen presentation by professional APCs which localize in the basal lamina
propria (Belkaid and Hand, 2014). APCs from the lamina propria may sample the
epithelial cell compartment or the epithelial cells (IECs) themselves may present
antigen in the context of Cryptosporidium infection. These questions may be
addressed using the Cre-Lox system to drive genetic ablation of MHC function in
specific cell types, in particular enterocytes and various professional APCs to
assess the impact T-cell response and parasite burden.
MEDLE2 localization in the host cytoplasm may be most favorable for
antigen presentation due to its proximity to APCs of the lamina propria and/or
antigen processing machinery of the host cell. For this reason, I hypothesize that
exported MEDLE2 will induce the greatest immune responses and that MEDLE2
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targeted to various other compartments will still be detected, but to a lesser
extent than exported MEDLE2. This hypothesis is rooted in the idea that
localization inside the PVM and parasite plasma membranes prevents detection
for the 11.5 hours the parasite resides within the infected cell. The PV is not an
immunoprivileged site and upon egress from the infected cell, these sequestered
antigens are then exposed. These experiments will advance our understanding
of how antigen presentation occurs to again inform about specific cell types that
must be stimulated for future vaccination efforts.

5.2 Explore the functional consequences of the unfolded protein response
(UPR) during Cryptosporidium infection
Pathways involved in ER stress are common targets for manipulation by
intracellular bacterial, viral, and protozoan pathogens to modulate host cell
survival and inflammatory responses (Abhishek et al., 2018; Alshareef et al.,
2021; Perera et al., 2017). The relationship between pathogens and ER stress is
complex and depending on cellular context, this response can promote pathogen
survival or contribute to its restriction (Alshareef et al., 2021). Introduction of
MEDLE2 to cells during infection or by transient transfection induced an ER
stress response in the host cell (Chapter 3). RNA sequencing and subsequent
qPCR validation identified ER stress response genes upregulated following
infection; however, it remains to be determined whether this response is a
byproduct of host detection of the disordered MEDLE2 protein in a novel
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environment, or if it is an active process purposefully triggered to promote
parasite survival.
We first attempted to address this question through exploring the role
DDIT3 plays during infection, as it was shown to be the most upregulated ER
stress gene emerging from the RNA sequencing analysis (Chapter 3). DDIT3 KO
mice infected with C. parvum exhibited a significantly reduced infection burden
when compared with C57BL/6J controls in a pilot experiment (n = 4; p < 0.001;
unpaired t test with Welch’s correction), suggesting a potential phenotype.
However, this experiment has not yet been repeated to demonstrate the
robustness of this finding. Additional evidence for the ER stress response
benefitting Cryptosporidium survival may be gathered utilizing intestinal epithelial
cell specific knockouts of ER stress response signaling pathways to dissect
which branches specifically are involved in the response. This may be
accomplished through crosses of Villin-Cre mice with IRE1, ATF6, and PERK flox
mice commercially available through The Jackson Laboratory. If the ER stress
response contributes to parasite survival, then knockout of at least one of the
signaling pathways will show a reduction in parasite burden similar to the DDIT3
KO mice. I hypothesize the reduction in infection of DDIT3 KO mice suggests
that the ER stress response is induced to promote Cryptosporidium survival.
Under normal conditions, the ER stress response is a host mechanism to
combat perturbations in ER homeostasis, and if left unresolved, results in cell
death to protect integrity of the cell. Pathogens utilize strategies to manipulate
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the ER stress response to overcome unique requirements encountered within
their intracellular niches. One such example includes the Brucella effector
proteins that help construct the Brucella-containing vacuole, which requires
interaction with ER exit sites for maturation, and subsequently results in ER
stress (Alshareef et al., 2021). RNAi knockdown of IRE1 reduces Brucella
replication, indicating the stress response helps promote bacterial replication
(Alshareef et al., 2021). Based upon the known consequences of the ER stress
response, I foresee two potential roles in which the ER stress response may
promote Cryptosporidium survival: (i) the ER stress response alters host
metabolism to facilitate parasite access to lipid stores to offset the streamlined
lipid synthesis of Cryptosporidium or (ii) ER stress is used to modulate cell death
pathways to benefit the parasite.
Cryptosporidium has reduced metabolic capabilities due to significant
gene loss and thus depends on a membranous feeder organelle at the hostparasite interface to scavenge nutrients and metabolites from its host. This
streamlined metabolism includes reduction in biosynthesis of many lipids
(Coppens, 2013). Studies of the UPR in neurodegenerative diseases, cancer,
and other metabolic have highlighted lipid synthesis and mobilization as an
important consequence of the UPR (Moncan et al., 2021). In addition to key
functions in protein synthesis, modification and trafficking, the ER also acts as
the main site for sterol and phospholipid synthesis, and is the residence of
numerous proteins and enzymes involved in lipid metabolism (Han and Kaufman,
190

2016). Future experiments could explore the metabolic consequences of the
MEDLE2 induced ER stress and its impact on infection. One approach to test this
hypothesis may be transient transfection of the MEDLE2-GFP and GFP control
plasmids into HCT8 cells followed by the measurement of different lipid
metabolites. A range of sensitive assays are available to detect glycerol,
triglyceride, cholesterol and cholesterol ester levels (Promega assays GlycerolGlo, Triglyceride-Glo, and Cholesterol/Cholesterol Ester-Glo) and transgenic
cells may be enriched by flow cytometry if necessary. I note that HCT8 cells are
cancer derived and may exhibit metabolic processes altered when compared to
normal tissue. It could thus be more informative to infect Ifng-/- mice with the
MEDLE2-HA-tdNeon fluorescent parasite line and isolate infected cells to
perform these studies using primary cells. Again, identification of the export
machine and isolation of “no export” parasite mutants would be most helpful to
dissect the contribution to effector proteins on this metabolic response.
Another consequence of the ER stress response that may be explored
with future experimentation is modulation of host cell death pathways and their
impact on parasite survival. Cells respond to perturbations of the ER by initiating
mechanisms aimed to overcome the perceived threat and restoring homeostasis,
but if not possible, resolve the stress by triggering apoptosis (Schönthal, 2012).
Induction of apoptotic cell death as a strategy to promote pathogen survival may
be counterintuitive, as it destroys the niche required for intracellular pathogens;
however, bacterial pathogenesis factors both induce and prevent host cell death
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depending upon the cellular context (Jorgensen et al., 2017; Weinrauch and
Zychlinsky, 1999). Induction of apoptosis is a strategy to promote pathogen
survival by eliminating of host immune cells, while the inhibition of the death of
the cells in which the pathogen resides may contribute to survival of pathogens
(Jorgensen et al., 2017). The role of apoptosis in limiting Cryptosporidium
infection remains unclear, as there are conflicting reports of apoptosis being both
inhibited and stimulated during infection (Chen et al., 1999; Chen et al., 2001; Liu
et al., 2008; McCole et al., 2000). It must be noted that many of these
experiments were preformed using in vitro culture systems that rely upon the use
of cancer cell lines, which may confound the conclusions. More recently, single
cell RNA sequencing from C. parvum infection of a homeostatic mini-intestine
revealed an apoptosis signature in both enterocytes and enteroendocrine cells
(Nikolaev et al., 2020b). Based upon our experimental observations, I
hypothesize the apoptotic signature detected within infection may be a
consequence of an unresolved ER stress response, which may serve to
disseminate the infection, similar to what has been observed for Shigella
(Weinrauch and Zychlinsky, 1999).
Testing of the hypothesis that Cryptosporidium infection impacts host cell
death pathways will require testing using in vivo or ex vivo model systems to
avoid cancer cell lines with altered cell death. To investigate the role of apoptosis
following the ER stress response during Cryptosporidium infection, MEDLE2-HAtdNeon parasites will be used to infect DDIT3 and C57BL/6J mice pretreated with
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anti- IFN-γ and Ifng-/- mice. Controls for each mouse strain will be treated with
anti- IFN-γ but remain uninfected. At the peak of infection, intestinal sections will
be removed for RNA extraction and qPCR with primer pairs specific for ER stress
genes, as well as genes involved in signaling for cell intrinsic apoptosis (Bcl-2,
Bax, Bak). Because the parasite line expresses the tdNeon fluorescent protein,
an alternative experiment could be to sort infected cells from the intestine and
perform RNA sequencing on infected and uninfected cells from the same mouse
strains mentioned above and then validate the findings by qPCR. Fluorescence
based assays to detect caspase cleavage could also be used within this context
to quantify cell death in infected cells.
The experiments proposed within this section will help to address
questions surrounding the role an ER stress response plays within
Cryptosporidium infection. Two potential hypotheses explaining why the parasite
triggers an ER stress response will be investigated to determine if this is an
active process deliberately triggered by the parasite to promote its own survival.
However, if the results of all the experiments are inconclusive, it is possible that
the ER stress response is an inadvertent consequence of the host cell detection
of the intrinsic disorder of MEDLE2. This would suggest the function of MEDLE2
during infection remains unknown and warrants future investigation.
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5.3 Ascertain whether the KDVSLI sequence is the Cryptosporidium Export
Element (CREXEL)
Apicomplexa rely upon effector proteins to manipulate the host for
promotion of their own survival and thus have evolved elaborate mechanisms to
translocate these proteins to the infected cell. Our previous experiments
established parallels between the mechanism of export of MEDLE2 by
Cryptosporidium and the better characterized mechanisms of export in P.
falciparum and T. gondii. Both of these parasites use species-specific host
targeting sequences to direct export of proteins beyond the parasite (Coffey et
al., 2015; Marti et al., 2004). For both organisms, processing of the host targeting
PEXEL and TEXEL motifs occurs following leucine residues (Coffey et al., 2015;
Marti et al., 2004). Using mutagenesis studies, we have uncovered an N terminal
KDVSLI motif in MEDLE2 that is critical for its export status (Chapter 4). Western
Blot analysis of cells infected with mutants that fail to export suggests that the
KDVSLI sequence is processed at L35 (Chapter 4).
While this correlative evidence suggests the KDVSLI sequence may
function as a Cryptosporidium Export Element (CREXEL), this requires additional
support, namely functional demonstration of proteolytic processing and validation
that the sequence is necessary and sufficient to direct export to the host cell.
BLASTp searches of the Cryptosporidium genome reveal 4 proteins containing
signal peptides and the exact KDVSLI sequence, all of which belong to the
MEDLE protein family. Two of these proteins, MEDLE1 and MEDLE6 were also
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demonstrated to be exported to the host cell (Chapter 3). Our mutagenesis
studies demonstrated that apart from L35, all the amino acids in this sequence
are dispensable. Introduction of less stringent requirements at various positions
in the KDVSLI sequence (ex: KxxSLI) resulted in varying numbers of predicted
exported proteins containing these sequences, ranging from 4 proteins for the
exact KDVSLI sequence to 379 proteins for KDxxLx. As a result, identification of
additional exported effectors outside of the MEDLE protein family may be
required to uncover amino acid sequence patterns, similar to the strategy used
for uncovering the PEXEL motif of P. falciparum (Marti et al., 2004). This may be
accomplished through introduction of HA epitope tags onto candidate proteins
selected based upon inclusion criteria established from the attributes we
identified as important for MEDLE2 export (N terminal signal peptide, intrinsic
disorder, transcript levels that peak following establishment of infection, and
leucine residue downstream of signal peptide) (Chapter 4). BLAST search tools
on CryptoDB can be used to prioritize search parameters for unfolded proteins
with signal peptides and a leucine reside. Visualization by IFA will reveal which
candidates are exported to the host cell and begin to create a list of host-targeted
proteins to give strength to the KDVSLI sequence if conserved.

5.3.1 Functionally demonstrate cleavage of the KDVSLI sequence after L35
Following identification of the RxLxE/D/Q PEXEL motif, mutagenesis
studies revealed the R and L resides were crucial for directing export of both
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soluble proteins (KAHRP, GBP130) and surface antigens (Rifin, PfEMP1) to their
proper localization (Marti et al., 2004). Removal or point mutagenesis of the
PEXEL motif at these sites resulted in accumulation of the proteins within the
parasite or PV (Marti et al., 2004). Once Plasmepsin V was identified as the
enzyme processing the PEXEL motif, in vitro cleavage assays using recombinant
protein similarly demonstrated the inability to process fluorogenic PEXEL motif
substrates with mutations at the R and L positions (Boddey et al., 2010). The
same techniques were then applied in T. gondii to identify the RRLxx TEXEL
motif to demonstrate the requirement of the RRL residues for cleavage of
substrates by Asp5 (Coffey et al., 2015). Our studies uncovered a potential host
targeting motif of Cryptosporidium, which we conclude is processed based upon
our measurements of the molecular weight by Western Blot. To bolster the claim
that this sequence is a CREXEL motif, future studies are needed to demonstrate
cleavage within this site.
One experimental method by which this could be accomplished is though
the generation of transgenic parasite strains with internal epitope tags (ex: myc)
introduced N terminal or C terminal of the KDVSLI sequence in an extra copy of
MEDLE2 that also expresses a C-terminal HA tag. A similar approach was
utilized in T. gondii to demonstrate processing of GRA16 and GRA24 by Asp5
(Curt-Varesano et al., 2016). The expectation would be that if the KDVSLI
sequence is processed at L35, the myc tag engineered C terminal of this site (ex:
after I36) would co-localize with the HA tag when visualized by IFA and Western
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Blot. In contrast, when the internal myc tag is engineered N terminal of the
KDVSLI sequence (ex: before K31), processing at L35 would remove the tag and
result in a loss of myc signal from both IFA and Western Blot. We have
successfully created transgenic parasites with an internal myc tag C terminal of
the KDVSLI sequence (10 aa int C term myc) but encountered challenges when
attempting to introduce an internal myc tag between the signal peptide and N
terminal of K31 (Chapter 4). Future efforts to develop this functional cleavage
assay rely upon introduction of the internal myc tag at the N terminus of MEDLE2
preceding the signal peptide. Processing of the signal peptide will remove the N
terminal myc tag; however, data from our Western blots suggest that processing
of the KDVSLI sequence and signal peptide occurs as a single step, similar to
what has been observed for P. falciparum (Marapana et al., 2018). Introduction
of the myc tag at this site will allow us to test this hypothesis and provide the
parasite lines required for establishment of a cleavage assay for protein export in
Cryptosporidium. Furthermore, these parasite strains will provide a convenient
assay to test chemical inhibition of export instead of relying upon complex
quantification of mean fluorescence intensity, as used for testing the
peptidomimetic compounds in Chapter 4. Finally, these experiments will satisfy
one requirement for formal establishment of the KDVSLI sequence as the
CREXEL motif.
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5.3.2 Establish the KDVSLI sequence is necessary and sufficient for export
Protein export in numerous pathogens requires signal sequences to direct
proper targeting of effector proteins to the host cell (Bhattacharjee et al., 2006;
Coffey et al., 2015; Green and Mecsas, 2016; Marti et al., 2004). These hosttargeting address sequences have been confirmed through mutagenesis studies
ablating export, as well as by gain of function studies demonstrating that host
targeting sequences can direct export of reporter proteins to the host cell
(Bhattacharjee et al., 2006; Marti et al., 2004; Pellé et al., 2015). The structure of
cargo proteins outside of the targeting motif can be of great importance and limit
the use of reporters in this context (Green and Mecsas, 2016). Specifically in
Plasmodium, the PEXEL sequence of some proteins may direct export of a GFP
reporter to the RBC, but export depends upon the distance between the motif
and the GFP tag, as well as the N terminus of the protein selected for use
(Knuepfer et al., 2005). Export of PEXEL-GFP is also life stage dependent, as
liver stage parasites have more stringent folding requirements than RBC stages
and do not tolerate ordered tags (Beck and Ho, 2021). The Cryptosporidium
exported protein MEDLE2 relies upon intrinsic disorder for translocation to the
host cell (Chapter 4). Future attempts to engineer assays to demonstrate the
KDVSLI sequence is necessary and sufficient for export must take this into
consideration.
Similar to the established reporter assays to study export in P. falciparum,
we previously attempted to generate parasites with the N terminus of MEDLE2
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encoding the signal peptide, KDVSLI sequence, and the 10 amino acids after the
KDVSLI fused to a GFP reporter; however, as expected, addition of the ordered
reporter prevented export. Future efforts to demonstrate that the KDVSLI
sequence is sufficient to direct export to the host cell relies upon generation of
additional transgenic parasite strains with other “less structured” reporters. Study
of host-targeted bacterial pathogenesis factors using Type III and Type IV
secretion systems, which also require unfolded substrates, has been enhanced
through the use of a 13-residue glycogen synthase kinase 3 beta (GSK3B) tag
(Brodsky et al., 2010; Garcia et al., 2006). Upon introduction to the cell, GSK3B
is phosphorylated by host cytoplasmic kinases, which is detectable by Western
Blot. Adaptation of this approach for use in Cryptosporidium will direct future
approaches to demonstrate the KDVSLI sequence can direct export. Transgenic
C. parvum will be engineered with the N terminus of MEDLE2 appended to
GSK3B tag driven by the MEDLE2 promoter expressed as an extra copy in the
TK locus. These parasites will then be used for Western Blot analysis to assess
export status. This experiment will require a non-export control, which, based
upon our previous findings, may be accomplished through treatment of one
infected culture with BFA to disrupt export or through generation of a DSP
MEDLE2-GSK3B strain.
Another alternative “unfolded” reporter that exists in the literature that may
be used for this purpose is a fragment from the tRNA synthetase-associated
scaffold protein p43 (dis) that was shown to permit export to the host cell nucleus
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when affixed to T.gondii GRA16 (Curt-Varesano et al., 2016). The
Cryptosporidium genome encodes a homologous sequence in cgd4_3880. I have
engineered a Cryptosporidium tagging vector to express the N terminus of
MEDLE2 with the disordered portion of this protein (p43 dis) in the TK locus with
a C terminal-HA tag; however, I have not yet had the opportunity to generate this
transgenic parasite. As a control, an ordered glutathione S-transferase (GST) like
domain from the same protein was cloned to replace p43 dis in the
Cryptosporidium expression vector, identical to the approach utilized for T. gondii
(Curt-Varesano et al., 2016). Future efforts to demonstrate the KDVSLI sequence
is necessary and sufficient to direct export may be helped if these constructs are
introduced to C. parvum and if IFA reveals export.

5.4 Identify the enzyme responsible for processing Cryptosporidium
exported proteins
BLAST searches indicated 3 putative aspartyl protease homologs with
homology to the Plasmepsin V and Asp5 enzymes known to be involved in
export. Our previous experiments have demonstrated two of these enzymes
(PMV1: cgd4_2190 and PMV3: cgd1_2240) are dispensable for parasite survival,
while the third enzyme (PMV2: cgd1_3690) is essential (Chapter 4). Because
Plasmepsin V and Asp5 differ in their requirement for parasite survival across the
lifecycles of their respective species, the essentiality of the aspartyl protease
homologs provides little clue as to which, if any, of these enzymes may be
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involved in Cryptosporidium protein export. The KO (PMV1 KO and PMV3 KO)
and conditional knockout parasites (PMV2-flox) generated in our previous
experiments can be used for future experiments to determine whether these
aspartyl protease candidates process MEDLE2 for export as tools become
available to engineer more complex mutants that target multiple independent loci.
Recent work in our lab has identified the mode of action for the bicyclic
azetadine BRD7929, a lead compound with potent anti-Cryptosporidial activity
(Vinayak et al., 2020). Introduction of mutations in the phenylalanyl-tRNA
synthetase conferred resistance to BRD7929, highlighting its potential use as a
second drug resistance marker for genetic modification of Cryptosporidium. This
allows for the possibility of genetic crosses between parasites with differing drug
resistance markers to select for progeny with two genetic changes. The PMV1
KO, PMV2-flox, and PMV3 KO parasites all express the neomycin drug
resistance marker and can be used in crossing experiments with a MEDLE2-myc
parasite line that is generated with BRD7929 resistance to determine how loss of
expression of these enzymes impacts MEDLE2 localization. IFA of the parasites
surviving selection following this cross will then be used to characterize how
aspartyl protease knockout or knockdown impacts MEDLE2 export to the host
cell in vitro as well as in vivo.
If any aspartyl proteases are involved in processing MEDLE2 for export,
their role can be confirmed with in vitro KDVSLI fluorogenic substrate cleavage
assays utilizing recombinant proteins, as was performed for Plasmepsin V and
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Asp5 (Boddey et al., 2010; Coffey et al., 2015). Insect cells were used to produce
functional Plasmepsin V and Asp5 enzymes, which were then incubated with
commercially synthesized peptides containing the PEXEL and TEXEL motifs
flanked by fluorogenic peptides (Boddey et al., 2010; Coffey et al., 2015). An
intact peptide quenches the fluorescence of the reporter, but upon cleavage of
the PEXEL and TEXEL motifs, inhibition is removed, and fluorescence is
measurable using a plate reader. Similar approaches could be used to generate
recombinant enzymes for the Cryptosporidium aspartyl protease candidates
(Boddey et al., 2010; Coffey et al., 2015). As another application of this assay,
the KDVSLI peptidomimetic compounds synthesized for our previous
experiments could be tested for impact on fluorogenic substrate cleavage within
this in vitro system. The results of studies using PEXEL motif peptidomimetic
compounds to assess substrate cleavage by Plasmepsin V indicated dramatic
differences in IC50 concentrations when used on recombinant proteins in vitro
and when used on parasites in culture (Hodder et al., 2015; Sleebs et al., 2014).
The partially reduced export of MEDLE2 when treated with the KDVSLI
peptidomimetics may be explained by limited permeability of these compounds,
which may be improved when used in vitro. Future experiments using these
compounds will also help provide additional evidence for the KDVSLI sequence
being a CREXEL motif.
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5.5 Utilize proteomics-based approaches to identify additional effectors in
the Cryptosporidium exported repertoire
Risk of infection and disease severity from Cryptosporidium infection
decreases with age during childhood, suggesting immunity that requires multiple
infections to develop (Chappell et al., 1999; Kabir et al., 2021; Kotloff et al., 2013;
Okhuysen et al., 1998). As a result, vaccine development to prevent
Cryptosporidium infection is a worthwhile endeavor but requires a more refined
understanding of both the host and parasite factors involved in this response. I
have described future experiments utilizing model antigens made possible by
identification of a host-targeted protein to profile the cell mediated antiCryptosporidium immune response. I have also described experiments to identify
additional exported proteins through engineering HA epitope tags on candidate
proteins chosen for genetic modification based upon shared features with
MEDLE2; however, this approach is targeted in nature and requires investigation
of candidate proteins individually. A high throughput screening approach, such as
utilizing proteomics-based methods, may be more appropriate to identify a larger
number of candidate host-interacting proteins that are prime targets for vaccine
development. One powerful proteomics-based approach that has been adapted
for use within multiple parasite systems to help advance protein-protein
interaction studies is proximity labeling by BioID (Cygan et al., 2019; Morriswood
et al., 2013; Nadipuram et al., 2020; Nessel et al., 2020). Identification of the
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enzyme processing proteins for export could afford the opportunity to use this
enzyme as bait to discover exported parasite proteins in an unbiased screen.
Generation of a transgenic parasite line in which a rapidly labeling
promiscuous biotin ligase (TurboID) is tagged onto the aspartyl protease involved
in export could make this possible. Based upon the topology of Plasmepsin V
and Asp5 in the ER and Golgi membranes respectively, I hypothesize that the
Cryptosporidium aspartyl protease homolog will localize similarly, with the Cterminal transmembrane anchoring the protein in the membrane, and the Nterminal domain with the catalytic DSG/DTG triad positioned within the lumen of
the organelle (Russo et al., 2010). As a result, to identify exported effectors
interacting with the enzyme, the TurboID tag must be engineered on the Nterminus of the enzyme. While N-terminal tagging is technically challenging, it is
not impossible, given that the 3 putative aspartyl protease homologs do not
contain signal peptides. Such a strategy will require design of gRNAs targeting
the N-terminus of the gene without disrupting the endogenous promoter or
targeting the intergenic region and driving expression of the TurboID-tagged
gene with an alternate promoter that is identical in temporal expression and
strength. Subsequent treatment of cultures with biotin during infection, pulldown
with streptavidin beads, and mass spectrometry analysis will uncover C. parvum
proteins interacting with the tagged enzyme within the intracellular compartment
in which it resides. The interactome can also be aligned to reveal any conserved
amino acid motifs, thereby providing an additional tool to help uncover the
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CREXEL motif. The host-targeted localization of identified candidate proteins will
then need to be validated by generation of transgenic parasites with HA epitope
tags for IFA.
Discovery of a larger repertoire of exported proteins will identify additional
antigens likely encountered by the host immune system, and these candidates
may be exploited in future vaccine development efforts. Our previous work has
uncovered MEDLE2 as a candidate antigen that may be utilized for this purpose.
However, MEDLE2 is a multicopy gene that belongs to an expanded family of
proteins with similar sequence, reminiscent of the VSG and var genes that
participate in antigenic variation strategies in other parasites. Such variation may
limit their value for vaccination. Transcriptomic data indicate MEDLE2 is the most
highly expressed member of the MEDLE gene family and that expression of the
other MEDLE genes varies across infection. Currently there is no evidence that
would support antigenic variation among the members of this gene family but
further experimentation directly testing this assertion is required before such a
conclusion may be drawn (Fei et al., 2018; Li et al., 2017; Su et al., 2019). Due to
the potential for variation, the multiple copies that exist, and the timing of MEDL2
expression, I would at this point be hesitant to design a vaccination strategy
relying solely on MEDLE2 as the target antigen. Instead, I hypothesize a better
suited approach would be to target interactions occurring during the
establishment of infection or those involving proteins that do not belong to
expanded gene families of homologous proteins as MEDLE2 does. Alternatively,
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another suggested approach would be to target a mix of proteins involved in
host-parasite interactions required across the lifecycle to reduce pressure
towards the development of resistance. In either case, a more complete
understanding of the host-interacting parasite proteins is required for selection of
candidate antigens for vaccine development and the previously described
experiments will help provide this information.

5.6 Characterize the molecular machinery that comprises the
Cryptosporidium Translocon of Exported Proteins (CTEX)
Our previous work has indicated the addition of ordered domains to
MEDLE2 disrupts trafficking to the host cell of not only MEDLE2, but also
additional effector proteins (Chapter 4). We conclude this indicates the presence
of an export machine to facilitate trafficking of MEDLE2 across multiple
membranes to the host cell cytoplasm, similar to the mechanisms of export of
other Apicomplexa. However, the molecular components of this machine and its
proposed localization remain unknown. The PTEX machine of P. falciparum was
identified using a combination of predictive criteria for selection of candidate
genes and proteomics based approaches for confirmation (de Koning-Ward et
al., 2009). In contrast, the T. gondii MYR complex was discovered with a loss of
function screen relying upon detection of host c-Myc induction as a readout for
effector secretion (Franco et al., 2016). Similar approaches may be adapted for
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future use in Cryptosporidium to identify the molecular machinery functioning to
translocate exported proteins.
The Cryptosporidium genome encodes few homologs of established
bacterial and apicomplexan secretion systems, with the only shared component
being HSP101 of the PTEX machine (Pellé et al., 2015). Data from our previous
experiments indicate the intrinsic disorder of MEDLE2 helps contribute to its
export status and suggests an unfoldase component may not be required as a
component of the export machine (Chapter 4). Nonetheless, the involvement of
the HSP101 homolog of Cryptosporidium (cgd7_2620) may be investigated by
generating a transgenic parasite strain in which the gene is targeted for knockout
and an extra copy of MEDLE2-HA is inserted into the locus to assess export in
the absence of the gene. This experimental approach assumes the HSP101
component is not an essential gene and that a reduction in export will be
quantifiable, which may or may not be the case. Additional candidate genes for
involvement in protein translocation may be established and explored similar to
the approach utilized for Plasmodium (de Koning-Ward et al., 2009). Criteria to
identify candidate genes of the CTEX machinery would include genes that (i) are
unique to Cryptosporidium and are not conserved across Apicomplexa, (ii) have
expression patterns consistent with the expression of MEDLE2, (iii) specifically
bind to exported protein cargo containing a CREXEL motif (once verified).
Involvement of candidate genes must then be assessed individually through
disruption of the gene with CRISPR/Cas9 approaches by introduction of an
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ectopic copy of MEDLE2 and assessing its translocation. Such an approach is
labor intensive and is limited to investigation of non-essential genes. As a result,
non-targeted, screening-based approaches may be better suited to
simultaneously explore a larger number of candidate genes. We have discovered
that introduction of MEDLE2 to host cells results in the induction of an ER stress
response (Chapter 3). Analogous to the screening approach used to identify the
MYR complex, a loss of function screen could be designed to search for loss of
an ER stress response in infected cells; however, this approach is met with
technical limitations for the tools currently available within the Cryptosporidium
field. This approach requires a Cryptosporidium whole genome mutant library,
which does not exist yet. Furthermore, there is no method to clone individual
parasite mutants from the population of parasites that exist following propagation
through a single host. Future developments in the Cryptosporidium field that
promote generation of mutant libraries (ie. Cre recombinase expressing parasite
strains) or allow for serial dilution and cloning of individual parasites (ie.
continuous culture in vitro) will permit such an approach to be adapted for use to
uncover the export machine. However, until then, we are limited to approaches
utilizing existing tools.
Promiscuous biotin ligases are powerful tools to identify protein-protein
interactions within specific compartments. To date, adaptation of the BioID (BirA)
and APEX2 approaches within P. falciparum and T. gondii have helped identify
proteins localizing to specific cellular compartments during these infections
208

(Birnbaum et al., 2020; Kehrer et al., 2020; Nadipuram et al., 2020). Genetic
modification of parasites in which TurboID, an enzymatically faster BirA mutant,
is appended to MEDLE2 will allow for identification interacting partners of
MEDLE2 during translocation to the host cell. A MEDLE2-TurboID parasite strain
was engineered; however, IFA revealed that introduction of the enzyme tag
prevented export to the host cell. While this is not ideal, depending upon the
cellular compartment in which MEDLE2 is trapped, this may still allow for
identification of interacting proteins that are a part of the secretory pathway or the
export machine. To explore this, cultures will be infected with the MEDLE2TurboID parasites and treated with biotin. Cells will then be lysed, and the
resulting biotinylated proteins will be immunoprecipitated with streptavidin beads
for mass spectrometry analysis. This method has been successful in identifying
protein-protein interactions within Plasmodium; however, this parasite infects the
RBC which is devoid of cellular organelles containing biotinylated host proteins.
Mammalian cells contain 4 naturally biotinylated proteins, which may contribute
to host background (Niers et al., 2011). Three of these proteins localize within the
mitochondria (Niers et al., 2011). If Cryptosporidium proteins are not detected by
mass spectrometry due to host background, then the host mitochondria will be
removed from the sample by commercially available mitochondria isolation kits
and the subsequent fraction will be immunoprecipitated as previously described.
Future experiments utilizing these approaches will help enhance our
understanding of the molecular components of the Cryptosporidium export
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machine. Genetic and pharmacological inhibition approaches have been
unsuccessful in complete ablation of export. Identification of the export machine
and subsequent genetic manipulation of its components may provide the first
condition in which export is fully removed to allow for phenotypic explorations of
how loss of export impacts parasite fitness.

210

Concluding Remarks
Cryptosporidium is a global cause of morbidity and mortality from diarrheal
disease. The development of novel technologies for both the treatment and
prevention of disease requires a more complete understanding of parasite
biology and the required interactions between the host and parasite for the
establishment and maintenance of infection. The work described in the preceding
chapters explores host-parasite interactions through the identification of proteins
exported to the host cell utilizing recently available genetic tools. Our work details
the first host-targeted effector protein of C. parvum and reveals the presence of a
secretion apparatus to deliver parasite proteins to the host cell to modulate this
novel environment. The findings of this work have provided a foundation of
research from which to build tools to study host-pathogen interactions and
reveals novel strategies for perturbation of protein export. Future experiments
applying these tools will enhance our understanding of host-Cryptosporidium
interactions and will direct efforts in identification of new drug and vaccine targets
utilized for prevention of this pathogen of high medical and veterinary
importance.
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Appendix 1: Primer Sequences Used for this Study
Name

Primer Sequence

g5_4590 F

gttgaggattatccggttcaagta

g5_4590 R

aaactacttgaaccggataatcct

5_4590 Lic
repair F

aaaaagaaaaagagaagagggggaaaagatgatcttagaggactattaagaggattatccggttcaagtaaagacatactacacgacttagagaaaa
ttggaagtggaggacgggaattc

5_4590 Lic
repair R

taattatcttgttaataacacatttgaatagtttatacttcacataaccaaattaagataaaaagaaaaacttaatcgatactatcctacacg

g4_4470 F
g4_4470 R
4_4470 Lic
repair F2

gttgatgaacttcttggaatacgt
aaacacgtattccaagaagttcat

4_4470 Lic
repair F

aaaattttaagaaacaatttaatcagtgtcttcaagctaaagaaggatataatgaacttcttggaatacgtagaaacacggacatccagg
agaagagtttgaagaagtcaacc
ggagaagagtttgaagaagtcaaccgcccaggaacggatcaacttgaacttaaagtacccgttcttgaacttgttcaaaattggaagtgg
aggacgggaattc

4_4470 Lic
repiar R

aagaaaaatattaacttgaacagttcaagtaaattttgattaaatttctgaattaagataaaaagaaaaacttaatcgatactatcctacacg

g5_3570 F

gttgcaacataggctatttaattg

g5_3570 R

aaaccaattaaatagcctatgttg

5_3570 Lic
repair F

caacaattacctaattttttaatttagtcacaaaggtaaaatgggccaggaaaaattggaagtggaggacgggaattc

5_3570 Lic
repair R

ataattaaacctaatatggagtattttgtgaaactttgagaatattactctaattaagataaaaagaaaaacttaatcgatactatcctacacg

g1_3850 F
g1_3850 R
1_3850 Lic
repair F1

gttggttgttattccacttgtaca
aaactgtacaagtggaataacaac

1_3850 Lic
repair F2

atactcagtgcattagagctgtgtggcagcttaattcaaactttgcatgaagtcgtaatccgctcgtgcacggtaaggagttgatgtacctcaa
gttgttagagaggacg
cctcaagttgttagagaggacgttcgtcaagttcttcatcaaattcttgatcttcctccagcagaagaaggacgagaaaattggaagtggagg
acgggaattc

1_3850 Lic
repair R

cgttgcaatttaatacaaacatttgaaaaggcatatccaattatatatctaaattaagataaaaagaaaaacttaatcgatactatcctacacgc

g8_30 F

gttgaaatctctcccttctagact

g8_30 R

aaacagtctagaagggagagattt

8_30 Lic
repair F1

gctcgagagggagttgatcaagatcttcacccaccagttgatcctcctgcagaagaaaaactccaaaattggaagtggaggacgggaattc

8_30 Lic
repair F2
8_30 Lic
repair R

tcattagaaaaatgcggtaacgcgattcaaatgttgcatttagaaattgcaccgagcctggagggaagggacttttttgaggcgaaattgctc
gagagggagttgatcaag
gaaacaaatacattagaaaacaatattgtttgactcgttaaatatttctaaaaagtccctgccctccaggcttggaattaagataaaaagaaaaa
cttaatcgatactatcctacacg

g8_3560 F

gttgggattaatcacttcacattt

g8_3560 R
8_3560 Lic
repair F
8_3560 Lic
repair R

aaacaaatgtgaagtgattaatcc
ggctttacgaaaattacaaaaatatttactaatcgcaagacgaggatttctggcttgataacctcgcacttgggttcggccgaccaaaaa
attggaagtggaggacgggaattc
aagaaataaaatgtaaaatattggtcacagtacaattcatattatatgccaaattaagataaaaagaaaaacttaatcgatactatcc
tacacg
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5' 5_4590 int
F

gccagtacttaagaatgtgaatttatca

Nluc Int R

ctttggatcggagttacggacac

Neo Int F

cgtatcgaacgtgctcgta

3' 5_4590 int
R

attagtatgaagaagtctaatcacaatatttcc

TK gene F

atggcaaaattatacttttactattcagcaatgaatgc

TK gene R

ttagaaattgtattcttcacaattaattatatgatgttttctgc

5' 8_30 int F

cgatcctcagaatgaacctaatcttaa

3' 8_30 int R

ctggaatattgcatgcaagtcaaa

5' 8_3560 int
F
3' 8_3560 int
R
g2
cgd6_5490 F
g2
cgd6_5490 R

gagcaagctctcaagaagatttatcat
caagttatgcgcaaactctatttgag
gttggaagtcaaggccaagaggttc
aaacgaacctcttggccttgacttc

6_5490g2 Lic
repair F1
6_5490g2 Lic
repair F2

gatcaggtaaacatttctctgagaagatttgcggaccttgtaagaacataaacatggaggacttagagaaaattggaag
tggaggacgggaattc
gattcaggtcgaaaacgtcaacataaaagaaaagtaaggaaaaataaaaataaatctagacctaggggatcaggtaa
acatttctctgagaagatttgc

6_5490 g2
Lic Lic R

tcttggttatatcttgtttaaaaatcataaaataataatcatattaacaacacatttgagaattaagataaaaagaaaaacttaa
tcgatactatcctacacg

g2cgd5_4580
F

gttggaagttaaggccaagaagttc

g2cdg5_4580
R

aaacgaacttcttggccttaacttc

Pexel 31 g2
Lic F

tgagaataaacatgatcaagtagattcaggtcaaaaacgccgaaaaaaaaaagaaaaaaaaaaagtagagactagcaaaattg
gaagtggaggacgggaattc

Pexel 31 g2
Lic R

cttccatactcaaatttttgtattgagcatatgcctttagtgaaaagtgtctaaattaagataaaaagaaaaacttaatcgatactat
cctacacg

Medle6
integration F

agctttacgaatgaaagatccgg

Medle 6
integration R

ctcttttctcatatcgaaactaataccaca

5' 5_4580 int
F
3' 5_4580 int
R
Medle2 prom
lin F
Medle2 prom
lin R
Medle1 with
prom insert F
Medle1 with
prom insert R

gccaaatttggaaatattgagatagag
cgaataaatttccacctaacattttttttttctc
aaaattggaagtggaggacggg
aaagggaacaaaagctgggtacc
aaagggaacaaaagctgggtaccatttaagattaaataaaaatcataaaatatgtaattaatagcga
cccgtcctccacttccaattttacttgtctctactttttttttttcttttttttttc
aaagggaacaaaagctgggtacctaactaactataatttgaattaattagaataacagtaataaatagttt
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Medle2 prom
ins F
Medle2 prom
ins R

aataataataataatattattattattttgttttttataaacatccttaattattcataatgcaaaaacaaaaaattaattaaac

Medle1 HA
lin F

atgtttataaaaaacaaaataataataatattattattattattatttattaactttttatttttgtttgaaaatataaccg

gMedle2 KO

gttggccatttgatgagccattaga

gMedle2 KO

aaactctaatggctcatcaaatggc

Medle2 KO
repair F

gtttgaaaatgtaaccgataattttttgtttaaaaaagatgtttcattaaaagataggtagcggtggtcg

Medle2 KO
repair R

ttccaaatcatgaagaatatccttacttgaaccggataatcctcttaatagtaattaagataaaaagaaaaacttaatc
gatactatcctacacg

lin LIC in
eno3' UTR

caattggttcgtggcgtgtagga

lin LIC in Neo
R

gaagacgatagaaggcgatacgttga

2AtdNeon F

aacgtatcgccttctatcgtcttcttgacgaattcttcggtgagggcaggggtagattg

2AtdNeon R

tacacgccacgaaccaattgtcacttgtacagctcgtccatgc

Lin LIC F

cccgggatgcatcttcatttag

Lin LIC R

gaattcccgtcctccacttc

mScarlet F

gaagtggaggacgggaattcatggtgagcaagggcgagg

mScarlet R

tgaagatgcatcccgggttacttgtacagctcgtccatgc

BLA F

gaagtggaggacgggaattcatgagtattcaacatttccgtgtcgc

BLA R

aatgaagatgcatcccgggttaccaatgcttaatcagtgaggcacc

lin 2A R

cgggccggggttctcctcaacg

tdTomato 2a
F
tdTomato
eno3' R
Cre tagging
Gibson F
Cre tagging
Gibson R
Lin in Lic site
inker F

cgttgaggagaaccccggcccgatggtgagtaagggcgaggaag
tcctacacgccacgaaccaattgtcacttatacagctcatccatgccg
gaggacgggaattcccctaggggcgcccccaag
actaaatgaagatgcatccccgggctagacagatctaaggc
aaaattggaagtggaggacgggaattc

Lin in Lic R

ggtacccagcttttgttccctttagt

MEDLE2 with
promoter F

actaaagggaacaaaagctgggtacctaactaactataatttgaattaattagaataacagtaataaatagttttatatc

MEDLE2 with
promoter R

gaattcccgtcctccacttccaattttttccaaatcatgaagaatatccttacttgaac

TK homology
with M2 prom
repair F

tccagtactatgctatggtttgagaacagactttaagggaaatttatttgataactaactataatttgaattaattagaataacag
taataaatagttttatatc
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TK homology
with M2 prom
repair R

tagcttttttgccacagcgacaaatagttttgatttcagtaagtttatcaaattaagataaaaagaaaaacttaatcgatactatcc
tacacg

gTK int

gttggaagtaaatacttattagca

gTK int

aaactgctaataagtatttacttc

lin Extra M2
for No SP F

cccgggatgcatcttcattta

lin Extra M2
for No SP R

ccttaattattcataatgcaaaaacaaaaaattaatt

M2 No SP F

ttttgtttttgcattatgaataattaaggatggaaaatgtaaccgataattttttgtttaaaaaagatg

M2 no SP R

taaatgaagatgcatcccgggttaggcataatctggaacatcgtaagg

lin Extra M2
Mut 1 F
lin Extra M2
Mut 1 R

aaaattaggaatgaaacaccaaatg
tttaaacaaaaaattatcggttacattttc

M2 Mut 1 F

gaaaatgtaaccgataattttttgtttaaagccgctgcagctgcagct

M2 Mut 1 R
lin Extra M2
Mut 2 F
lin Extra M2
Mut 2 R

catttggtgtttcattcctaattttagctgcagctgcagcggc

M2 Mut 2 F

ggaggaggtagtggtggtaaagccgctgcagctgcagct

M2 Mut 2 R
lin Extra M2
Mut 3 F
lin Extra M2
Mut 3 R

accacctttttttgataaattcacagctgcagctgcagcggc

M2 Mut 3 F

gtggtggtaaaaagccagtacttgccgctgcagctgcagct

M2 Mut 3 R
lin Extra M2
Mut 4 F
lin Extra M2
Mut 4 R

caatttccagcaccaccttttttagctgcagctgcagcggc

M2 Mut 4 F

gaagagggggaaaagatgatcttgccgctgcagctgcagctgcagccgct

M2 Mut 4 R
lin extra copy
M2 F
lin extra copy
M2 R

ccaaatcatgaagaatatccttacttgaagcggctgcagctgcagctgcagcggc

M2 P1 F

gaaaatgtaaccgataattttttgtttaaagccgatgtttcattaata

M2 P1 R

catttggtgtttcattcctaatttttattaatgaaacatcggc

M2 P2 F

gaaaatgtaaccgataattttttgtttaaaaaagctgtttcattaata

M2 P2 R

catttggtgtttcattcctaatttttattaatgaaacagcttt

M2 P3 F

gaaaatgtaaccgataattttttgtttaaaaaagatgcatcattaata

M2 P3 R

catttggtgtttcattcctaatttttattaatgatgcatcttt

M2 P4 F

gaaaatgtaaccgataattttttgtttaaaaaagatgttgctttaata

M2 P4 R

catttggtgtttcattcctaatttttattaaagcaacatcttt

M2 P5 F

gaaaatgtaaccgataattttttgtttaaaaaagatgtttcagcaata

gtgaatttatcaaaaaaaggtggtgc
tttaccaccactacctcctcc

aaaaaaggtggtgctggaaattg
aagtactggctttttaccaccac

tcaagtaaggatattcttcatgatttggaa
aagatcatcttttccccctcttct

cccgggatgcatcttcatt
ttttattaatgaaacatcttttttaaacaaaaaattatcg

243

M2 P5 R

catttggtgtttcattcctaatttttattgctgaaacatcttt

M2 P6 F

gaaaatgtaaccgataattttttgtttaaaaaagatgtttcattagct

M2 P6 R

catttggtgtttcattcctaattttagctaatgaaacatcttt

M13 F

tgtaaaacgacggccagt

M13 R
HA seq R
primer
Medle2 entire
gene F
lin for mut 1
F
lin for mut 1
R
mut 1 trans
ins F
mut 1 trans
ins R
lin for mut 2
F
lin for mut 2
R
mut 2 trans
ins F
mut 2 trans
ins R
lin for mut 3
F
lin for mut 3
R
mut 3 trans
ins F
mut 3 trans
ins R
lin for mut 4
F
lin for mut 4
R
mut 4 trans
ins F
mut 4 trans
ins R
eGFP trans
R
eGFP trans
R
linEGFP
remove F
eGFP insert
F
eGFP insert
R

caggaaacagctatgacc

lin eGFP F2

agcggccgcgactctagatc

lin eGFP R2
Recod M2
insert F
Recod M2
insert R

ggcgctagcggatctgacg

mTRIB3 F

ctgcgtcgctttgtcttcagca

mTRIB3 R

ctgagtatctctggtcccacgt

cgtcgtacgggtacctagg
gagttacaatcttttaaggatatcttatttctacgag
aagatccgcaatgagaccc
tttaaaaaggaagttgtctgtcac
gtgacagacaacttcctttttaaagccgctgcagctgcagct
gggtctcattgcggatcttagctgcagctgcagcggc
gtgaatctgtcaaagaagggcggcgc
cttgccgccggaaccgcc
ggcggttccggcggcaaggccgctgcagctgcagct
gcgccgcccttctttgacagattcacagctgcagctgcagcggc
aagaagggcggcgcagg
cagtacaggtttcttgccgccg
cggcggcaagaaacctgtactggccgctgcagctgcagct
cctgcgccgcccttcttagctgcagctgcagcggc
agttccaaggacatacttcacgat
caagtcatccttaccccctcttc
gaagagggggtaaggatgacttggccgctgcagctgcagctgcagccgct
atcgtgaagtatgtccttggaactagcggctgcagctgcagctgcagcggc
gaagtggaggacgggaattcatggtgagcaagggcgag
ctagagtcgcggccgcttttacttgtacagctcgtccatgc
agcggccgcgactctagatc
cgtcagatccgctagcgccatggtgagcaagggcgag
gatctagagtcgcggccgctttacttgtacagctcgtccatgc

cgtcagatccgctagcgccatggagaatgtgacagacaacttcc
gaattcccgtcctccacttccaattttttcgagatcgtgaagtatgtccttg
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mCHAC1 F

tgaccctccttgaagaccgtga

mCHAC1 R

agtgtcatagccaccaagcacg

mDDIT3 F

ggaggtcctgtcctcagatgaa

mDDIT3 R

gctcctctgtcagccaagctag

mNUPR1 F

gaatatgatcagtacagcctggc

mNUPR1 R

cagagttctggaacttggtcagc

18s F

ctccaccaactaagaacggcc

18s R

tagagattggaggttgttcct

B actin F

ggctgtattcccctccatcg

B actin R

ccagttggtaacaatgccatgt
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